COVID-19 Evidence Reviews
as of 10/22/21
menu
 
 

Clinical Characteristics
 
= living review
= draft/preprint   |  
= meets mimimum quality standards   |  

A review with this mark was peer-reviewed, described systematic search and study selection, and included critical appraisal of primary studies.
latest update
date
report
select
10/14/21
Pramana Witarto A, Samarta Witarto B, Er Putra AJ, et al. | Iran Biomed J
Aim: To assess the role of serum KL-6 in reflecting the severity of lung injury in COVID-19 patients.
CLINICAL CHARACTERISTICS
10/14/21
Groff D, Sun A, Ssentongo AE, et al. | JAMA Netw Open
Aim: To estimate organ system-specific frequency and evolution of PASC.
CLINICAL CHARACTERISTICS
10/14/21
Jayant K, Reccia I, Bachul PJ, et al. | J Clin Med
Aim: To better understand the clinical course of COVID-19 in kidney transplant recipients and to identify factors associated with clinical outcomes and mortality.
RECENTLY UPDATED
CLINICAL CHARACTERISTICS
10/14/21
Harapan H, Fajar JK, Supriono S, et al.  | Rev Med Virol
Aim: To determine the prevalence, predictors and outcomes of ALI among patients with COVID-19.
CLINICAL CHARACTERISTICS
10/13/21
Hirschfeld AS | Neurol Neurochir Pol
Aim: To systematically review scientific reports presenting patients with hyperkinetic movement disorders as one of the neurological symptoms.
CLINICAL CHARACTERISTICS
10/13/21
Chong WH, Saha BK, Medarov BI | J Intensive Care Med
Aim: To compare the clinical characteristics between COVID-19 survivors and nonsurvivors requiring ECMO support.
RECENTLY UPDATED
CLINICAL CHARACTERISTICS
10/13/21
Misra S, Kolappa K, Prasad M, et al. | Neurology
Aim: To summarize the frequency of neurological manifestations reported in COVID-19 patients and investigate the association of these manifestations with disease severity and mortality.
CLINICAL CHARACTERISTICS
10/13/21
Lu H, Shi Y, Chen K, et al. | J Zhejiang Univ Sci B
Aim: To provide a comprehensive perspective into the association between anticancer regimens and the outcomes of cancer patients with COVID-19.
CLINICAL CHARACTERISTICS
10/12/21
Mirmoeeni S, Azari Jafari A, Hashemi SZ, et al. | J Cardiovasc Thorac Res
Aim: To determine the rates of CVDs in COVID-19 patients based on the incidence proportion of cardiac manifestations, laboratory findings, and related comorbidities.
CLINICAL CHARACTERISTICS
10/12/21
Jiménez-Ruiz CA, López-Padilla D, Alonso-Arroyo A, et al. | Arch Bronconeumol
Aim: To review the evidence on whether tobacco use in COVID-19 patients associated with a negative progression and adverse outcome of the disease.
CLINICAL CHARACTERISTICS
10/12/21
Agouridis AP, Pagkali A, Zintzaras E, et al. | Atheroscler Plus
Aim: To systematically address all the relevant evidence of the association between high-density lipoprotein cholesterol (HDL-C) and COVID-19 infection.
CLINICAL CHARACTERISTICS
10/12/21
Sinha A, Bhaskar SMM | Int Forum Allergy Rhinol
Aim: To estimate the prevalence of mucormycosis amongst hospitalized COVID-19, and COVID-19 among hospitalized mucormycosis patients.
CLINICAL CHARACTERISTICS
10/12/21
Mahat RK, Rathore V, Singh N, et al. | Clin Nutr ESPEN
Aim: To evaluate the association of lipid parameters (total cholesterol, HDL-cholesterol, LDL-cholesterol, and triacylglycerols) with the severity and mortality in COVID-19 patients.
RECENTLY UPDATED
CLINICAL CHARACTERISTICS
10/12/21
Sandler CX, Wyller VBB, Moss-Morris R, et al. | Open Forum Infect Dis
Aim: To review the evidence on post-COVID fatigue.
CLINICAL CHARACTERISTICS
10/12/21
Udomkarnjananun S, Kerr SJ, Townamchai N, et al.  | Sci Rep
Aim: To systematically analyze published evidence for risk factors associated with mortality in COVID-19 KTR. 
CLINICAL CHARACTERISTICS
10/12/21
Renaud-Charest O, Lui LMW, Eskander S, et al. | J Psychiatr Res
Aim: To synthesize the extant evidence reporting on the frequency and factors associated with depression in post-COVID-19 syndrome.
RECENTLY UPDATED
CLINICAL CHARACTERISTICS
10/12/21
Jain A, Taneja S | Oral Maxillofac Surg
Aim: To collate and evaluate the data to enable clinicians to understand the disease pattern and types of mycosis and provide meticulous management of these infections in COVID-19 patients.
CLINICAL CHARACTERISTICS
10/12/21
Soetedjo NNM, Iryaningrum MR, Damara FA, et al. | Clin Nutr ESPEN
Aim: To evaluate the prognostic properties of hypoalbuminemia for poor prognosis and factors that may influence the relationship.
RECENTLY UPDATED
CLINICAL CHARACTERISTICS
10/8/21
Sodeifian F, Seyedalhosseini ZS, Kian N, et al. | Front Med
Aim: To examine DILI in COVID-19 patients.
CLINICAL CHARACTERISTICS
10/6/21
Reininghaus EZ, Manchia M, Dalkner N, et al. | Eur Neuropsychopharmacol
Aim: To elucidate the risk and treatment effect of COVID-19 in BD and research on vaccinations in individuals with BD.
CLINICAL CHARACTERISTICS
10/6/21
Farooq H, Aemaz Ur Rehman M, Asmar A, et al. | J Taibah Univ Med Sci
Aim: To recognize the novel association of IgAN and IgAV with COVID-19 and describe its underlying pathogenesis.
CLINICAL CHARACTERISTICS
10/5/21
Rahman MM, Bhattacharjee B, Farhana Z, et al. | J Prev Med Hyg
Aim: To estimate the prevalence of all reported symptoms and comorbidities, and then identified the risk factors associated with age of COVID-19 infected patients.
CLINICAL CHARACTERISTICS
10/5/21
Patel S, Parikh C, Verma D, et al. | Int J Clin Pract
Aim: To provide a holistic review of our current understanding of COVID-19 induced bowel ischemia.
CLINICAL CHARACTERISTICS
10/5/21
Alimohamadi Y, Tola HH, Abbasi-Ghahramanloo A, et al. | J Prev Med Hyg
Aim: To assess the pooled CFR of COVID-19.
CLINICAL CHARACTERISTICS
10/5/21
Kan C, Zhang Y, Han F, et al. | Front Endocrinol
Aim: To assess various antidiabetic agents’ association with mortality in patients with type 2 diabetes (T2DM) who have coronavirus disease 2019 (COVID-19).
UPDATED
CLINICAL CHARACTERISTICS
10/5/21
Yin Y, Rohli KE, Shen P, et al. | Prim Care Diabetes
Aim: To summarize epidemiologic evidence of COVID-19 in patients with Type 2 diabetes, explore pathophysiological mechanisms, and integrate recommendations and guidelines for patient management.
CLINICAL CHARACTERISTICS
10/5/21
Farooq H, Aemaz Ur Rehman M, Asmar A, et al. | J Taibah Univ Med Sci
Aim: To recognize the novel association of IgAN and IgAV with COVID-19 and describe its underlying pathogenesis.
CLINICAL CHARACTERISTICS
10/4/21
Martins-Filho PR, Pereira de Andrade AL, Pereira de Andrade AJ, et al.  | J Clin Neurol
Aim: To describe the clinical features of MFS in patients with COVID-19.
CLINICAL CHARACTERISTICS
10/4/21
Wilairatana P, Masangkay FR, Kotepui KU, et al. | PLoS Negl Trop Dis
Aim: To synthesize, qualitatively and quantitatively, information on the prevalence and characteristics of malaria infection among COVID-19-infected individuals. 
UPDATED
CLINICAL CHARACTERISTICS
10/1/21
Mehraeen E, Oliaei S, SeyedAlinaghi S, et al. | Infect Disord Drug Targets
Aim: To reflect on the current knowledge and practice of COVID-19 among children.
CLINICAL CHARACTERISTICS
10/1/21
Teo KY, Invernizzi A, Staurenghi G, et al. | Am J Ophthalmol
Aim: To evaluate the occurrence of retinal micro-vasculopathy in patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and developed coronavirus disease (COVID-19).
CLINICAL CHARACTERISTICS
9/30/21
Singh P, Singh SP, Verma AK, et al. | Visc Med
Aim: To evaluate key imaging manifestations of COVID-19 on abdominal imaging.
UPDATED
CLINICAL CHARACTERISTICS
9/30/21
Shah VP, Farah WH, Hill JC, et al.  | Open Forum Infect Dis
Aim: To assess the association between CT values and clinical outcomes, including the risk of hospitalization among patients with COVID-19 and the risk of disease severity and death in such patients.
UPDATED
CLINICAL CHARACTERISTICS
9/30/21
Michelen M, Manoharan L, Elkheir N, et al. | BMJ Glob Health
Aim: To regularly synthesise evidence on long COVID characteristics, to help inform clinical management, rehabilitation strategies and interventional studies to improve long-term outcomes.
CLINICAL CHARACTERISTICS
9/30/21
Jain S, Khanna P, Sarkar S | Monaldi Arch Chest Dis
Aim: To identify the overall incidence of VAP, common organisms associated with it, and outcome in COVID-19 patients in comparison to the non-SARS-CoV-2 infected critically ill ventilated COVID-19 patients. 
CLINICAL CHARACTERISTICS
9/30/21
Attisani L, Pucci A, Luoni G, et al.  | J Cardiovasc Surg
Aim: To analyze the outcomes of acute limb ischemia (ALI) in patients suffering from the novel Coronavirus COVID-19 (Sars-Cov-2).
CLINICAL CHARACTERISTICS
9/30/21
Bissacco D, Lomazzi C, Buongiovanni G, et al. | J Cardiovasc Surg
Aim: To present evidence published on COVID-19 and aortic-related issues, highlighting some challenging aspects regarding management, treatment and outcomes.
CLINICAL CHARACTERISTICS
9/30/21
Aggarwal AN, Agarwal R, Dhooria S, et al. | Respir Care
Aim: To evaluate whether asthma increases the risk of severe disease and adverse outcomes among subjects with COVID-19.
CLINICAL CHARACTERISTICS
9/30/21
Zhou C, Zhao Y, Wang X, et al. | Pediatr Pulmonol
Aim: To characterize the laboratory parameters of MIS-C compared with those of KD and Kawasaki disease shock syndrome (KDSS).
UPDATED
CLINICAL CHARACTERISTICS
9/30/21
Maiese A, Frati P, Del Duca F, et al. | Diagnostics
Aim: To evaluate the current knowledge about postmortem cardiac findings in patients who died of COVID-19.
CLINICAL CHARACTERISTICS
9/30/21
Musa SS, Bello UM, Zhao S, et al. | Viruses
Aim: To summarize the evidence from existing systematic reviews about the effects of SARS-CoV-2 infections on maternal perinatal and neonatal outcomes.
CLINICAL CHARACTERISTICS
9/28/21
Chong WH, Saha BK, Neu KP | Infection
Aim: To assess the clinical characteristics and outcomes of patients diagnosed with CAPA compared to those without CAPA.
UPDATED
CLINICAL CHARACTERISTICS
9/28/21
Sakthiswary R, Chuah HY, Chiang KS, et al. | Lupus
Aim: To determine the predictors of severe COVID-19 infection in SLE by comparing the mild to moderate cases with the severe to critical ones.
CLINICAL CHARACTERISTICS
9/28/21
Santos RPD, Lordani TVA, Peres LAB, et al. | Nefrologia
Aim: To determine the AKI incidence in patients hospitalized with COVID-19.
CLINICAL CHARACTERISTICS
9/27/21
Siemieniuk RA, Bartoszko JJ, Díaz Martinez JP, et al. | BMJ
Aim: To evaluate the efficacy and safety of antiviral antibody therapies and blood products for the treatment of novel coronavirus disease 2019 (covid-19).
CLINICAL CHARACTERISTICS
9/27/21
Pizzol D, Shin JI, Trott M, et al.  | J Endocrinol Invest
Aim: To calculate the pooled prevalence of ED amongst healthcare workers.
CLINICAL CHARACTERISTICS
9/27/21
Fernández-de-Las-Peñas C, Navarro-Santana M, Plaza-Manzano G, et al. | Pain
Aim: To synthesize the prevalence of post-COVID pain symptoms of musculoskeletal origin in hospitalized/non-hospitalized patients recovered from SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
9/24/21
Whear R, Abbott RA, Bethel A, et al. | J Adv Nurs
Aim: To review the evidence on the provision of fundamental nursing care to hospitalized patients with a highly infectious virus and the effectiveness of adaptations to overcome barriers to care.
UPDATED
CLINICAL CHARACTERISTICS
9/24/21
Quante M, Brake L, Tolios A, et al. | Transplant Proc
Aim: To produce a current synoptic assessment of mortality and clinical outcomes subsequent to infection and COVID-19 in SOT recipients.
CLINICAL CHARACTERISTICS
9/24/21
Sengupta P, Leisegang K, Agarwal A | Arab J Urol
Aim: To provide a concise update on the effects of coronavirus disease 2019 (COVID-19) on male reproduction.
CLINICAL CHARACTERISTICS
9/23/21
Keshavarz P, Haseli S, Yazdanpanah F, et al. | Acad Radiol
Aim: To categorize and summarize the imaging data in COVID-19-induced anosmia.
CLINICAL CHARACTERISTICS
9/23/21
Patel P, DeCuir J, Abrams J, et al. | JAMA Netw Open
Aim: To summarize the descriptive epidemiology and clinical characteristics of MIS-A.
CLINICAL CHARACTERISTICS
9/23/21
Erbas GS, Botsali A, Erden N, et al. | Int J Dermatol
Aim: To review the evidence on specific manifestations of COVID-19 in the oral mucosa.
CLINICAL CHARACTERISTICS
9/23/21
Srivastava R, Parveen R, Mishra P, et al. | Int J Clin Pract
Aim: To assess the association of venous thromboembolism with severity of COVID-19 disease.
CLINICAL CHARACTERISTICS
9/22/21
Lashkari A, Ranjbar R | J Neurovirol
Aim: To review the case studies of COVID-19-related acute cerebrovascular diseases such as ischaemic stroke, intracerebral hemorrhage, and cerebral sinus thrombosis. 
CLINICAL CHARACTERISTICS
9/22/21
Sánchez-García V, Hernández-Quiles R, de-Miguel-Balsa E, et al. | J Eur Acad Dermatol Venereol
Aim: To assess the prevalence of COVID-19 (diagnosed using PCR and/or serology) in patients with CLL.
UPDATED
CLINICAL CHARACTERISTICS
9/22/21
Wiedenmann M, Goutaki M, Keiser O, et al. | Swiss Med Wkly
Aim: To review the evidence on the role of children and adolescents in the SARS-CoV-2 pandemic, specifically the severity of SARS-CoV-2 presentation, risk of SARS-CoV-2 infection and risk of transmitting SARS-CoV-2.
CLINICAL CHARACTERISTICS
9/21/21
Hossein Kazemi M, Kuhestani Dehaghi B, et al. | Iran J Med Sci
Aim: To explore the possible association of HScore parameters with severity in COVID-19 patients. 
UPDATED
CLINICAL CHARACTERISTICS
9/21/21
Geng J, Yu X, Bao H, et al. | Front Med
Aim: To determine the predictive value of chronic diseases for the severity and mortality of COVID-19.
CLINICAL CHARACTERISTICS
9/21/21
Long Q, Li J, Hu X, et al. | Front Med
Aim: To determine the adverse effects on multiple systems and differences between severe and non-severe patients in the post-acute phase.
UPDATED
CLINICAL CHARACTERISTICS
9/20/21
Diaz-Arocutipa C, Saucedo-Chinchay J, Argulian A | Clin Cardiol
Aim: To review the evidence on the prognostic utility of right ventricular dysfunction (RVD) in patients with coronavirus disease 2019 (COVID-19).
CLINICAL CHARACTERISTICS
9/20/21
Zamani R, Pouremamali R, Rezaei N | Rev Neurosci
Aim: To determine the profile and possible mechanisms behind CNS inflammatory diseases in the context of Covid-19.
CLINICAL CHARACTERISTICS
9/20/21
von Bartheld CS, Hagen MM, Butowt R | ACS Chem Neurosci
Aim: To review the evidence on the role of COVID-19 and genetics on the presentation of anosmia in COVID-19 patients.
CLINICAL CHARACTERISTICS
9/20/21
Alemzadeh E, Alemzadeh E, Ziaee M, et al. | Immun Inflamm Dis
Aim: To analyze the correlation between admission to ICU and hospital, disease severity, mortality, D-dimer count, lymphocyte count, and serum calcium levels.
CLINICAL CHARACTERISTICS
9/16/21
Ghayda RA, Lee KH, Kim JS, et al. | Int J Med Sci
Aim: To document the chest CT findings in patients with confirmed COVID-19 and their association with the clinical severity.
CLINICAL CHARACTERISTICS
9/16/21
Martins LA, Santos DVD, Marques PF, et al. | Rev Gaucha Enferm
Aim: To identify in the scientific literature the clinical overview of the pediatric population that tested positive for SARS-CoV-2 and care recommendations and recommendations among children who tested positive for SARS-CoV-2. 
CLINICAL CHARACTERISTICS
9/15/21
Mazzaccaro D, Giannetta M, Fancoli F, et al. | J Cardiovasc Surg
Aim: To review the prevalence, the risk factors and the outcomes of venous thrombosis (VT) in patients hospitalized for COronaVirus Disease 19 (COVID-19).
CLINICAL CHARACTERISTICS
9/15/21
Ming W, Zuo J, Han J, et al. | Eur Arch Otorhinolaryngol
Aim: To analyze the impact of AAD on the severity and mortality of COVID-19 patients and compare clinical outcomes between patients with and without AAD.
UPDATED
CLINICAL CHARACTERISTICS
9/14/21
Marasco G, Maida M, Morreale GC, et al. | Can J Gastroenterol Hepatol
Aim: To estimate the rate of gastrointestinal bleeding in COVID-19 patients and its association with mortality.
CLINICAL CHARACTERISTICS
9/14/21
Liu L, Ni SY, Yan W, et al. | EClinicalMedicine
Aim: To assess the overall and type-specific risk of mental and neurological disorders for COVID-19 infection and clinical outcomes. 
UPDATED
CLINICAL CHARACTERISTICS
9/14/21
Aragoneses J, Suárez A, Algar J, et al. | Front Med
Aim: To investigate the types of oral manifestations of COVID-19 and their prevalence.
CLINICAL CHARACTERISTICS
9/13/21
Becchetti C, Gschwend SG, Dufour JF, et al. | J Clin Med
Aim: To analyze and summarize the published literature concerning LT recipients with COVID-19.
CLINICAL CHARACTERISTICS
9/13/21
Prakash J, Bhattacharya PK, Yadav AK, et al. | J Crit Care
Aim: To determine the predictive accuracy of the ROX index for predicting HFNC failure in COVID-19 patients with AHRF.
UPDATED
CLINICAL CHARACTERISTICS
9/13/21
de Freitas RF, Torres SC, Martín-Sánchez FJ, et al. | Auton Neurosci
Aim: To systematically review the recent published literature that describes syncope or presyncope as a symptom of COVID-19, having it been observed in the days before or after the diagnosis.
CLINICAL CHARACTERISTICS
9/10/21
Saniasiaya J, Kulasegarah J, Narayanan P | J Laryngol Otol
Aim: To elucidate olfactory dysfunction amongst children and adolescents with coronavirus disease 2019.
CLINICAL CHARACTERISTICS
9/9/21
Zinellu A, Paliogiannis P, Fois AG, et al. | Front Public Health
Aim: To capture and interpret the available evidence regarding the relationship between COVID-19 and lipid profile.
UPDATED
CLINICAL CHARACTERISTICS
9/9/21
Corica B, Marra AM, Basili S, et al. | Sci Rep
Aim: To evaluate the prevalence of RVD and associated outcomes in patients with COVID-19
UPDATED
CLINICAL CHARACTERISTICS
9/8/21
Subramaniam A, Lim ZJ, Ponnapa Reddy M, et al. | Intern Med J
Aim: To investigate the incidence, characteristics, and outcomes of patients who were readmitted to hospital emergency departments or required re-hospitalization following an index hospitalization with a diagnosis of COVID-19.
CLINICAL CHARACTERISTICS
9/8/21
Nayeri ND, Nadali J, Divani A, et al. | J Res Med Sci
Aim: To systematically review of symptoms, laboratory and radiologic findings, treatment, and outcomes of patients with COVID-19.
CLINICAL CHARACTERISTICS
9/8/21
Shams Vahdati S, Ala A, et al. | Egypt J Neurol Psychiatr Neurosurg
Aim: To systematically review the previous systematic reviews which addressed the neurological manifestations of the COVID-19 infection.
CLINICAL CHARACTERISTICS
9/8/21
Tan X, Guo J, Chen Z, et al. | Therap Adv Gastroenterol
Aim: To report on clinical outcomes of COVID-19 patients who underwent GI endoscopy.
UPDATED
CLINICAL CHARACTERISTICS
9/8/21
Malekifar P, Pakzad R, Shahbahrami R, et al. | Biomed Res Int
Aim: To identify the viral coinfection prevalence among infected people with SARS-CoV-2.
UPDATED
CLINICAL CHARACTERISTICS
9/7/21
Sari Motlagh R, Abufaraj M, Karakiewicz PI, et al.  | World J Urol
Aim: To assess the risk of SARS-CoV-2 infection and the severity of disease in PCa patients treated with ADT. 
UPDATED
CLINICAL CHARACTERISTICS
9/7/21
Minh LHN, Abozaid AA, Ha NX, et al. | Rev Med Virol
Aim: To estimate the frequency of clinical symptoms by comparing different clinical presentations based on the severity and living status of the cases.
CLINICAL CHARACTERISTICS
9/7/21
Kim JY, Han K, Suh YJ | J Cardiovasc Magn Reson
Aim: To investigate the prevalence of abnormal CMR findings in recovered COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
9/3/21
Mutneja HR, Bhurwal A, Arora S, et al. | Scand J Gastroenterol
Aim: To evaluate whether COVID-19 affects the severity and outcomes associated with acute pancreatitis.
CLINICAL CHARACTERISTICS
9/1/21
Malik P, Patel K, Pinto C, et al. | J Med Virol
Aim: To evaluate pooled prevalence of poor quality of life in post-acute COVID-19 syndrome (PCS) and conduct meta-regression to evaluate effects of persistent symptoms and ICU admission on poor quality of life.
CLINICAL CHARACTERISTICS
8/31/21
Wang Y, Wang Y, Huo L, et al. | J Neurol
Aim: To review the evidence on the acute and post-infectious manifestations of SARS-CoV-2-associated ADEM to guide long-term management and health service reorganization.
CLINICAL CHARACTERISTICS
8/30/21
Kornitzer J, Johnson J, Yang M, et al. | Int J Environ Res Public Health
Aim: To assess the spectrum of COVID-19 presentation in children, with special emphasis on characteristics associated with multisystem inflammatory syndrome (MIS-C). 
CLINICAL CHARACTERISTICS
8/30/21
O'Loughlin L, Alvarez Toledo N, Budrie L, et al. | Neurol Int
Aim: To provide an updated review of the current published data on pediatric patients with COVID-19 and coexisting severe neurological manifestations.
CLINICAL CHARACTERISTICS
8/30/21
Manzano GS, McEntire CRS, Martinez-Lage M, et al. | Neurol Neuroimmunol Neuroinflamm
Aim: To synthesize the clinical features of ADEM and AHLE, response to treatments, and clinical outcomes to better understand the nature of this neurologic consequence of COVID-19 infection.
CLINICAL CHARACTERISTICS
8/30/21
Aram K, Patil A, Goldust M, et al. | Dermatol Ther
Aim: To evaluate presentations, post-infection change in the manifestation, diagnosis, and management of flare-ups of underlying dermatologic disease in patients with COVID-19. 
CLINICAL CHARACTERISTICS
8/30/21
Sanchez-Ramirez DC, Normand K, Zhaoyun Y, et al. | Biomedicines
Aim: To explore persistent effects of COVID-19 beyond 3 months follow-up on patient chest computed tomography (CT), lung function, respiratory symptoms, fatigue, functional capacity, quality of life, and the ability to return to work. 
UPDATED
CLINICAL CHARACTERISTICS
8/30/21
Treskova-Schwarzbach M, Haas L, Reda S, et al. | BMC Med
Aim: To summarise the evidence on age-adjusted associations between multiple pre-existing health conditions and clearly defined COVID-19 outcomes separating the effects between the geographical regions.
UPDATED
CLINICAL CHARACTERISTICS
8/30/21
Rathore SS, Hussain N, Manju AH, et al. | J Med Virol
Aim: To evaluate the correlation between COVID-19 disease and pleural effusion.
CLINICAL CHARACTERISTICS
8/30/21
Treglia G, Cuzzocrea M, Giovanella L, et al. | Pharmaceuticals
Aim: To calculate the prevalence of hypermetabolic lymph nodes after COVID-19 infection.
CLINICAL CHARACTERISTICS
8/27/21
Ousseiran ZH, Fares Y, Chamoun WT | Int J Neurosci
Aim: To study and summarize the different neurological manifestations of this virus.
CLINICAL CHARACTERISTICS
8/27/21
Sarkar S, Kannan S, Khanna P, et al  | J Med Virol
Aim: To explore the utility of PLR as a prognostic predictor of COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
8/26/21
Qian W, Ye Y, Zuo L, et al. | Immunotherapy
Aim: To quantify the effects of immune checkpoint inhibitors (ICIs) on the prognosis of COVID-19.
CLINICAL CHARACTERISTICS
8/26/21
Saniasiaya J, Prepageran N | J Laryngol Otol
Aim: To outline the impact on quality of life in coronavirus disease 2019 patients with olfactory dysfunction.
CLINICAL CHARACTERISTICS
8/26/21
Kyiakoulis KG, Kollias A, Kyrakoulis IG, et al. | Curr Vasc Pharmacol
Aim: To identify published guidance reports by national and international societies regarding thromboprophylaxis strategies in COVID-19 patients in different settings (outpatients, hospitalized, post-discharge).
CLINICAL CHARACTERISTICS
8/23/21
Sullivan BN, Fischer T | Front Aging Neurosci
Aim: To gain insight into the types of neurological complications associated with SARS-CoV-2 infection and their possible relationship with age, sex, COVID-19 severity, and comorbidities.
CLINICAL CHARACTERISTICS
8/23/21
An W, Kang J, Wang Q, et al. | J Infect Public Health
Aim: To systematically investigate the relationship between cardiac biomarkers and COVID-19 severity and mortality.
CLINICAL CHARACTERISTICS
8/23/21
Ghorbani SS, Taherpour N, Bayat S, et al. | J Med Virol
Aim: To review the evidence on the frequency and definitions of re-infection rates, recurrence, and hospital readmission following SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
8/23/21
Yan Q, Qiu D, Liu X, et al. | Front Pediatr
Aim: To examine the pooled prevalence of smell or taste dysfunctions among children with COVID-19.
CLINICAL CHARACTERISTICS
8/23/21
Bhattacharyya A, Sarma P, Sharma DJ, et al. | Indian J Pharmacol
Aim: To review the evidence on COVID-19-associated mucormycosis.
CLINICAL CHARACTERISTICS
8/23/21
Mashayekhi F, Sairafianpour F, Mohammad AP, et al. | Int J Clin Pract
Aim: To review the evidence on presentations of severe potential life-threatening skin eruptions in COVID-19.
CLINICAL CHARACTERISTICS
8/23/21
Han T, Ma S, Sun C, et al. | Arch Med Res
Aim: To further explore queries about effects of anti-diabetic agents on mortality and poor composite outcomes of COVID-19 in diabetic patients.
CLINICAL CHARACTERISTICS
8/17/21
Finsterer J, Scorza FA, Scorza C, et al. | Bosn J Basic Med Sci
Aim: To summarize and discuss the recent advances concerning the clinical presentation, pathophysiology, diagnosis, treatment, and outcomes of SARS-CoV-2 associated cranial nerve mononeuropathies or polyneuropathies. 
CLINICAL CHARACTERISTICS
8/16/21
Ismail II, Salama S | J Neurol
Aim: To investigate the available evidence regarding the different types of CNS demyelination in association with SARS-CoV-2 infection, and the proposed pathophysiological mechanisms in these cases.
CLINICAL CHARACTERISTICS
8/16/21
Sunjaya AP, Allida SM, Di Tanna GL, et al. | Eur Respir J
Aim: To review the evidence on whether people with asthma at a higher risk of being infected, hospitalised or of poorer clinical outcomes from COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
8/16/21
Karaoulanis SE, Christodoulou NG | Psychiatriki
Aim: To clarify whether patients with schizophrenia spectrum disorders are at greater risk for poor COVID-19 outcomes.
CLINICAL CHARACTERISTICS
8/16/21
Alsagaff MY, Oktaviono YH, Dharmadjati BB, et al.  | J Arrythm
Aim: To evaluate the latest evidence on the association of ECG on admission and the poor outcomes in COVID?19.
CLINICAL CHARACTERISTICS
8/16/21
Maiese A, Manetti AC, Bosetti C, et al. | Brain Pathol
Aim: To review the evidence on the neuropathological features of COVID-19.
CLINICAL CHARACTERISTICS
8/16/21
Abate V, Casoria A, Rendina D, et al. | Semin Thromb Hemost
Aim: To describe the prevalence and the clinical characteristics of SMH in COVID-19 patients.
CLINICAL CHARACTERISTICS
8/13/21
Kazemi SN, Hajikhani B, Didar H, et al. | PLoS One
Aim: To understand better the potential effects of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) on fetal loss in infected mothers presented with abortion following this infection.
CLINICAL CHARACTERISTICS
8/13/21
AbdelHamid S, Refaat AA, Benjamin AM, et al. | Environ Sci Pollut Res Int
Aim: To study the impact of host or viral epigenetic modulation on COVID-19 infection susceptibility and/or outcome.
UPDATED
CLINICAL CHARACTERISTICS
8/13/21
Llamas M, Garo ML, Giovanella L | Clin Chem Lab Med
Aim: To assess the prognostic role of fT3 serum levels in patients with COVID-19.
CLINICAL CHARACTERISTICS
8/12/21
Sah P, Fitzpatrick MC, Zimmer CF, et al. | Proc Natl Acad Sci USA
Aim: To review the evidence on laboratory-confirmed infections to estimate the percentage of SARS-CoV-2 infections that are truly asymptomatic. 
CLINICAL CHARACTERISTICS
8/12/21
Sen S, Kanna NB, Kumar J, et al. | Int Ophthalmol
Aim: To summarize all retinal manifestations secondary to COVID-19 disease recorded till date since the beginning of the pandemic.
CLINICAL CHARACTERISTICS
8/11/21
Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. | Sci Rep
Aim: To identify studies assessing long-term effects of COVID-19 and estimates the prevalence of each symptom, sign, or laboratory parameter of patients at a post-COVID-19 stage.
UPDATED
CLINICAL CHARACTERISTICS
8/10/21
Chung EY, Palmer SC, Natale P, et al. | Am J Kidney Dis
Aim: To assess the incidence and outcomes of COVID-19 in people with CKD.
CLINICAL CHARACTERISTICS
8/10/21
Yang Y, Cai Z, Zhang J | Front Endocrinol
Aim: To determine the association between insulin injection and the outcomes of COVID-19.
CLINICAL CHARACTERISTICS
8/10/21
Qian Z, Lu S, Luo X, et al. | Front Med
Aim: To summarize the current existing evidence on the outcome of critically ill patients with COVID-19 as well as to evaluate the effectiveness of clinical interventions.
CLINICAL CHARACTERISTICS
8/9/21
Athanasios A, Daley I, Patel A, et al. | Eur Neurol
Aim: To review the prevalence of cerebrovascular accident in COVID-19 patients.
CLINICAL CHARACTERISTICS
8/9/21
Alves VP, Casemiro FG, Araujo BG, et al. | Int J Environ Res Public Health
Aim: To evaluate the factors associated with mortality of elderly Brazilians and Italians diagnosed with the new coronavirus who resided in institutions or who were hospitalized as a result of the disease.
UPDATED
CLINICAL CHARACTERISTICS
8/9/21
Gómez CA, Sun CK, Tsai IT, et al. | Sci Rep
Aim: To determine, in patients with coronavirus disease 2019 (COVID-19) infection, the associations of pulmonary embolism (PE) with mortality and risk factors for PE as well as the therapeutic benefit of anticoagulant prophylaxis.
UPDATED
CLINICAL CHARACTERISTICS
8/9/21
Cabreira V, Abreu P, Soares-Dos-Reis R, et al. | Vaccines
Aim: To review the evidence on the incidence and outcomes of COVID-19 in MS patients on DMTs.
CLINICAL CHARACTERISTICS
8/9/21
Ho TC, Chang CC, Chan HP, et al. | Pathogens
Aim: To analyze the pulmonary findings of [18F]FDG PET/CT on asymptomatic COVID-19 patients.
CLINICAL CHARACTERISTICS
8/9/21
Sadiq Z, Rana S, Mahfoud Z, et al. | Clin Imaging
Aim: To determine the most common appearances of lung abnormalities in COVID-19 patients.
CLINICAL CHARACTERISTICS
8/9/21
Prada L, Santos CD, Baião RA, et al. | J Clin Pharmacol
Aim: To systematically evaluate the risk of SARS-CoV-2 infection and mortality and the risk of severe coronavirus disease 2019 (COVID-19) associated with previous exposure to NSAIDs. 
UPDATED
CLINICAL CHARACTERISTICS
8/5/21
Zhang Z, Ai G, Chen L, et al. | BMC Infect Dis
Aim: To explore the association of immunological features with COVID-19 severity.
CLINICAL CHARACTERISTICS
8/4/21
Tsheten T, Clements ACA, Gray DJ, et al. | BMC Infect Dis
Aim: To collate and synthesise current knowledge on the clinical features and outcomes of COVID-19 and dengue virus co-infection.
CLINICAL CHARACTERISTICS
8/4/21
Yadav AK, Ghosh S, Dubey S | Med J Armed Forces India
Aim: To summarize and synthesize evidence from all available case series and case reports published on re-positive COVID-19 cases.
CLINICAL CHARACTERISTICS
8/4/21
Cosentino G, Todisco M, Hota N, et al. | Eur J Neurol
Aim: To review the evidence on neuropathological findings and their clinical correlations in COVID-19.
CLINICAL CHARACTERISTICS
8/3/21
Yadav AK, Ghosh S, Dubey S | Med J Armed Forces India
Aim: To summarize and synthesize evidence from all available case series and case reports published on re-positive COVID-19 cases.
UPDATED
CLINICAL CHARACTERISTICS
8/3/21
Wang JG, Zhong ZJ, Li M, et al. | Biochem Res Int
Aim: To describe the clinical symptoms, laboratory findings, treatment, and outcomes of coronavirus disease 2019-related multisystem inflammatory syndrome in children to provide a reference for clinical practice.
CLINICAL CHARACTERISTICS
8/3/21
Taheri Soodejani M, Basti M, Tabatabaei SM, et al. | Int J Mol Epidemiol Genet
Aim: To investigate published literature about the association between measles, mumps, and rubella (MMR) vaccine and COVID-19. 
CLINICAL CHARACTERISTICS
8/3/21
Moore N, Bosco-Levy P, Thurin N, et al. | Drug Saf
Aim: To collate the evidence regarding the possible risks associated with the use of NSAIDs in COVID-19.
CLINICAL CHARACTERISTICS
8/3/21
Ferreira de Araújo JL, Menezes D, Saraiva-Duarte JM, et al. | Rev Med Virol
Aim: To review genetic association studies evaluating Covid-19 severity or susceptibility to SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
8/3/21
Wu D, Wang VY, Chen YH, et al. | Auris Nasus Larynx
Aim: To determine how initial symptoms of OGD can be used to screen patients for COVID-19 laboratory testing.
CLINICAL CHARACTERISTICS
8/2/21
Katzenschlager S, Zimmer AJ, Gottschalk C, et al. | PLoS One
Aim: To assess demographic, laboratory and clinical indicators as predictors for severe courses of COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
8/2/21
Ansari Ramandi MM, Yarmohammadi H, Beikmohammadi S, et al. | J Cardiovasc Thorac Res
Aim: To gather all possible cardiovascular manifestations of the coronavirus family in the literature. 
UPDATED
CLINICAL CHARACTERISTICS
8/2/21
SeyedAlinaghi S, Karimi A, MohsseniPour M, et al.  | Immun Inflamm Dis
Aim: To investigate the impact of COVID-19 on patients infected with HIV.
CLINICAL CHARACTERISTICS
7/29/21
Ceban F, Nogo D, Carvalho IP, et al. | JAMA Psychiatry
Aim: To assess whether preexisting mood disorders are associated with a higher risk of COVID-19 susceptibility, hospitalization, severe complications, and death.
UPDATED
CLINICAL CHARACTERISTICS
7/29/21
Zinellu A, Paliogiannis P, Carru C, et al. | Adv Med Sci
Aim: To review the evidence on the international normalized ratio (INR) in COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
7/29/21
Shenoy S | World J Crit Care Med
Aim: To identify whether quantitative SARS-CoV-2 viral load assay correlates with clinical outcome in COVID-19 infections.
CLINICAL CHARACTERISTICS
7/28/21
Zhu Y, Xing W, Wang H, et al. | Infect Dis
Aim: To analyze the differences of the baseline characteristics and therapeutic features between STEMI patients admitted before and after the start of the COVID-19 pandemic.
CLINICAL CHARACTERISTICS
7/28/21
Azab MA, Hasaneen SF, Hanifa H, et al. | Interdiscip Neurosurg
Aim: To report a case manifested as post-COVID-19 optic neuritis, in addition to make a quantitative analysis (meta-analysis) for the published similar case reports around the world.
CLINICAL CHARACTERISTICS
7/27/21
Goswami J, MacArthur TA, Sridharan M, et al. | Shock
Aim: To summarize and discuss the current literature on laboratory coagulation disruptions associated with COVID-19 and the clinical effects of thromboembolic events in COVID-19. 
CLINICAL CHARACTERISTICS
7/27/21
Szarpak L, Rafique Z, Gasecka A, et al. | Cardiol J
Aim: To establish a connection between vitamin D status and COVID-19 infection.
CLINICAL CHARACTERISTICS
7/27/21
Zhao R, Su Z, Komissarov AA, et al. | Front Immunol
Aim: To explore the relationships between the plasma D-dimer level on admission with demographics, laboratory tests, fatal cardiopulmonary function, radiology, interventions, complications, and outcomes.
CLINICAL CHARACTERISTICS
7/27/21
Shafiabadi Hassani N, Talakoob H, Karim H, et al. | J Magn Reson Imaging
Aim: To systematically review the main cardiac MRI findings in COVID-19 adult survivors.
CLINICAL CHARACTERISTICS
7/27/21
Rastogi A, Dogra H, Jude EB, et al. | Diabetes Metab Syndr
Aim: To identify the prevalence, risk factors and outcomes of lower extremity ischemic complications.
CLINICAL CHARACTERISTICS
7/27/21
Zahedi M, Yousefi M, Abounoori M, et al. | Iran J Med Sci
Aim: To establish the characteristics of liver function tests in COVID-19 patients.
CLINICAL CHARACTERISTICS
7/27/21
Zhang K, Zhang X, Ding W, et al. | Front Med
Aim: To evaluate the prognostic accuracy of the NEWS2 on predicting clinical deterioration for patients with COVID-19. 
UPDATED
CLINICAL CHARACTERISTICS
7/26/21
Karimi A, Nowroozi A, Alilou S, et al. | Urol J
Aim: To study the effect of androgen deprivation therapy (ADT) on COVID-19 in patients with prostate cancer.
UPDATED
CLINICAL CHARACTERISTICS
7/26/21
Shah K, Upadhyaya M, Kandre Y, et al. | QJM
Aim: To provide comprehensive overview of epidemiological, clinical and biomarker profile of COVID-19 infection in pediatric population.
CLINICAL CHARACTERISTICS
7/26/21
Purja S, Shin H, Lee JY, et al. | Arch Pharm Res
Aim: To examine the association between COVID-19 severity and loss of smell (LOS) in patients with COVID-19.
CLINICAL CHARACTERISTICS
7/26/21
Shah K, Varna PV, Pandya A, et al. | QJM
Aim: To study the relationship between vitamin D level, risk and severity of COVID-19 infection in pediatric population through systematic review.
CLINICAL CHARACTERISTICS
7/26/21
Conde-Agudelo A, Romero R | Am J Obstet Gynecol
Aim: To examine the relationship between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during pregnancy and the risk of preeclampsia.
UPDATED
CLINICAL CHARACTERISTICS
7/26/21
Ferro A, Kotecha S, Auzinger G, et al. | Br J Oral Maxillofac Surg
Aim: To determine the cumulative incidence of complications, mortality, time to decannulation and ventilatory weaning.
CLINICAL CHARACTERISTICS
7/26/21
Zaffanello M, Piacentini G, Nosetti L, et al. | Thromb Res
Aim: To review the literature for thrombotic complications in children with COVID-19 infection and MIS-C.
CLINICAL CHARACTERISTICS
7/23/21
Ghidini S, Gasperetti A, Winterton D, et al. | Int J Cardiovasc Imaging
Aim: To summarize current knowledge on TTE-based RV assessment in COVID-19.
CLINICAL CHARACTERISTICS
7/23/21
Moradi G, Gholami F, Rasouli MA, et al. | Med J Islam Repub Iran
Aim: To determine possible scenarios of Coronavirus 2019 (COVID-19) iceberg using published articles.
CLINICAL CHARACTERISTICS
7/22/21
McGrowder DA, Miller F, Cross MA, et al. | Diseases
Aim: To review the evidence on abnormal liver biochemistry tests in COVID-19 and the possible pathogenesis involved.
UPDATED
CLINICAL CHARACTERISTICS
7/22/21
Zhang D, Huang WJ, Lan MQ | Eur Rev Med Pharmacol Sci
Aim: To systematically review the role of SAA levels in distinguishing among patients with mild, severe, and critical COVID-19.
CLINICAL CHARACTERISTICS
7/22/21
Dioguardi M, Cazzolla AP, Arena C, et al. | Pediatr Rep
Aim: To summarize aspects of innate immunity by focusing on the role of ACE2 expression and viral infections in children in modulating the antibody response to SARS-CoV-2 infection. 
CLINICAL CHARACTERISTICS
7/22/21
Ganesh A, Reis IR, Varma M, et al. | Can J Neurol Sci
Aim: To review the evidence on the various neurological and atypical HEENT manifestations of COVID-19.
CLINICAL CHARACTERISTICS
7/22/21
Zuin M, Gentili V, Cervellati C, et al. | Infect Dis Rep
Aim: To investigate the possible difference in the SARS-CoV-2 viral load between asymptomatic and symptomatic COVID-19 patients.
CLINICAL CHARACTERISTICS
7/20/21
Gupta S, Jawanda MK, Taneja N, et al. | J Clin Neurosci
Aim: To evaluate the reported cases of COVID-19 positive patients, presented with Bell's palsy as the only major neurological manifestation, and to investigate the association of SARS-CoV2 and Bell's palsy.
CLINICAL CHARACTERISTICS
7/20/21
Kulkarni AV, Tevethia HV, Premkumar M, et al. | EClinicalMedicine
Aim: To analyse the outcomes of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in LT recipients.
CLINICAL CHARACTERISTICS
7/20/21
Vai B, Mazza MG, Delli Colli C, et al. | Lancet Psychiatry
Aim: To assess the specific risks of COVID-19-related mortality, hospitalisation, and intensive care unit (ICU) admission associated with any pre-existing mental disorder, and specific diagnostic categories of mental disorders, and exposure to psychopharmacological drug classes.
UPDATED
CLINICAL CHARACTERISTICS
7/20/21
Cirillo N | J Infect Public Health
Aim: To facilitate a timely understanding of the differences in the prevalence of gustatory disturbances (GD) in individuals infected with SARS-CoV-2.
UPDATED
CLINICAL CHARACTERISTICS
7/19/21
Andrianto, Al-Farabi MJ, Nugraha RA, et al. | Microvasc Res
Aim: To assess biomarkers of endothelial cells in patients with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
7/19/21
Rashedi S, Keykhaei M, Pazoki M, et al. | Nutr Clin Pract
Aim: To ascertain risk indicators of in-hospital mortality and severity as well as to provide a comprehensive systematic review and meta-analysis to investigate the prognostic significance of the prognostic nutrition index (PNI) as a predictor of adverse outcomes in hospitalized coronavirus disease 2019 (COVID-19) patients.
CLINICAL CHARACTERISTICS
7/19/21
Maddaloni E, D'Onofrio L, Siena A, et al. | Intern Emerg Med
Aim: To clarify the association of cardiovascular disease with Covid-19 outcomes.
CLINICAL CHARACTERISTICS
7/19/21
Kim PH, Kim M, Suh CH, et al. | Korean J Radiol
Aim: To evaluate the incidence of radiologically demonstrated neurologic complications and detailed neuroimaging findings associated with COVID-19.
CLINICAL CHARACTERISTICS
7/19/21
van Kessel SAM, Olde Hartman TC, Lucassen PLBJ, et al. | Fam Pract
Aim: To create an overview of the nature and frequency of persistent symptoms experienced by patients after mild COVID-19 infection.
CLINICAL CHARACTERISTICS
7/16/21
Iwamura APD, Tavares da Silva MR, Hümmelgen AL, et al.  | Rev Med Virol
Aim: To collate and critically appraise the literature relating to the inflammatory and immunological parameters of the SARS-CoV-2.
CLINICAL CHARACTERISTICS
7/16/21
El-Qushayri AE, Ghozy S, Reda A, et al. | Rev Med Virol
Aim: To review the impact of PD on the prognosis of Covid-19 patients.
CLINICAL CHARACTERISTICS
7/15/21
Karakike E, Giamarellos-Bourboulis EJ, Kyprianou M, et al. | Crit Care Med
Aim: To describe the prevalence of coronavirus disease 2019-related sepsis.
UPDATED
CLINICAL CHARACTERISTICS
7/15/21
Saragih ID, Advani S, Saragih IS, et al. | Geriatr Nurs
Aim: To study the impacts of frailty on COVID-19 outcomes.
UPDATED
CLINICAL CHARACTERISTICS
7/15/21
Mir A, Farmanfarma KK, Salehiniya H, et al. | Monaldi Arch Chest Dis
Aim: To investigate laboratory and demographic findings among patients with COVID-19 worldwide.
CLINICAL CHARACTERISTICS
7/15/21
de Medeiros KS, da Silva LAS, de Araujo Macedo LT, et al. | Rev Assoc Med Bras
Aim: To study the clinical features and morbidity, and mortality outcomes of COVID-19 patients with HIV/AIDS coinfection.
CLINICAL CHARACTERISTICS
7/15/21
Yetmar Z, Chesdachai S, Kashour T, et al. | Open Forum Infect Dis
Aim: To examine the association between prior statin use and outcomes of patients with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
7/14/21
Yassin A, Ghzawi A, Al-Mistarehi AH, et al. | Future Sci OA
Aim: To describe the mortality difference between acute ischemic stroke (AIS) and non-AIS groups within COVID-19 patients.
CLINICAL CHARACTERISTICS
7/13/21
Nasa P, Juneja D, Jain R, et al. | Asian Cardiovasc Thorac Ann
Aim: To analyse the types of air leaks in COVID-19 and their outcomes.
CLINICAL CHARACTERISTICS
7/13/21
Wu X, Xu Y, Jin L, et al. | Front Med
Aim: To investigate the mortality of patients with COVID-19 in relation to preexisting asthma and other allergic diseases associated with changes in respiratory function.
CLINICAL CHARACTERISTICS
7/13/21
Zinellu A, Sotgia S, Carru C, et al. | Front Cardiovasc Med
Aim: To conduct a meta-regression of studies reporting plasma BNP or NT-proBNP concentrations in COVID-19 patients with different disease severity.
CLINICAL CHARACTERISTICS
7/13/21
Dadashi M, Khaleghnejad S, Abedi Elkhichi P, et al.  | Front Med
Aim: To systematically review the literature on COVID-19 co-infections with the influenza virus (type A and/or B).
CLINICAL CHARACTERISTICS
7/13/21
Akobeng AK, Grafton-Clarke C, Abdelgadir I, et al. | Frontline Gastroenterol
Aim: To summarise the published evidence on the gastrointestinal manifestations of COVID-19 in children and to determine the prevalence of gastrointestinal symptoms.
UPDATED
CLINICAL CHARACTERISTICS
7/13/21
Hariyanto TI, Lugito NPH, Yanto TA, et al. | Endocr Metab Immune Disord Drug Targets
Aim: To evaluate the possible association between insulin and the poor composite development of COVID-19.
CLINICAL CHARACTERISTICS
7/13/21
Raeisi T, Mozaffari H, Sepehri N, et al. | Eat Weight Disord
Aim: To evaluate the global prevalence of obesity in COVID-19 patients and to investigate whether obesity is a risk factor for the COVID-19, COVID-19 severity, and its poor clinical outcomes including hospitalization, intensive care unit (ICU) admission, need for mechanical ventilation, and mortality.
CLINICAL CHARACTERISTICS
7/12/21
Shi C, Wang L, Ye J, et al. | BMC Infect Dis
Aim: To assess the potential predictors of mortality in patients with COVID-19.
CLINICAL CHARACTERISTICS
7/12/21
Savage HR, Santos VS, Edwards T, et al. | PLoS Negl Trop Dis
Aim: To review the evidence on the proportion of individuals with SARS-CoV-2 neutralising antibodies after infection and how this proportion varies with selected covariates.
CLINICAL CHARACTERISTICS
7/12/21
Kollias A, Kyriakoulis KG, Kyriakoulis IG, et al. | Atherosclerosis
Aim: To review the evidence regarding statin treatment and COVID-19 related mortality.
CLINICAL CHARACTERISTICS
7/12/21
Mansory E, Srigunapalan S, Lazo-Langner A | TH Open
Aim: To evaluate the epidemiology of VTE in hospitalized intensive care unit (ICU) and non-ICU patients.
UPDATED
CLINICAL CHARACTERISTICS
7/9/21
Schwartzberg L, Advani S, Clancy DC, et al. | Skin Health Dis
Aim: To summarize cutaneous manifestations associated with COVID?19.
UPDATED
CLINICAL CHARACTERISTICS
7/9/21
Barssoum K, Victor V, Salem A, et al. | Echocardiography
Aim: To provide an overview of current findings and recommendations in cardiovascular imaging in patients with COVID-19.
CLINICAL CHARACTERISTICS
7/9/21
Rathore SS, Rojas GA, Sondhi M, et al. | Int J Clin Pract
Aim: To compile and illustrate clinical characteristics, diagnostic findings, management, and outcomes manifesting in myocarditis linked with Covid-19.
CLINICAL CHARACTERISTICS
7/8/21
Ramlah R | Ann Hepatobiliary Pancreat Surg
Aim: To determine the relationship between COVID-19 and acute pancreatitis.
CLINICAL CHARACTERISTICS
7/8/21
Najt P, Richards HL, Fortune D | Brain Behav Immun Health
Aim: To synthesise the potential evidence of the brain correlates of SARS-CoV-2.
UPDATED
CLINICAL CHARACTERISTICS
7/8/21
Gaythorpe K, Bhatia S, Mangal T, et al. | Sci Rep
Aim: To review the evidence on the susceptibility of children to SARS-CoV-2 infection, the severity and clinical outcomes in children with SARS-CoV-2 infection, and the transmissibility of SARS-CoV-2 by children.
UPDATED
CLINICAL CHARACTERISTICS
7/8/21
Ulloque-Badaracco JR, Salas-Tello WI, Al-Kassab-Cordova A, et al. | Int J Clin Pract
Aim: To evaluate the prognostic value of the NLR in patients diagnosed with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
7/8/21
Chisale MRO, Ramazanu S, Mwale SE, et al. | Rev Med Virol
Aim: To estimate the seroprevalence of anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in residents of African countries and explore its associated factors.
UPDATED
CLINICAL CHARACTERISTICS
7/7/21
Soltani S, Faramarzi S, Zandi M, et al. | New Microbes New Infect
Aim: To systematically review and identify the pooled prevalence of the bacterial coinfection in the related articles.
CLINICAL CHARACTERISTICS
7/7/21
Pardhan S, Wood S, Vaughan M, et al. | Front Med
Aim: To examine the adjusted risk of COVID-19 related hospitalsation, intensive care unit (ICU) admission, and mortality in patients with vs. without asthma or COPD.
UPDATED
CLINICAL CHARACTERISTICS
7/6/21
Kremer D, Pieters TT, Verhaar MC, et al. | Am J Transplant
Aim: To assess all current evidence to provide an updated and robust insight in the clinical course and outcome of COVID-19 in KTR.
UPDATED
CLINICAL CHARACTERISTICS
7/6/21
Lassi ZS, Ana A, Das JK, et al. | J Glob Health
Aim: To determine the clinical presentation, risk factors, and pregnancy and perinatal outcomes in pregnant women with confirmed COVID-19 and identify if these are different based on COVID-19 severity.
UPDATED
CLINICAL CHARACTERISTICS
7/6/21
Correia de Sá T, Soares C, Rocha M | World J Gastrointest Surg
Aim: To review and to explore the relationship between SARS-CoV-2 infection and AP, and to provide an overview of the existing literature on possible mechanisms of SARS-CoV-2-induced pancreatic lesion.
CLINICAL CHARACTERISTICS
7/6/21
Lee AC, Tse Li W, Apostol L, et al. | Comput Struct Biotechnol J
Aim: To examine the extent that age influences correlation results and by analyzing patients with severe COVID-19 and patients who died from COVID-19 separately.
CLINICAL CHARACTERISTICS
7/6/21
Alhumaid S, Al Mutair A, Al Alawi Z, et al. | Pathogens
Aim: To calculate the prevalence of coinfections with bacteria, fungi, and respiratory viruses in patients with SARS-CoV-2.
CLINICAL CHARACTERISTICS
7/6/21
Omidi F, Hajikhani B, Kazemi SN, et al. | Front Cardiovasc Med
Aim: To systematically review the current published literature to evaluate clinical and paraclinical characteristics of CMPs in patients infected with SARS-CoV-2.
CLINICAL CHARACTERISTICS
7/6/21
Dube R, Kar SS | BMJ Paediatr Open
Aim: To determine the effects of confirmed cases of COVID-19 in pregnant women from the foetal perspective by estimation of mother to child transmission, perinatal outcome and possible teratogenicity.
CLINICAL CHARACTERISTICS
7/6/21
Eljaaly K, Malibary H, Alsulami S, et al. | Pathogens
Aim: To describe the characteristics of clinical trials that focused on COVID-19 patients with cytokine release syndrome (CRS) and the variability in CRS definitions.
CLINICAL CHARACTERISTICS
7/6/21
Fernández Villalobos NV, Ott JJ, Klett-Tammen CJ, et al. | Syst Rev
Aim: To review the evidence on the relation between individual co-morbidities and disease severity (e.g., as measured by ICU admission) and further identify potential interactions with age.
CLINICAL CHARACTERISTICS
7/6/21
Wibowo A, Pranata R, Lim MA, et al. | Int J Infect Dis
Aim: To compare the level of von Willebrand Factor (vWF) antigen in patients with poor outcome compared to those without. 
UPDATED
CLINICAL CHARACTERISTICS
7/6/21
Lee SA, Park R, Yang JH, et al. | Sci Rep
Aim: To investigate the association between RAAS blockade exposure and COVID-19-related AKI in hospitalized patients through meta-analysis.
CLINICAL CHARACTERISTICS
7/6/21
Singh AK, Singh R, Joshi SR, et al. | Diabetes Metab Syndr
Aim: To find out the patient's characteristics having mucormycosis and COVID-19.
CLINICAL CHARACTERISTICS
7/6/21
Mude W, Oguoma VM, Nyanhanda T, et al. | J Glob Health
Aim: To review the evidence on disparities in prevalence, hospitalisation, and deaths from COVID-19 by racial minority populations.
CLINICAL CHARACTERISTICS
7/6/21
Foret T, Dufrost V, du Mont LS, et al. | Curr Rheumatol Rep
Aim: To analyze the frequency of aPL in COVID-19 patients in different settings and to evaluate their persistence over time and to analyze the role of aPL during the infection in particular their participation in thrombotic events.
CLINICAL CHARACTERISTICS
7/6/21
Romero Starke K, Mauer R, Karskens E, et al. | Int J Environ Res Public Health
Aim: To collect evidence on the impact of temperature and humidity on COVID-19 mortality. 
UPDATED
CLINICAL CHARACTERISTICS
7/6/21
Beukes E, Ulep AJ, Eubank T, et al. | J Clin Med
Aim: To systematically review what has been published regarding tinnitus during the coronavirus disease 2019 (COVID-19) pandemic up to March 2021.
UPDATED
CLINICAL CHARACTERISTICS
7/6/21
Akbar MR, Pranata R, Wibowo A, et al. | Front Med
Aim: To assess the prognostic value of hyponatremia in patients with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
7/2/21
Zein AFMZ, Sulistiyana CS, Khasanah U, et al. | Postgrad Med J
UPDATED
CLINICAL CHARACTERISTICS
7/1/21
Melo AKG, Milby KM, Caparroz ALMA, et al. | PLoS One
Aim: To describe the laboratory parameters and biomarkers of the cytokine storm syndrome associated with severe and fatal COVID-19 cases.
UPDATED
CLINICAL CHARACTERISTICS
7/1/21
Ciapponi A, Bardach A, Comande D, et al.  | PLoS One
Aim: To summarize the best evidence regarding the effect of COVID-19 on maternal and child health.
UPDATED
CLINICAL CHARACTERISTICS
7/1/21
Taylor EH, Marson EJ, Elhadi M, et al. | Anaesthesia
Aim: To determine factors associated with mortality among adults with COVID-19 admitted to intensive care.
CLINICAL CHARACTERISTICS
7/1/21
Kula B, Clancy CJ, Nguyen MG, et al. | Lancet Microbe
Aim: To establish the prevalence of autopsy-proven tissue-invasive IMD and analyse individual-level data to assess potential risk factors.
UPDATED
CLINICAL CHARACTERISTICS
7/1/21
Sitek AN, Ade JM, Chiarella SE, et al. | Allergy Asthma Proc
Aim: To review the evidence on whether asthma is a risk factor associated with worse outcomes among patients with COVID-19.
CLINICAL CHARACTERISTICS
6/30/21
Arian M, Valinejadi A, Vakilian F | Iran J Public Health
Aim: To report the findings of the first Electrocardiography (ECG), before therapy initiation and receiving medication in COVID-19 patients, and to compare them with the ECG findings of healthy men.
CLINICAL CHARACTERISTICS
6/30/21
Crafa A, Cannarella R, Condorelli RA, et al. | EClinicalMedicine
Aim: To assess whether hypovitaminosis D is a risk factor for developing SARS-CoV-2 infection and whether it affects the worsening of the clinical course of COVID-19.
CLINICAL CHARACTERISTICS
6/29/21
Iqbal U, Anwar H, Siddiqui Hux, et al. | Clin Endosc
Aim: To evaluate the outcomes of COVID-19 patients with signs and symptoms of acute gastrointestinal bleeding (GIB).
CLINICAL CHARACTERISTICS
6/29/21
Arian M, Valinejadi A, Vakilian F | Iran J Public Health
Aim: To report the findings of the first Electrocardiography (ECG), before therapy initiation and receiving medication in COVID-19 patients, and to compare them with the ECG findings of healthy men.
CLINICAL CHARACTERISTICS
6/29/21
Crafa A, Cannarella R, Condorelli RA, et al. | EClinicalMedicine
Aim: To assess whether hypovitaminosis D is a risk factor for developing SARS-CoV-2 infection and whether it affects the worsening of the clinical course of COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
6/28/21
Ramadan MS, Bertolino L, Zampino R, et al. | Clin Microbiol Infect
Aim: To assess the range of cardiac sequelae after COVID-19 recovery.
CLINICAL CHARACTERISTICS
6/28/21
Song WL, Zou N, Guan WH, et al. | World J Pediatr
Aim: To assess clinical profiles of COVID-19 in family clusters with children.
CLINICAL CHARACTERISTICS
6/28/21
Teles Abrao Trad A, Ibirogba ER, Elrefaei A, et al. | Hypertens Pregnancy
Aim: To add to the growing evidence on SARS-CoV-2 infection during pregnancy, so as to better inform clinical decision making and optimize patient outcomes.
CLINICAL CHARACTERISTICS
6/28/21
Mark EG, McAleese S, Golden WC, et al. | Pediatr Infect Dis J
Aim: To review outcomes in pregnant women with COVID-19 and neonates with perinatal exposure.
CLINICAL CHARACTERISTICS
6/28/21
Figueiro-Filho EA, Yudin M, Farine D, et al. | J Perinat Med
Aim: To identify the most significant studies reporting on COVID-19 during pregnancy and to provide an overview of SARS-CoV-2 infection in pregnant women and perinatal outcomes.
CLINICAL CHARACTERISTICS
6/28/21
Silva CRACD, Oliveira LV, Lopes LP, et al. | Rev Assoc Med Bras
Aim: To review the immunological aspects of the 2019 coronavirus disease (COVID-19) in pregnancy.
CLINICAL CHARACTERISTICS
6/28/21
Kim CNH, Hutcheon J, van Schalkwyk J, et al. | Am J Obstet Gynecol
Aim: To estimate the CFR of pregnant women infected with SARS-CoV-2 admitted to the intensive care unit (ICU). 
CLINICAL CHARACTERISTICS
6/28/21
Irani M, Pakfetrat A, Mask MK, et al. | J Educ Health Promot
Aim: To evaluate the association of COVID-19 and perinatal outcomes in pregnant women.
CLINICAL CHARACTERISTICS
6/28/21
Fernández-de-Las-Peñas C, Palacios-Ceña D, Gómez-Mayordomo V, et al. | Eur J Intern Med
Aim: To analyze the prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized patients recovered from COVID-19 .
CLINICAL CHARACTERISTICS
6/28/21
Bellou V, Tzoulaki I, van Smeden M, et al. | Eur Respir J
Aim: To present a state-of-the-art systematic review and meta-analysis on the prognostic factors for adverse outcomes in COVID-19 patients.
CLINICAL CHARACTERISTICS
6/25/21
Ren X, Wang X, Ge Z, et al. | Int J Immunopathol Pharmacol
Aim: To examine immune function status-related manifestations and laboratory indicators of COVID-19 patients with recurrent virus PCR positivity.
UPDATED
CLINICAL CHARACTERISTICS
6/25/21
Bobrovitz N, Arora R, Cao C, et al.  | PLoS ONE
Aim: To synthesize seroprevalence data to better estimate the burden of SARS-CoV-2 infection, identify high-risk groups, and inform public health decision making.
UPDATED
CLINICAL CHARACTERISTICS
6/25/21
Zinellu A, Mangoni A | Front Immunol
Aim: To investigate possible differences in the serum concentrations of two routinely measured complement components, C3 and C4, in COVID-19 patients with different severity and survival status.
UPDATED
CLINICAL CHARACTERISTICS
6/25/21
Yamamoto S, Saito M, Tamura A, et al. | PLoS One
Aim: To evaluate existing evidence on the association between the microbiome and COVID-19 in humans and summarize this data in the pandemic era.
UPDATED
CLINICAL CHARACTERISTICS
6/24/21
Wang Z, Joshi A, Leopold K, et al. | Clin Endocrinol
Aim: To evaluate the association between vitamin D deficiency and severity of COVID-19 infection.
CLINICAL CHARACTERISTICS
6/24/21
Samidoust P, Nikoupour H, Hemmati H, et al. | Ethiop J Health Sci
Aim: To explore available information on clinical presentations, laboratory finding and outcomes of SARS-COV-2 in liver transplant patients.
CLINICAL CHARACTERISTICS
6/24/21
Diaz-Arocutipa C, Carvallo-Castaneda D, Luis-Ybanez O, et al. | Clin Transplant
Aim: To summarize the clinical features, treatment, and outcomes of heart transplant recipients with COVID-19. 
CLINICAL CHARACTERISTICS
6/24/21
Gajbhiye RK, Sawant MS, Kuppusamy P, et al. | Int J Gynaecol Obstet
Aim: To compare clinical perinatal outcomes of women with COVID-19 from high-income countries (HICs) and low- to middle-income countries (LMICs).
CLINICAL CHARACTERISTICS
6/23/21
Tripathy SK, Varghese P, Panigrahi S, et al. | Chin J Traumatol
Aim: To evaluate the 30-day mortality and complications in COVID-19 + and COVID-19 ? patients with hip fractures.
UPDATED
CLINICAL CHARACTERISTICS
6/23/21
Dautzenberg B, Levi A, Adler M, et al. | Respir Med Res
Aim: To conduct a systematic analysis of the nicotine doses used, the duration of use, the progressive increase or decrease of the doses, the side-effects leading, or not, to an interruption of the treatment, and the risk of developing a nicotine addiction in non-smokers.
CLINICAL CHARACTERISTICS
6/22/21
Manca R, De Marco M, Ince PG, et al. | Front Aging Neurosci
Aim: To summarize the literature on neuroimaging and neuropathological findings in older over-60 patients with COVID-19 following a cognitive neuroscientific perspective, to clarify the most vulnerable brain areas and speculate on the possible cognitive consequences.
CLINICAL CHARACTERISTICS
6/22/21
Kumar A, Haider Y, Passey J, et al. | Bull Emerg Trauma
Aim: To analyze the factors associated with mortality in fracture patients with concomitant COVID-19 infection based on the available published data.
CLINICAL CHARACTERISTICS
6/21/21
Lewis A, Frontera J, Placantonakis DG, et al. | Clin Neurol Neurosurg
Aim: To review the literature on cerebrospinal fluid (CSF) testing in patients with altered olfactory/gustatory function due to COVID-19 for evidence of viral neuroinvasion.
CLINICAL CHARACTERISTICS
6/21/21
Amdal CD, Pe M, Falk RS, et al. | Qual Life Res
Aim: To identify all relevant health-related quality of life (HRQoL) issues associated with COVID-19.
CLINICAL CHARACTERISTICS
6/21/21
Prakash A, Singh H, Sarma P, et al.  | Sci Rep
Aim: To discuss the prevalence of neurological involvement of the 2019-nCoV patients and assess the symptomatic trend of events as compared to the 2002 "SARS" and 2012 "MERS" pandemics. 
CLINICAL CHARACTERISTICS
6/21/21
Christensen J, O'Callaghan K, Sinclair H, et al. | Intern Med J
Aim: To review the evidence on subacute thyroiditis secondary to COVID-19.
CLINICAL CHARACTERISTICS
6/18/21
Pal R, Singh B, Bhadada SK, et al. | Mycoses
Aim: To review the evidence on COVID-19-associated mucormycosis.
CLINICAL CHARACTERISTICS
6/18/21
Chua PEY, Shah SU, Gui H, et al. | J Investig Med
Aim: To compare clinical presentation, outcomes, and care management among patients with COVID-19 during the early phase of the pandemic.
CLINICAL CHARACTERISTICS
6/17/21
Nopsopon T, Kittrakulrat J, Takkavatakarn K, et al. | PLoS Negl Trop Dis
Aim: To evaluate the prevalence and case fatality rate of COVID-19 in patients with ESRD with RRT.
UPDATED
CLINICAL CHARACTERISTICS
6/17/21
Yusuf F, Fahriani M, Mamada SS, et al. | F1000Res
Aim: To determine the cumulative prevalence of prolonged gastrointestinal (GI) symptoms, including nausea, vomiting, diarrhea, lack of appetite, abdominal pain, and dysgeusia, in survivors of both mild and severe COVID-19 worldwide and to discuss the potential pathogenesis.  
UPDATED
CLINICAL CHARACTERISTICS
6/17/21
Raina R, Mahajan ZA, Vasistha P, et al. | Blood Purif
Aim: To review the evidence on the incidence and outcomes of AKI in COVID-19 patients.
CLINICAL CHARACTERISTICS
6/16/21
Taheri L, Gheiasi SF, Taher M, et al. | Compr Child Adolesc Nurs
Aim: To identify and summarize the existing evidence on clinical characteristics of COVID-19 in pediatric patients. 
UPDATED
CLINICAL CHARACTERISTICS
6/16/21
Ramanathan K, Shekar K, Ling RR, et al. | Crit Care
Aim: To summarise outcome data during the first year of the pandemic and identify risk factors for an unfavourable outcomes in order to guide clinical decision-making and further research.
UPDATED
CLINICAL CHARACTERISTICS
6/16/21
Negrini F, de Sire A, Andrenelli E, et al. | Eur J Phys Rehabil Med
Aim: To investigate the literature on rehabilitation services for COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
6/15/21
Buso G, Becchetti C, Berzigotti A | Dig Liver Dis
Aim: To review the evidence on acute splanchnic vein thrombosis in patients with COVID-19.
CLINICAL CHARACTERISTICS
6/15/21
He Y, Wang J, Ren J, et al. | Front Endocrinol
Aim: To provide a comprehensive overview of the topic of whether COVID-19 can impact on male reproductive system.
CLINICAL CHARACTERISTICS
6/15/21
Iloanusi S, Mgbere O, Essien EJ | J Am Pharm Assoc
Aim: To summarize the available literature on the association between polypharmacy and specific drug classes, and clinical outcomes among COVID-19 patients.
CLINICAL CHARACTERISTICS
6/14/21
Li Y, Deng Y, Ye L, et al. | Front Med
Aim: To illuminate the clinical significance of plasma D-dimer in COVID-19 mortality.
CLINICAL CHARACTERISTICS
6/14/21
Pizuorno A, Fierro NA, Copado-Villagrana ED, et al. | BMC Infect Dis
Aim: To study the symptoms and comorbidities that associate with this pandemic in 3 different regions of Mexico.
CLINICAL CHARACTERISTICS
6/14/21
Chan KW, Yu KY, Lee PW, et al. | Front Med
Aim: To assess the association between AKI, mortality, underlying non-communicable diseases, and clinical risk factors.
UPDATED
CLINICAL CHARACTERISTICS
6/14/21
Xin H, Wong JY, Murphy C, et al. | Clin Infect Dis
Aim: To review published estimates of the incubation period distribution with a particular interest in the methodology applied and potential biases.
CLINICAL CHARACTERISTICS
6/14/21
Kay I, Madran B, Keske S, et al. | Clin Microbiol Infect
Aim: To investigate the seroprevalence of SARS-CoV-2 among HCWs and related risk factors.
CLINICAL CHARACTERISTICS
6/11/21
Harrison SL, Buckley BJR, Rivera-Caravaca JM, et al. | Eur Heart J Qual Care Clin Outcomes
Aim: To consolidate evidence to determine (i) the association between cardiovascular risk factors and health outcomes with coronavirus 2019 (COVID-19); and (ii) the impact of COVID-19 on cardiovascular health.
CLINICAL CHARACTERISTICS
6/11/21
Akbar M, Pranata R, Wibowo A, et al | Eur Rev Med Pharmacol Sci
Aim: To evaluate the association between the prealbumin and severity and mortality in COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
6/10/21
SeyedAlinaghi S, Mirzapour P, Dadras O, et al. | Eur J Med Res
Aim: To characterize the different variants of SARS-CoV-2 and explore the related morbidity and mortality.
CLINICAL CHARACTERISTICS
6/10/21
Lewis A, Jain R, Frontera J, | J Neuroimaging
Aim: To evaluate cerebrospinal fluid (CSF) results from patients with coronavirus disease 2019 (COVID-19) who had neurological symptoms and had an MRI that showed (1) central nervous system (CNS) hyperintense lesions not attributed to ischemia and/or (2) leptomeningeal enhancement. 
CLINICAL CHARACTERISTICS
6/10/21
Guimarães D, Pissarra R, Reis-Melo A, et al. | Int J Clin Pract
Aim: To analyze current literature and reported cases of MISC, concerning its clinical spectrum, complications associated, therapeutic strategies and distinguishing features of other clinical syndromes.
CLINICAL CHARACTERISTICS
6/9/21
Asiimwe IG, Pushpakom S, Turner R, et al | Br J Clin Pharmacol
Aim: To continually evaluate the rapidly evolving evidence base on the role of cardiovascular drugs in COVID-19 clinical outcomes (susceptibility to infection, hospitalization, hospitalization length, disease severity, and all-cause mortality).
UPDATED
CLINICAL CHARACTERISTICS
6/8/21
Nikoloski Z, Alqunaibet AM, Alfawaz RA, et al. | BMC Public Health
Aim: To systematize the available evidence on the link between non-communicable diseases and Covid-19.
CLINICAL CHARACTERISTICS
6/8/21
Yang J, D'souza R, Kharrat A, et al. | Acta Obstet Gynecol Scand
Aim: To conduct a living systematic review and meta-analyses of studies reporting pregnancy and neonatal outcomes by comparing the pandemic and pre-pandemic periods.
UPDATED
CLINICAL CHARACTERISTICS
6/8/21
Mohan N, Fayyaz MA, Del Rio C, et al. | Egypt J Neurol Psychiatr Neurosurg
Aim: To evaluate and correlate the neuro-radiological and neurological manifestations in patients diagnosed with SARS-CoV2.To identify neuro-invasive pathways of COVID infection.
CLINICAL CHARACTERISTICS
6/8/21
Sarkar S, Kannan S, Khanna P, et al. | Rev Med Virol
Aim: To explore the utility of RDW in the prognosis of COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
6/8/21
Zugaj M, van Ditzhuijzen NS, Golebski K, et al. | Rhinology
Aim: To review the effects of the 7 known human coronaviruses on olfaction to determine if SARS-CoV-2 distinctly affects the olfactory system.
CLINICAL CHARACTERISTICS
6/7/21
Liu X, Wang H, Shi S, et al. | Postgrad Med J
Aim: To evaluate the association between IL-6 and severe disease and mortality in COVID-19 disease.
UPDATED
CLINICAL CHARACTERISTICS
6/7/21
Guerrero JI, Barragan LA, Martinez JD, et al. | BMC Infect Dis
Aim: To describe the features of the central and peripheral nervous system involvement by COVID-19 in terms of pathophysiology, clinical manifestations, neuropathology, neuroimaging, electrophysiology, and cerebrospinal fluid findings.
UPDATED
CLINICAL CHARACTERISTICS
6/7/21
Messina A, Sanfilippo F, Milani A, et al. | J Crit Care
Aim: To summarise the current knowledge regarding cardiac dysfunction in COVID-19 as assessed by echocardiography, both in ICU and non-ICU subjects.
UPDATED
CLINICAL CHARACTERISTICS
6/7/21
Zuin M, Rigatelli G, Bilato C, et al. | Acta Cardiol
Aim: To evaluate the pooled incidence of acute HF as a cardiac complication of COVID-19 disease and to estimate the related mortality risk in these patients.
CLINICAL CHARACTERISTICS
6/7/21
Siracusa L, Cascio A, Giordano S, et al. | Ital J Pediatr
Aim: To describe clinical characteristics, laboratory tests, radiological data and outcome of pediatric cases with SARS-CoV-2 infection complicated by neurological involvement.
CLINICAL CHARACTERISTICS
6/7/21
Rogers JP, Watson CJ, Badenoch J, et al. | J Neurol Neurosurg Psychiatry
Aim: To describe the characteristics of the early literature and estimate point prevalences for neurological and neuropsychiatric manifestations.
UPDATED
CLINICAL CHARACTERISTICS
6/7/21
Chong WH, Saha BK, Hu K, et al. | Heart Lung
Aim: To describe the incidence, clinical characteristics, and outcomes of COVID-19-related pneumothorax.
CLINICAL CHARACTERISTICS
6/7/21
Mai V, Tan BK, Mainbourg S, et al. | Vascul Pharmacol
Aim: To compare the rate of VTE between COVID-19 and non-COVID-19 cohorts with similar disease severity.
CLINICAL CHARACTERISTICS
6/3/21
Reyes FM, Hache-Marliere M, Karamanis D, et al. | J Clin Med
Aim: To explore the association of COPD and asthma with in-hospital mortality in patients with COVID-19.
CLINICAL CHARACTERISTICS
6/3/21
Jimenez-Cebrian AM, Castro-Mendez A, Garcia-Podadera B, et a;/ | J Clin Med
Aim: To analyze and synthesize the published reviews on manifestations of COVID-19 at the foot level. 
UPDATED
CLINICAL CHARACTERISTICS
6/3/21
Leyser M, Marques FJP, do Nascimento OJM | Rev Paul Pediatr
Aim: To perform a systematic literature review to analyze existing data on the neurological effects of coronavirus on newborns.
CLINICAL CHARACTERISTICS
6/3/21
Santana MAC, Cano JAA, Kanan AD, et al. | Medicina
Aim: To contrast the existing evidence regarding the relationship between periodontal disease (PD) and diabetes mellitus (DM) with the possibly increased risk of SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
6/3/21
Wang R, Liu M, Liu J | Vaccines
Aim: To assess the association between influenza vaccination and SARS-CoV-2 infection and clinical outcomes.
UPDATED
CLINICAL CHARACTERISTICS
6/3/21
Khan DSA, Pirzada AN, Ali A, et al. | Int J Environ Res Public Health
Aim: To investigate the differences in clinical presentation, management, and prognosis of COVID-19 infection in pregnant and non-pregnant women.
UPDATED
CLINICAL CHARACTERISTICS
6/3/21
Ippolito M, Misseri G, Catalisano G, et al. | Antibiotics
Aim: To estimate the pooled occurrence of ventilator-associated pneumonia (VAP) among patients admitted to an intensive care unit with COVID-19 and mortality of those who developed VAP.
CLINICAL CHARACTERISTICS
6/2/21
Franchini M, Cruciani M, Mengoli C, et al. | Blood Transfus
Aim: To assess the relationship between the ABO blood group and the occurrence and severity of COVID-19.
CLINICAL CHARACTERISTICS
6/2/21
Wang MX, Gwee SXW, Pang J | Nutrients
Aim: To systematically assess the associations between micronutrient supplementation or deficiency, with novel coronavirus incidence and disease severity.
UPDATED
CLINICAL CHARACTERISTICS
6/2/21
Schulte EC, Hauer L, Kunz AB, et al. | Eur J Neurol
Aim: To review cases of ATM described in the context of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection.
CLINICAL CHARACTERISTICS
6/1/21
Grove A, Osokogu O, Al-Khudairy L, et al. | BMJ Open
Aim: To systemically review and critically appraise published studies of the association between vitamin D supplementation or serum vitamin D level and susceptibility to SARS-CoV-2 infection or COVID-19, including clinical course, morbidity and mortality outcomes.
UPDATED
CLINICAL CHARACTERISTICS
6/1/21
Dumitrascu F, Branje KE, Hladkowicz ES, et al. | J Am Geriatr Soc
Aim: To identify, describe, and synthesize studies reporting the association of frailty with outcomes (informed by the Institute for Healthcare Improvement's Triple Aim [health, resource use, and experience]) in individuals with COVID-19.
CLINICAL CHARACTERISTICS
6/1/21
Carroll E, Melmed KR, Frontera J, et al. | Seizure
Aim: To review the CSF results in published case reports and case series of patients with COVID-19 who had seizures to evaluate for evidence of viral neuroinvasion.
CLINICAL CHARACTERISTICS
6/1/21
da Silva RP, Goncalves JIB, Zanin RF, et al. | Front Immunol
Aim: To summarize the available evidence of the association of plasma protein levels of type I IFN with the severity of COVID-19.
CLINICAL CHARACTERISTICS
6/1/21
Bolia R, Goel AD, Badkur M, et al. | J Trop Pediatr
Aim: To determine the GI manifestations of pediatric COVID-19 and to evaluate their role as risk factors for a severe clinical course.
CLINICAL CHARACTERISTICS
6/1/21
Kaur H, Thakur JS, Paika R, et al. | Asian Pac J Cancer Prev
Aim: To explore the prevalence of comorbidities among cancer patients with SARS CoV-2 infection and their impact on mortality.
UPDATED
CLINICAL CHARACTERISTICS
6/1/21
Tagliamento M, Agostinetto E, Bruzzone M, et al. | Crit Rev Oncol Hematol
Aim: To estimate the mortality in patients with cancer and SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
6/1/21
Singh S, Verma N, Kanaujia R, et al. | Mycoses
Aim: To synthesize the results of primary studies on CAPA and to provide pooled mortality estimators of in-hospital mortality of the disease and potential predictors of outcome.
CLINICAL CHARACTERISTICS
6/1/21
Almazroa A, Alamri S, Alabdulkader B, et al. | Int Health
Aim: To review the evidence on ocular transmission and manifestations of SARS-CoV-2.
CLINICAL CHARACTERISTICS
6/1/21
Zawawi A, Naser AY, Alwafi H, et al. | Front Immunol
Aim: To evaluate the inflammatory cytokines profile associated with severe human coronavirus diseases, including three stains: MERS-CoV, SARS-CoV SARS-CoV-2, in severe patients.
UPDATED
CLINICAL CHARACTERISTICS
6/1/21
O Murchu E, Byrne P, Carty PG, et al. | Rev Med Virol
Aim: To evaluate the risk and relative risk of SARS-CoV-2 reinfection over time, comparing previously infected individuals to those without evidence of prior infection.
CLINICAL CHARACTERISTICS
6/1/21
Hou H, Li Y, Zhang P, et al. | Nicotine Tob Res
Aim: To explore the association between smoking and mortality of coronavirus disease 2019 (COVID-19) patients utilizing a quantitative meta-analysis on the basis of adjusted effect estimates.
CLINICAL CHARACTERISTICS
6/1/21
Kabrah SM, Kabrah AM, Flemban AF, et al. | Transfus Apher Sci
Aim: To evaluate the existing evidence on the susceptibility of the ABO blood group to COVID-19 infection.
CLINICAL CHARACTERISTICS
5/28/21
Nasserie T, Hittle M, Goodman SN | JAMA Netw Open
Aim: To conduct a systematic review of studies examining the frequency and variety of persistent symptoms after COVID-19 infection.
CLINICAL CHARACTERISTICS
5/28/21
Iqbal FM, Lam K, Sounderajah V, et al. | EClinicalMedicine
Aim: To characterise the clinical features between acute and chronic post-COVID syndrome.
UPDATED
CLINICAL CHARACTERISTICS
5/28/21
Kastora S, Kounidas G, Perrott S, et al. | EClinicalMedicine
Aim: To quantify the impact of clinical frailty scale (CFS) by increasing severity of frailty and to identify other personal prognostic factors associated with increased mortality from COVID-19.
CLINICAL CHARACTERISTICS
5/28/21
Panda S, Nanda R, Tripathy PK, et al. | J Family Med Prim Care
Aim: To summarize the alteration in the immunological and inflammatory markers of COVID-19 cases reported in currently available observational studies and their associations with the severity of disease process.
CLINICAL CHARACTERISTICS
5/28/21
Fahmy OH, Daas FM, Salunkhe V, et al. | Crit Care Explor
Aim: To retrieve and report the findings of postmortem studies including the histopathologic data of deceased coronavirus disease 2019 patients and to review the manifestations of coronavirus disease 2019–associated thrombotic pathologies reported in the recent literature.
CLINICAL CHARACTERISTICS
5/28/21
de Sousa Neto AR, de Carvalho ARB, de Oliveira EMN, et al. | Rev Gaucha Enferm
Aim: To identify symptoms of COVID-19 in adults in the scientific literature.
CLINICAL CHARACTERISTICS
5/24/21
Massarvva T | Epidemiol Health
Aim: To systematically review up-to-date studies reporting on the clinical outcomes of COVID-19 amongst HIV patients.
CLINICAL CHARACTERISTICS
5/24/21
Barzegar M, Mirmosayyeb O, Gajarzadeh M, et al. | Neurol Neuroimmunol Neuroinflamm
Aim: To systematically review the literature on COVID-19 in patients with multiple sclerosis (MS).
CLINICAL CHARACTERISTICS
5/24/21
Shah S, Akhade K, Ganguly S, et al. | J Family Med Prim Care
Aim: To summarize the major patterns of dermatological manifestations associated with SARS-CoV-2 virus infection.
CLINICAL CHARACTERISTICS
5/24/21
Chmielewska B, Barratt I, Townsend R, et al. | Lancet Glob Health
Aim: To assess the collateral effects on maternal, fetal, and neonatal outcomes of the global COVID-19 pandemic.
CLINICAL CHARACTERISTICS
5/24/21
SeyedAlinaghi S, Mehrtak M, MohsseniPour M, et al. | Eur J Med Res
Aim: To investigate the available evidence for the genetic susceptibility to COVID-19.
CLINICAL CHARACTERISTICS
5/24/21
Salamanna F, Veronesi F, Martini L, et al. | Front Med
Aim: To assess the current evidence on the long-term symptoms in COVID-19 patients.
CLINICAL CHARACTERISTICS
5/24/21
Abate SM, Chekole YA, Estifanos MB, et al. | Clin Nutr ESPEN
Aim: To investigate the prevalence and outcome of malnutrition among patients with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
5/24/21
Mathew HR, Choi MY, Parkins MD, et al. | BMC Pulm Med
Aim: To systematically survey published accounts of COVID-19 in CF and determine if individuals with CF are disproportionally affected by SARS-CoV-2 and development of COVID-19.
CLINICAL CHARACTERISTICS
5/21/21
Singhal S, Kumar P, Singh S, et al. | BMC Geriatr
Aim: To review the evidence on the clinical characteristics of older COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
5/21/21
Bzeizi K, Abdulia M, Mohammed N, et al. | Sci Rep
Aim: To assess the available evidence on the clinical effects of SARS-CoV-2 on liver function laboratory tests and coagulation profile in affected individuals. 
UPDATED
CLINICAL CHARACTERISTICS
5/21/21
Xiong X, Chi J, Gao Q | Thromb J
Aim: To determine the prevalence and risk factors of thrombotic events on COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
5/20/21
Alcock H, Moppett EA, Moppett IK | Bone Jt Open
Aim: To understand the impact of coexistent hip fracture and SARS-CoV-2 for informed decision-making at patient and service levels.
CLINICAL CHARACTERISTICS
5/20/21
Manoharan L, Cattrall JW, Harris C, et al. | PLoS One
Aim: To summarize the early literature on clinical characteristics of patients admitted to hospital, and evaluates the quality of evidence produced during the initial stages of the pandemic.
CLINICAL CHARACTERISTICS
5/20/21
Haghpanah A, Masjedi F, Salehipour M, et al. | Prostate Cancer Prostatic Dis
Aim: To explore the potential mechanisms of SARS-CoV-2 in targeting the prostate gland, leading to exacerbation of benign prostatic hyperplasia (BPH) symptoms and greater risks of BPH complications such as acute urinary retention.
CLINICAL CHARACTERISTICS
5/20/21
Pannone G, Caponio VCA, De Stefano IS, et al. | Infect Agent Cancer
Aim: To summarize lung histopathological characteristics of COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
5/20/21
Dhar D, Dey T, Samim MM, et al. | Pediatr Res
Aim: To review the evidence on the demographic profile, clinical characteristics, complications, management, and prognosis of MIS-C associated with COVID-19.
CLINICAL CHARACTERISTICS
5/19/21
Scheiner NS, Smith AK, Wohlleber M, et al. | J Acad Consult Liaison Psychiatry
Aim: To review the extant literature describing catatonia in the setting of COVID-19 disease and highlight commonalities among the cases.
CLINICAL CHARACTERISTICS
5/19/21
Azab MA, Azzam AY | Brain Disord
Aim: To perform a meta-analysis of the available published data concerning the management of glioma patients in the published literature from the beginning of the pandemic to the end of 2020 concerning the number of operated surgeries, postoperative complications, and mortality outcomes.
CLINICAL CHARACTERISTICS
5/19/21
Quesada JA, Lopez-Pineda A, Gil-Guillen VF, et al. | Rev Clin Esp
Aim: To provide a more accurate estimate of the incubation period of COVID-19.
CLINICAL CHARACTERISTICS
5/17/21
Bircakova B, Bruha R, Lambert L, et al. | Scand J Gastroenterol
Aim: To review clinical and laboratory findings in patients with SARS-Cov-2 (COVID-19) related acute pancreatitis.
CLINICAL CHARACTERISTICS
5/17/21
Hernandez-Perez A, Garcia-Gomez L, Rodriguez-Llamazares S, et al. | Salud Publica Mex
Aim: To describe the possible risks associated to smoking in the spread and complications of Covid-19, emphasizing in the benefits of quitting smoking.
CLINICAL CHARACTERISTICS
5/17/21
Shao SC, Lai CC, Chen YH, et al. | Age Aging
Aim: To summarize the evidence on prevalence, incidence and mortality of delirium in COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
5/17/21
Wingert A, Pillay J, Gates M, et al. | BMJ Open
Aim: To determine the magnitude of association between potential risk factors and severity of COVID-19, to inform vaccine prioritisation in Canada.
CLINICAL CHARACTERISTICS
5/17/21
Severo Bem Junior L, do Rego Aquino PL, Nunes Rabelo N, et al. | J Neurol Res
Aim: To reveal the current knowledge regarding CNS manifestation in SARS-CoV-2. 
CLINICAL CHARACTERISTICS
5/17/21
Mitra S, Ling RR, Yang IX, et al. | Ann Acad Med Singap
Aim: To review the evidence on COVID-19-induced coagulopathy.
CLINICAL CHARACTERISTICS
5/14/21
Biswas M, Most SKK | Sci Rep
Aim: To assess aggregated risk by investigating the association of ACEIs/ARBs users against non-users of ACEIs/ARBs with the risk of mortality or severe clinical manifestations or magnitude of SARS-CoV-2 test positivity in COVID-19 patients.
CLINICAL CHARACTERISTICS
5/14/21
Soeroto AY, Purwiga A, Pranggono EH, et al. | Asian Pac J Allergy Immunol
Aim: To investigate the association between asthma and composite poor outcome in patients with coronavirus disease (COVID-19).
CLINICAL CHARACTERISTICS
5/14/21
Wu T, Yu P, Li Y, et al. | J Asthma
Aim: To analyze the association between COVID-19 and asthma.
CLINICAL CHARACTERISTICS
5/14/21
Lim KH, Soong F, Low YF, et al. | J Clin Virol
Aim: To determine the clinical manifestations of neonatal COVID-19 and outcomes based on severity groups. 
CLINICAL CHARACTERISTICS
5/14/21
Khodeir MM, Shabana HA, Alkhamiss AS, et al. | J Infect Public Health
Aim: To review different biomarkers to systematically analyze these values to evaluate whether are they are correlated with the severity of COVID-19 disease and so their ability to be a predictor for progression.
CLINICAL CHARACTERISTICS
5/14/21
Siow I, Lee KS, Zhang JJY, et al. | Eur J Neurol
Aim: To describe the incidence, clinical course and outcomes of patients who suffer from encephalitis as a complication of COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
5/14/21
Chambergo-Michilot D, Barros-Sevillano S, Rivera-Torrejon O, et al. | Eur J Neurol
Aim: To systematically review the factors associated with COVID-19 in people with PD.
UPDATED
CLINICAL CHARACTERISTICS
5/14/21
Paternoster G, Bertini P, Innelli P, et al. | J Cardiothorac Vasc Anesth
Aim: To describe the features of right ventricular impairment and pulmonary hypertension in coronavirus disease (COVID-19) and assess their effect on mortality.
UPDATED
CLINICAL CHARACTERISTICS
5/14/21
James PT, Ali Z, Armitage AE, et al. | J Nutr
Aim: To review the latest evidence on how malnutrition across all its forms (under- and overnutrition and micronutrient status) may influence both susceptibility to, and progression of, COVID-19.
CLINICAL CHARACTERISTICS
5/13/21
Kang S, Gong X, Yuan Y | Epidemiol Infect
Aim: To systematically assess the association between smoking and cardiovascular disease and disease progression among novel coronavirus pneumonia (COVID-19) cases.
UPDATED
CLINICAL CHARACTERISTICS
5/13/21
Martimbianco ALC, Pacheco RL, Bagattini AM, et al. | Int J Clin Pract
Aim: To identify, systematically evaluate and summarise the best available evidence on the frequency of long COVID (post-acute COVID-19 syndrome), its clinical manifestations and the criteria used for diagnosis.
UPDATED
CLINICAL CHARACTERISTICS
5/12/21
Round T, L'Esperance V, Bayly J, et al. | Br J Cancer
Aim: To review the evidence on delivering lung cancer care during the COVID-19 pandemic.
CLINICAL CHARACTERISTICS
5/11/21
Keshavarz P, Yazdanpanah F, Azhdari S, et al. | J Med Virol
Aim: To demonstrate the relationship between severely ill cases of MIS-C and COVID-19.
CLINICAL CHARACTERISTICS
5/11/21
Zippi M, Fiorino S, Budriesi R, et al. | World J Clin Cases
Aim: To identify studies on the relationship between the intake of PPIs and coronavirus disease 2019 (COVID-19) in patients affected by SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
5/11/21
Las Casas Lima MH, Cavalcante ALB, Leão SC | Braz J Otorhinolaryngol
Aim: To analyze current scientific evidence intended to elucidate the pathophysiological relationship between COVID-19 and the cause of olfactory disorders.
CLINICAL CHARACTERISTICS
5/11/21
Oscanoa TJ, Amado J, Vidal X, et al. | Adv Respir Med
Aim: To conduct a metanalysis of the association between 25-hydroxyvitamin D (25(OH)D) concentration and SARS-CoV-2 infection severity or mortality.
CLINICAL CHARACTERISTICS
5/10/21
Kim H, Hwang H, Hong H, et al. | Sci Rep
Aim: To review the differences in risk factors for critical outcomes of patients with COVID-19 according to the continent on which the studies were performed.
CLINICAL CHARACTERISTICS
5/10/21
Ghodsi A, Bijari M, Alamdaran SA, et al. | World J Pediatr
Aim: To evaluate the chest computed tomography (CT) findings in infants with confirmed COVID-19 infection
CLINICAL CHARACTERISTICS
5/10/21
Menon T, Gandhi SAQ, Tariq W, et al. | Cureus
Aim: To provide an association between CKD and the clinical prognosis of COVID-19.
CLINICAL CHARACTERISTICS
5/10/21
Ippolito M, Catalisano G, Marino C, et al. | Resuscitation
Aim: To estimate the mortality rate, the rate of return of spontaneous circulation (ROSC) and survival with favorable neurological outcome in patients with COVID-19 after in-hospital cardiac arrest (IHCA) and attempted cardiopulmonary resuscitation (CPR).
CLINICAL CHARACTERISTICS
5/10/21
Musuuza JS, Watson L, Parmasad V, et al. | PLoS One
Aim: To examine the occurrence of co-infections and superinfections and their outcomes among patients with SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
5/7/21
Gulsen A, Konig I, Jappe U, et al. | Respirology
Aim: To examine in detail whether the underlying chronic obstructive pulmonary diseases (COPD), asthma and chronic respiratory diseases (CRDs) were associated with an increased risk of more severe COVID-19. 
UPDATED
CLINICAL CHARACTERISTICS
5/7/21
Mutiawati E, Syahrul S, Fahriani M, et al. | F1000Res
Aim: To determine the prevalence of headache in coronavirus disease 2019 (COVID-19) and to assess its association as a predictor for COVID-19.
CLINICAL CHARACTERISTICS
5/7/21
Aladawi M, Elfil M, Abu-Esheh B, et al. | Can J Neurol Sci
Aim: To review the evidence on the association between Guillain Barre Syndrome and COVID-19.
CLINICAL CHARACTERISTICS
5/7/21
Dembrovszky F, Váncsa S, Farkas N, et al. | Viruses
Aim: To evaluate which prognostic factors may impact repeated SARS-CoV-2 positivity (RSP) and their association with immunoglobulin detectability among recovered patients. 
UPDATED
CLINICAL CHARACTERISTICS
5/7/21
Aldien AS, Ganesan GS, Wahbeh F, et al. | Cardiovasc Revasc Med
Aim: To investigate the possible role of hyperinflammation in inducing cardiac injury as one of the severe complications of COVID-19.
CLINICAL CHARACTERISTICS
5/7/21
Lu Y, Zhao J, Ye M, et al. | Neurol Sci
Aim: To determine the risk of acute ischemic stroke in patients with severe and non-severe coronavirus disease 2019 (COVID-19).
CLINICAL CHARACTERISTICS
5/7/21
Cosco TD, Best J, Davis D, et al. | Age Aging
Aim: To quantify the association between frailty and COVID-19 in relation to mortality in hospitalised patients.
UPDATED
CLINICAL CHARACTERISTICS
5/6/21
Angelico R, Blasi F, Manzia TM, et al. | Medicina
Aim: To investigate the current management of IS therapy in KT recipients with COVID-19. 
CLINICAL CHARACTERISTICS
5/5/21
Szarpak L, Borkowska M, Peacock FW, et al. | Cardiol J
Aim: To review interventional outcome studies in patients with in-hospital cardiac arrest before and during the coronavirus disease 2019 (COVID-19) pandemic period.
CLINICAL CHARACTERISTICS
5/5/21
Li X, Zhong X, Wang Y, et al. | PLoS One
Aim: To systematically identify the possible risk factors responsible for severe cases.
CLINICAL CHARACTERISTICS
5/5/21
Rehman MA, Farooq H, Ali MM, et al. | SN Compr Clin Med
Aim: To identify cases of subacute thyroiditis associated with COVID-19 and evaluated patient-level demographics, major clinical features, laboratory findings and outcomes.
CLINICAL CHARACTERISTICS
5/4/21
Du P, Li D, Wang A, et al. | Can J Infect Dis Med Microbiol
Aim: To screen the risk factors for severe illness and death and provide help for early clinical treatment of the new coronavirus (COVID-19).
CLINICAL CHARACTERISTICS
5/4/21
Dos Santos ACM, Dos Santos BRC, Dos Santos BB, et al. | Infect Genet Evol
Aim: to review the effect of single nucleotide polymorphisms in the development of severe acute respiratory syndrome (SARS).
UPDATED
CLINICAL CHARACTERISTICS
5/4/21
Hariyanto TI, Rosalind J, Christian K, et al. | South Afr J HIV Med
Aim: To explore the impact of HIV and SARS-CoV-2 co-infection on mortality.
CLINICAL CHARACTERISTICS
5/4/21
Nepal G, Shrestha GS, Rehrig JH, et al. | J Nepal Health Res Counc
Aim: To review the evidence on neurological involvement in COVID-19 associated MIS-C.
CLINICAL CHARACTERISTICS
5/4/21
Liang M, Luo N, Chen M, et al. | Infect Dis Ther
Aim: To investigate the prevalence and mortality in PLWHA co-infected with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
5/3/21
Mogensen MA, Wangaryattawanich P, Hartman J, et al. | Br J Radiol
Aim: To describe outcomes associated with abnormal neuroimaging findings among adult COVID-19 patients.
CLINICAL CHARACTERISTICS
4/30/21
Lee J, Song J | J Med Virol
Aim: To investigate the diagnostic accuracy of the Xpert Xpress and the ID NOW assays for rapid detection of SARS-CoV-2.
CLINICAL CHARACTERISTICS
4/30/21
Peiris S, Mesa H, Aysola A, et al. | PLoS One
Aim: To summarize the reported pathologic findings on biopsy and autopsy in patients with severe/fatal COVID-19 and documented the presence and/or effect of SARS-CoV-2 in all organs.
CLINICAL CHARACTERISTICS
4/29/21
Choudary MC, Crain CR, Qiu X, et al.  | Clin Infect Dis
Aim: To characterize the hallmarks of reinfecting sequences and the rate of viral evolution in persistent infection.
UPDATED
CLINICAL CHARACTERISTICS
4/28/21
Hayward SE, Deal A, Cheng C, et al. | J Migr Health
Aim: To assess clinical outcomes of COVID-19 in migrant populations (cases, hospitalisations, deaths), indirect health and social impacts, and to determine key risk factors.
UPDATED
CLINICAL CHARACTERISTICS
4/27/21
Sheikh AB, Chourasia PK, Javed N, et al. | J Neuroimmunol
Aim: To determine demographic characteristics, clinical features, lab evaluation, management and complications of the studies focusing on Guillain-Barre syndrome (GBS) as a sequele of novel coronavirus (COVID-19) infection.
UPDATED
CLINICAL CHARACTERISTICS
4/27/21
Yu J, Wu B, Feng L, et al. | J Tissue Viability
Aim: To summarize the pressure injuries caused by COVID-19 and the corresponding preventive measures and treatments.
CLINICAL CHARACTERISTICS
4/27/21
Mitaka H, Kuno T, Takagi H, et al. | Mycoses
Aim: To determine the incidence and mortality of CAPA in critically ill patients with COVID-19 to improve guidance on surveillance and prognostication.
CLINICAL CHARACTERISTICS
4/27/21
Patralekh MK, Jain V, Iyengar K, et al.  | J Clin Orthop Trauma
Aim: To evaluate the impact of COVID-19 on patients with PFF and assessed associated mortality.
UPDATED
CLINICAL CHARACTERISTICS
4/27/21
Wu Y, Li H, Zhang Z, et al. | Ann Palliat Med
Aim: To evaluate the in-hospital mortality and risk factors of death in COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
4/26/21
Garcia-Zamora S, Lee S, Haseeb S, et al. | Pacing Clin Electrophysiol
Aim: To examine the prevalence of cardiac arrhythmias detected by the electrocardiogram and their relationships with adverse outcomes in patients with COVID-19.
CLINICAL CHARACTERISTICS
4/26/21
Ma Z, Wang MP, Liu L, et al. | Aging
Aim: To review the evidence on whether ACEI and/or ARB are associated with the risk of SARS-COV2 infection and whether they are associated with adverse outcomes in patients with COVID-19.
CLINICAL CHARACTERISTICS
4/26/21
Singh J, Malik P, Patel N, et al. | Clin Exp Med
Aim: To identify prevalence and association of comorbid chronic kidney disease (CKD), acute kidney injury (AKI) and utilization prevalence of continuous renal replacement therapy (CRRT) in COVID-19-hospitalized patients as a function of severity status. 
CLINICAL CHARACTERISTICS
4/26/21
Parsons N, Outsikas A, Parish A, et al. | AJNR Am J Neuroradiol
Aim: To quantitatively evaluate whether a network diffusion model can explain the spread of small neurologic events.
CLINICAL CHARACTERISTICS
4/26/21
Hariyanto TI, Kurniawan A | Sleep Med
Aim: To analyze the relationship between OSA and poor outcomes of COVID-19.
CLINICAL CHARACTERISTICS
4/26/21
Dmytriw AA, Chibbar R, Chen PPY, et al. | Expert Rev Respir Med
Aim: To review the evidence on the outcomes of patients with COVID-19-related ARDS compared to ARDS unrelated to COVID-19.
CLINICAL CHARACTERISTICS
4/26/21
Chong WH, Neu KP | J Hosp Infect
Aim: To discuss the incidence, characteristics, diagnostic criteria, biomarkers, and outcomes of hospitalized patients diagnosed with CAPA.
CLINICAL CHARACTERISTICS
4/26/21
Iwu CJ, Iwu CD, Wiysonge CS | Pan Afr Med J
Aim: To synthesize evidence on the long-term effects of the SARS-CoV-2 infection among survivors.
CLINICAL CHARACTERISTICS
4/22/21
Thakur B, Dubey P, Benitez J, et al.  | Sci Rep
Aim: To determine geographical, age, and gender related differences in the prevalence of comorbidities and associated severity and mortality rates among COVID-19 patients.
CLINICAL CHARACTERISTICS
4/22/21
Menon T, Sharma R, Saurabh K, et al.  | Cureus
Aim: To measure the prevalence of acute kidney injury (AKI) in COVID-19 and its association with the disease severity and mortality in COVID-19 patients.
CLINICAL CHARACTERISTICS
4/21/21
Chowdhury AI, Alam MR, Rabbi MF, et al.  | Obes Med
Aim: To estimate the effects of overweight and obesity on COVID-19 disease severity.
CLINICAL CHARACTERISTICS
4/21/21
Medaglia AA, Siracusa L, Gioè C, et al.  | Ital J Pediatr
Aim: To review the medical literature on Kawasaki disease recurrence and reported a new case of Kawasaki disease recurrence in a child with SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
4/21/21
Dy LF, Lintao RCV, Cordero CP, et al.  | Sci Rep
Aim: To estimate the proportion of COVID-19 patients with cardiac abnormalities and to determine the association between the cardiac abnormalities in COVID-19 patients and disease severity and mortality.
CLINICAL CHARACTERISTICS
4/20/21
Cheng MP, Cau A, Lee TC, et al.  | Crit Care Med
Aim: To compare the rates of cardiac injury by angiotensin-converting enzyme-2-binding viruses from viruses that do not bind to angiotensin-converting enzyme-2.
CLINICAL CHARACTERISTICS
4/20/21
Pizarro-Pennarolli C, Sánchez-Rojas C, Torres-Castro R, et al.  | PeerJ
Aim: To understand the impact of COVID-19 on ADL performance of adult patients and to describe the common scales used to assess performance of ADL on patients post-COVID-19.
CLINICAL CHARACTERISTICS
4/20/21
Artemios A, Andreas L, Hadjigeorgiou L, et al. | Neurol Res
Aim: To characterize all – to date – reported cases with COVID-19 related myelopathy.
CLINICAL CHARACTERISTICS
4/20/21
Mondello C, Roccuzzo S, Malfa O, et al.  | Front Pharmacol
Aim: To review the main post-mortem findings reporting data on the infection effects on several organs.
CLINICAL CHARACTERISTICS
4/20/21
Parra-Medina R, Herrera S, Jaime M, et al. | Acta Haematol
Aim: To review cases in the literature about COVID-19 autopsies that reported microthrombi in different organs.
CLINICAL CHARACTERISTICS
4/20/21
Long J, Luo Y, Wei Y, et al. | Am J Emerg Med
Aim: To evaluate the mortality risks associated with CVD and cardiac injury among hospitalized COVID-19 patients, especially in subgroups of populations in different countries.
CLINICAL CHARACTERISTICS
4/17/21
Sing A, Hussain S, Antony B | Diabetes Metab Syndr
Aim: To systematically review the evidence on clinical outcomes in NAFLD patients with COVID-19.
CLINICAL CHARACTERISTICS
4/16/21
Akbar MR, Wibowo A, Pranata R, et al. | Front Nutr
Aim: To assess whether low serum 25-hydroxyvitamin D (25-OHD) level is associated with susceptibility to COVID-19, severity, and mortality related to COVID-19.
CLINICAL CHARACTERISTICS
4/16/21
Zuin M, Rigatelli G, Bilato C, et al. | J Interv Card Electrophysiol
Aim: To investigate the pooled prevalence of pre-existing AF and its short-term mortality risk in COVID-19 patients.
CLINICAL CHARACTERISTICS
4/15/21
Kashetsky N, Mukovozov IM, Bergman J. | J Cutan Med Surg
Aim: To summarize reports of CLL coinciding with SARS-CoV-2 infection to clarify the prevalence, clinical relevance, and prognostic value of these lesions.
CLINICAL CHARACTERISTICS
4/15/21
Nopsopon T, Kittrakulrat J, Takkavatakarn K, et al. | Kidney Int Rep
Aim: To evaluate the prevalence and case fatality rate (CFR) of COVID-19 infection in ESRD patients with hemodialysis, peritoneal dialysis, and kidney transplantation.
CLINICAL CHARACTERISTICS
4/15/21
Nopsopon T, Pongpirul W, Takkavatakarn K, et al. | Kidney Int Rep
Aim: To evaluate the prevalence and case fatality rate (CFR) of COVID-19 infection in ESRD patients with hemodialysis.
CLINICAL CHARACTERISTICS
4/15/21
Nopsopon T, Eiamsitrakoon T, Takkavatakarn K, et al. | Kidney Int Rep
Aim: To evaluate the prevalence and case fatality rate (CFR) of COVID-19 infection in PD patients.
CLINICAL CHARACTERISTICS
4/15/21
Nopsopon T, Kittrakulrat J, Takkavatakarn K, et al. | Kidney Int Rep
Aim: To evaluate the prevalence and case fatality rate (CFR) of COVID-19 infection in KT patients.
CLINICAL CHARACTERISTICS
4/14/21
Qi K, Zeng W, Ye M, et al. | Medicine
Aim: To describe the clinical, laboratory, and imaging characteristics of children with COVID-19 based on published data of pediatric COVID-19 cases.
CLINICAL CHARACTERISTICS
4/14/21
Mondal R, Deb S, Shome G, et al. | Mult Scler Relat Disord
Aim: To summarize so far available pieces of evidence documenting de novo novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) mediated spinal cord demyelinating diseases.
UPDATED
CLINICAL CHARACTERISTICS
4/14/21
Flook M, Jackson C, Vasileiou E, et al. | BMC Infect Dis
Aim: To review the evidence on the risk factors for severity, disease, and mortality for COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
4/13/21
Katoto PDMC, Brand AS, Bakan B, et al. | Environ Health
Aim: To review the evidence on whether exposure to acute and chronic air pollution influences the COVID-19 epidemiologic curve.
CLINICAL CHARACTERISTICS
4/13/21
Yao MQ, Zheng QX, Xu J, et al. | Zhejiang Univ Sci B
Aim: To summarize the demographical, clinical, and laboratorial characteristics of non-recurrence and recurrence groups.
CLINICAL CHARACTERISTICS
4/13/21
Handayani DR, Juliastuti H, Nawangsih EN, et al. | Obes Med
Aim: To assess the prognostic value of fasting hyperglycemia in patients with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
4/13/21
Pranata R, Huang I, Lawrensia S, et al. | Pharmacol Rep
Aim: To address the current interest of whether the administration of PPI could increase the susceptibility and risk of poor outcome in COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
4/13/21
Hariyanto TI, Kurniawan A | Nutr Metab Cardiovasc Dis
Aim: To analyze the association between statin use and composite poor outcomes of COVID-19.
CLINICAL CHARACTERISTICS
4/13/21
Trimboli P, Camponovo C, Scappaticcio L, et al. | Rev Endocr Metab Disord
Aim: To review the evidence on thyroid dysfunction in COVID-19 patients.
CLINICAL CHARACTERISTICS
4/12/21
Greyson SR, Auerbach AD, Mitchell MD, et al. | J Gen Intern Med
Aim: To review published guidance and collected discharge protocols and procedures to identify and synthesize common practices.
CLINICAL CHARACTERISTICS
4/12/21
Jafari Z, Kolb BE, Mohajerani MH | Can J Neurol Sci
Aim: To systematically review current evidence regarding hearing loss, tinnitus, and dizziness caused by SARS-CoV-2, as well as determine the occurrence frequency of these symptoms through a meta-analysis.
CLINICAL CHARACTERISTICS
4/12/21
Damayanthi HDWT, Prabani KIP | Arch Gerontol Geriatr
Aim: To identify the prevalence of malnutrition and levels of nutrients associated with outcomes of the older patients with COVID-19.
CLINICAL CHARACTERISTICS
4/12/21
Zhang Y, Cen M, Hu M, et al. | Clin Transl Gastroenterol
Aim: To evaluate the prevalence and the duration of shedding of fecal RNA in patients with COVID-19 infection.
CLINICAL CHARACTERISTICS
4/12/21
Palaiodimou L, Stefanou MI, Katsanos AH, et al. | Eur J Neurol
Aim: To critically appraise the published literature related to GBSs and COVID-19, and evaluate prevalence, clinical features and outcomes of GBSs in pateints with COVID-19 compared to non-COVID-19 contemporary or historical controls.
UPDATED
CLINICAL CHARACTERISTICS
4/12/21
Dhouib W, Maatoug J, Ayouni I, et al. | Syst Rev
Aim: To identify studies that recruited symptomatic patients, regardless of sex or age diagnosed with COVID-19, and calculated or estimated the incubation period between December 2019 and December 2020.
UPDATED
CLINICAL CHARACTERISTICS
4/8/21
Mutiawati E, Fahriani M, Mamada SS, et al. | F1000Res
Aim: To determine the global prevalence of anosmia and dysgeusia in coronavirus disease 2019 (COVID-19) patients and to assess their association with severity and mortality of COVID-19. 
UPDATED
CLINICAL CHARACTERISTICS
4/8/21
Saragih ID, Saragih IS, Batubara SO, et al. | Geriatr Nurs
Aim: To systematically examine the association between dementia and mortality among older adults with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
4/8/21
Islam MA, Kundu S, Alam SS, et al. | PLoS One
Aim: To conduct a systematic review and meta-analysis to estimate the overall pooled prevalence of fever and chills in addition to fever characteristics (low, medium, and high temperature) in both adult and paediatric COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
4/7/21
Saha S, Al-Rifai RH, Saha S | J Diabetes Metab Disord
Aim: To quantify the overall and subgroup weighted prevalence of mortality among diabetic (primary outcome) and non-diabetic (secondary outcome) and the weighted prevalence of DM (secondary outcome), in hospitalized COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
4/7/21
Zuin M, Rigatelli G, Bilato C, et al. | QJM
Aim: To perform a systematic review and meta-analysis of prevalence and mortality risk in COVID-19 patients with pre-existing dyslipidaemia.
CLINICAL CHARACTERISTICS
4/7/21
Camara AB, Brandao IA | Curr Med Chem
Aim: To study the receptor's family and functions most related to COVID-19 infection, also suggesting the tissue and cell location that the majority of COVID-19 receptors are mainly expressed.
CLINICAL CHARACTERISTICS
4/6/21
Alzahrani SH, Al-Rabia MW | Cardiol Res Pract
Aim: To assess the role of cardiac injury biomarkers measured on admission and during hospitalization as risk factors for subsequent death in COVID-19 patients.
CLINICAL CHARACTERISTICS
4/6/21
Mardi P, Esmaeili M, Iravani P, et al. | Front Pediatr
Aim: To assess the demographic, laboratory, and clinical characteristics of children with KD-like syndrome during the COVID-19 pandemic and evaluate efficacy of treatments and patients' outcome. 
CLINICAL CHARACTERISTICS
4/6/21
Hoang T | Ann Glob Health
Aim: To examine the characteristics of repositive COVID-19 cases.
UPDATED
CLINICAL CHARACTERISTICS
4/6/21
Hariyanto TI, Kurniawan A | J Diabetes Metab Disord
Aim: To analyze the potential association between DPP-4 inhibitor and the composite poor outcome of COVID-19.
CLINICAL CHARACTERISTICS
4/6/21
Kollias A, Kyrikoulis KG, Lagou S, et al. | Vasc Med
Aim: To review the current evidence regarding the prevalence of VTE in patients with COVID-19 screened/assessed with lower limb ultrasonography or computed tomography pulmonary angiography.
UPDATED
CLINICAL CHARACTERISTICS
4/5/21
Mirbeyk M, Saghazadeh A, Rezaei N | Arch Gynecol Obstet
Aim: To review the evidence concerning pregnant women with confirmed COVID-19 and their neonates.
CLINICAL CHARACTERISTICS
4/5/21
Kopanska M, Banas-Zabczyk A, Lagowska A, et al. | J Clin Med
Aim: To review the latest research on changes in EEG in patients with COVID-19 as a basis for further quantitative electroencephalogram (QEEG) diagnostics and EEG neurofeedback training. 
CLINICAL CHARACTERISTICS
4/5/21
Lee KW, Yap SF, Ngeow YF, et al.  | Int J Environ Res Public Health
Aim: To determine the epidemiological characteristics, clinical signs and symptoms, blood parameters, and clinical outcomes among PLHIV who contracted COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
4/5/21
Chmielewska B, Barratt I, Townsend R, et al. | Lancet Glob Health
Aim: To assess the collective evidence on the effects on maternal, fetal, and neonatal outcomes of the pandemic.
UPDATED
CLINICAL CHARACTERISTICS
4/5/21
Váncsa S, Dembrovsky F, Farkas N, et al.  | Viruses
Aim: To evaluate the clinical significance of repeatedly positive testing after coronavirus disease 2019 (COVID-19) recovery.
UPDATED
CLINICAL CHARACTERISTICS
4/5/21
Wildwing T, Holt N | Ther Adv Chronic Dis
Aim: To summarize findings from a systematic overview of systematic reviews of the neurological symptoms seen in patients with COVID-19. 
CLINICAL CHARACTERISTICS
4/5/21
Zhao Y, Jin Y, Rao W, et al. | J Affect Disord
Aim: To compare the prevalence of psychiatric comorbidities in all subpopulations during the SARS and COVID-19 epidemics.
UPDATED
CLINICAL CHARACTERISTICS
4/5/21
Marchi R, Sugita B, Centa A, et al. | Infect Genet Evol
Aim: To describe the role, function, and association of miRNAs in SARS-CoV-2 human infection and COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
4/5/21
Gisondi P, Di Leo S, Bellinato F, et al. | Dermatol Ther
Aim: To systematically review the studies reporting the time of onset of selected skin lesions with respect to the reported onset of the COVID-19 core symptoms.
UPDATED
CLINICAL CHARACTERISTICS
4/2/21
Zhao Y, Zhao L, Yang X, et al. | Rev Cardiovasc Med
Aim: To find the association between COVID-19 and cardiovascular complications. 
CLINICAL CHARACTERISTICS
4/2/21
Zhang L, Hou J, Ma FZ, et al. | Arch Virol
Aim: To identify risk factors for COVID-19 severity and mortality. 
UPDATED
CLINICAL CHARACTERISTICS
4/1/21
Zhang X, Lewis AM, Moley JR | Sci Rep
Aim: To investigate the relationship between adverse COVID-19 outcomes and obesity.
CLINICAL CHARACTERISTICS
4/1/21
Baral R, Tsampasian V, Debski M, et al. | JAMA Netw Open
Aim: To conduct an updated and comprehensive systematic review and meta-analysis comparing mortality and severe adverse events (AEs) associated with receipt vs nonreceipt of ACEIs or ARBs among patients with COVID-19.
CLINICAL CHARACTERISTICS
4/1/21
Shi Y, Guo M, Yang W, et al. | Expert Rev Vaccines
Aim: To investigate the impact of SARS-CoV-2 on neurodegenerative diseases and the latest developments in COVID-19 vaccines.
CLINICAL CHARACTERISTICS
4/1/21
Yassin A, Nawaiseh M, Shaban A, et al.  | BMC Neurol
Aim: To address the neurological aspects of COVID-19 including NM, NC, and ND findings.
UPDATED
CLINICAL CHARACTERISTICS
4/1/21
Zakka K, Chidambaram S, Mansour S, et al. | Obes Surg
Aim: To evaluate the outcomes of COVID-19 patients suffering from obesity, and the effect of the COVID-19 pandemic on the obesity pandemic itself.
CLINICAL CHARACTERISTICS
3/30/21
Tang K, Hsu B, Chen D | Front Immunol
Aim: To review the evidence on the autoimmune and rheumatic manifestations associated with COVID-19.
CLINICAL CHARACTERISTICS
3/30/21
Aski BH, Anari AM, Choobdar FA, et al. | Int J Cardiol Heart Vasc
Aim: To systematically assess the incidence of such cardiac abnormalities due to MIS-C in children suffering Covid-19.
CLINICAL CHARACTERISTICS
3/30/21
Papadopoulos V, Koutroulos MV, Zikoudi DG, et al. | Diabetol Int
Aim: To examine diabetes-related acute metabolic emergencies in COVID-19 patients
UPDATED
CLINICAL CHARACTERISTICS
3/30/21
Kaminska H, Szarpak L, Kosior D, et al. | Acta Diabetol
Aim: To summarize and synthesize the evidence published about the impact of diabetes mellitus on in-hospital mortality in patients with COVID-19.
CLINICAL CHARACTERISTICS
3/30/21
Peter HJ, Vancsa S, Ocskay K, et al. | Front Med
Aim: To evaluate if MAFLD or NAFLD are associated with a more severe disease course of COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
3/30/21
Vidale S | Cerebrovasc Dis
Aim: To describe the clinical features and etiological characteristics of ischemic stroke patients with CO-VID-19 infection.
CLINICAL CHARACTERISTICS
3/30/21
Iheanacho CO, Odili VU, Eze UIH | Futur J Pharm Sci
Aim: To systematically review available evidence for associations between exposure to RAAS inhibitors with susceptibility to SARS-CoV-2 infection and clinical outcomes in infected persons.
CLINICAL CHARACTERISTICS
3/30/21
Mahat RK, Panda S, Rathore V, et al. | Clin Epidemiol Glob Health
Aim: To evaluate the association of inflammatory parameters with the severity and mortality in COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
3/30/21
Petrelli F, Luciani A, Perego G, et al. | J Steroid Biochem Mol Biol
Aim: To assess the association between vitamin D and risk, severity, and mortality for COVID-19 infection.
CLINICAL CHARACTERISTICS
3/29/21
Gabbai-Armelin PR, de Oliveira AB, Ferrisse TM, et al. | Eur J Clin Invest
Aim: To review the evidence on the relation of COVID-19 and thrombotic events and identify prognostic factors.
UPDATED
CLINICAL CHARACTERISTICS
3/29/21
Nahshon C, Segev Y, Schmidt M, et al. | J Chemother
Aim: To review the evidence on the outcomes of diagnosed COVID-19 cancer patients.
CLINICAL CHARACTERISTICS
3/29/21
Li Y, Ashcroft T, Chung A, et al. | J Glob Health
Aim: To synthesise all available evidence regarding the risk factors for poor outcomes in hospitalised COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
3/29/21
Gratz J, Miegele M, Maleczek M, et al. | Front Med
Aim: To provide robust estimates of clinically relevant VTE incidence rates in adult critically ill patients with COVID-19 together with estimates of bleeding rates.
CLINICAL CHARACTERISTICS
3/26/21
Cheng S, Zhao Y, Wang F, et al. | Medicine
Aim: To estimate the association of chronic comorbidities in severe and non-severe cases.
CLINICAL CHARACTERISTICS
3/26/21
Castiello T, Georgiopoulous G, Finocchiaro G, et al. | Heart Fail Rev
Aim: To review the challenges in the early diagnosis and management of myocarditis in patients with COVID-19 infection.
UPDATED
CLINICAL CHARACTERISTICS
3/26/21
Dubey P, Thakur B, Reddy S, et al. | BMC Pregnancy Childbirth
Aim: To review the evidence on any geographicaly differences in pregnant women with COVID-19.
CLINICAL CHARACTERISTICS
3/25/21
Gerayeli FV, Milne S, Cheung C, et al. | EClinicalMedicine
Aim:  To determine whether COPD is a risk factor for poor outcomes in COVID-19, focusing on the specific endpoints of hospitalization, severe disease, and mortality.
UPDATED
CLINICAL CHARACTERISTICS
3/25/21
Kong X, Qi Y, Huang J, et al.  | Cancer Lett
Aim: To review the evidence on the prevalence of cancer in coronavirus disease 2019 (COVID-19)-infected patients and the severe illness incidence and mortality of COVID-19 patients with cancer.
UPDATED
CLINICAL CHARACTERISTICS
3/25/21
Hayashi Y, Wagatsuma K, Nojima M, et al. | J Gastroenterol
Aim: To undertake a systematic review and meta-analysis to determine whether the presence of gastrointestinal (GI) symptoms contributed toward COVID-19 severity, and identify the GI symptoms characteristic of severe COVID-19.
CLINICAL CHARACTERISTICS
3/24/21
Kasemi A, Mohammadi V, Aghababaee SK, et al. | Adv Nutr
Aim: To summarize and clarify the evidence on the association between 25(OH)D concentrations and COVID-19 risk and outcomes.
UPDATED
CLINICAL CHARACTERISTICS
3/24/21
Almufarrij I, Munro K | Int J Audiol
Aim: To systematically review the literature to December 2020, in order to provide a timely summary of evidence on SARS-CoV-2, COVID-19 and audio-vestibular symptoms.
UPDATED
CLINICAL CHARACTERISTICS
3/24/21
Longchamp G, Manzocchi-Besson S, Longchamp A, et al. | Thromb J
Aim: To systematically review and meta-analyze the risk of clinically relevant VTE in patients hospitalized for COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
3/24/21
So M, Kabata H, Fukunaga K, et al. | BMC Pulm Med
Aim: To clarify the characteristics of radiological and functional lung sequelae of COVID-19 patients described in follow-up period.
CLINICAL CHARACTERISTICS
3/23/21
Artusi CA, Romagnolo A, Ledda C, et al. | J Parkinsons Dis
Aim: To assess whether the prevalence and outcome of COVID-19 in PD patients are different from those observed in the general population.
CLINICAL CHARACTERISTICS
3/23/21
Peng J, Wang Q, Mei H, et al. | Aging
Aim: To investigate the association between fungal co-infection and mortality due to COVID-19.
CLINICAL CHARACTERISTICS
3/23/21
Tiruneh SA, Tesema ZT, Azanaw MM, et al. | Syst Rev
Aim: To assess the pooled incidence of COVID-19 complications and to identify the association between the incidence of complications and age.
UPDATED
CLINICAL CHARACTERISTICS
3/23/21
Teshome A, Adane A, Girma B, et al. | Front Public Health
Aim: To summarize the available evidence regarding the association between Vitamin D levels and the risk of COVID-19 infection.
CLINICAL CHARACTERISTICS
3/22/21
Menon T, Sharma R, Earthineni G, et al. | Cureus
Aim: To measure whether GI manifestations warrant the testing for SARS-CoV-2 alone or in combination with lung manifestations and the association of GI manifestations with severe disease and mortality. 
CLINICAL CHARACTERISTICS
3/22/21
Ssentongo P, Heilbrunn ES, Ssentongo A, et al. | Sci Rep
Aim: To conduct a systematic review and meta-analysis of the prevalence of HIV in patients hospitalized for COVID-19 and delineating clinical outcomes including mortality.
UPDATED
CLINICAL CHARACTERISTICS
3/22/21
Zinellu A, Paliogiannis P, Carru C, et al. | Int J Infect Dis
Aim: To review the clinical implications of SAA concentrations in patients with COVID-19.
CLINICAL CHARACTERISTICS
3/22/21
Dono F, Nucera B, Lanzone J, et al. | Epilepsy Behav
Aim: To summarize the available data on clinical features, diagnosis, and therapy of SE associated with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
3/22/21
Wei SQ, Bilodeau-Bertrand MB, Liu S, et al.  | CMAJ
Aim: To evaluate the association between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during pregnancy and adverse pregnancy outcomes.
CLINICAL CHARACTERISTICS
3/22/21
Zhao Y, Yin L, Jenil P, et al. | J Med Virol
Aim: To characterize inflammatory markers of MIS-C patients with COVID-19, Kawasaki disease (KD), and coronary artery abnormalities. 
UPDATED
CLINICAL CHARACTERISTICS
3/22/21
Barbalho SM, Matias JN, Flato UAP, et al. | Gastroenterology Res
Aim: To evaluate what influenza and COVID-19 may represent for patients with IBD.
CLINICAL CHARACTERISTICS
3/19/21
Zhang XM, Jiao J, Cao J, et al. | BMC Geriatr
Aim: To systematically review and quantify the results of the associations between frailty and mortality.
UPDATED
CLINICAL CHARACTERISTICS
3/18/21
Karimi L, Makvandi S, Vahedian-Azimi A, et al. | J Pregnancy
Aim: To investigate the effects of coronavirus disease 2019 (COVID-19) on mortality of pregnant and postpartum women.
CLINICAL CHARACTERISTICS
3/18/21
Cares-Marambio K, Montenegro-Jimenez Y, Torres-Castro R, et al. | Chron Respir Dis
Aim: To determine the prevalence of respiratory symptoms in survivors of hospital admission after COVID-19 infection.
UPDATED
CLINICAL CHARACTERISTICS
3/18/21
Giovanella L, Ruggeri RM, Ovcaricek PP, et al. | Clin Transl Imaging
Aim: To assess the prevalence of thyroid dysfunction in patients with COVID-19.
CLINICAL CHARACTERISTICS
3/18/21
Hassib M, Hamilton S, Elkhouly A, et al. | Cureus
Aim: To assess whether ACEi/ARB use in patients with COVID-19 conferred worsened severity of illness or increased mortality.
CLINICAL CHARACTERISTICS
3/18/21
Kazemi E, Nejat RS, Ashkan F, et al. | Ann Clin Microbiol Antimicrobiol
Aim: To show the differences of laboratory findings of COVID-19 patients with different severity and survivability who had been admitted in hospital.
CLINICAL CHARACTERISTICS
3/16/21
Kaur A, Setia AS, Kashyap A, et al. | Eur J Mol Clin Med
Aim: To highlight the existing literature and organize data associating the mortality of coronavirus disease 2019 (COVID-19) in patients with and without asthma.
CLINICAL CHARACTERISTICS
3/16/21
Dalia T, Lahan S, Ranka S, et al. | Indian Heart J
Aim: To delineate the influence of various cardiac conditions (especially CHF) on outcomes of patients with COVID-19 and to determine the prognostic value of cardiac biomarkers — Troponin I, Creatine Kinase-MB (CK-MB), and N-terminal-proB-type Natriuretic Peptide (NT-proBNP).
CLINICAL CHARACTERISTICS
3/15/21
Mackey K, Arkhipova-Jenkins I, Armstrong C, et al. | Agency for Healthcare Research and Quality
Aim: To synthesize evidence on the prevalence, levels, and durability of the antibody response to SARS-CoV-2 infection among adults and how antibodies correlate with protective immunity.
CLINICAL CHARACTERISTICS
3/15/21
Allotey J, Stallings E, Bonet M, et al. | BMJ
Aim: To determine the clinical manifestations, risk factors, and maternal and perinatal outcomes in pregnant and recently pregnant women with suspected or confirmed coronavirus disease 2019 (covid-19).
UPDATED
CLINICAL CHARACTERISTICS
3/12/21
Oltean I, Tran J, Lawrence S, et al. | Heliyon
Aim: To illustrate findings in a narrative fashion pertaining to SARS-CoV-2 on placental pathology, maternal, and neonatal outcomes.
UPDATED
CLINICAL CHARACTERISTICS
3/11/21
Pellicori P, Doolub G, Wong CM, et al. | Cochrane Database Syst Rev
Aim: To assess the prevalence of pre?existing cardiovascular comorbidities associated with suspected or confirmed cases of COVID?19 in a variety of settings, including the community, care homes and hospitals. 
UPDATED
CLINICAL CHARACTERISTICS
3/11/21
Alkhathami M, Advani SM, Abalkhail AA, et al. | Lung India
Aim: To determine the prelavence and mortality of chronic lung diseases which include COPD, lung cancer, asthma, and cystic fibrosis in confirmed COVID-19 cases.
UPDATED
CLINICAL CHARACTERISTICS
3/11/21
Wang Q, Liu J, Shao R, et al.  | Rheumatol Int
Aim: To integrate data on the epidemiology of COVID-19 in the RD population and to analyze the risk of COVID-19 infection and its complications in RD patients compared with the general population.
UPDATED
CLINICAL CHARACTERISTICS
3/10/21
Kumar P, Jindal K, Aggarwal S, et al. | Indian J Orthop
Aim: To ascertain the impact of a co-existent infection on the 30-day mortality and inpatient mortality of patients with hip fractures including neck femur, intertrochanteric and subtrochanteric fractures. 
CLINICAL CHARACTERISTICS
3/10/21
Osman M, Klopfenstein T, Belfeki N, et al. | Viruses
Aim: To compare the clinical features and outcome, laboratory, and radiological findings of COVID-19 patients with influenza adult patients.
CLINICAL CHARACTERISTICS
3/10/21
Pal R, Banerjee M, Mukherjee S, et al. | Ther Adv Endocrinol Metab
Aim: To provide a precise summary of the effect of DPP4i use (preadmission or in-hospital) and mortality in COVID-19 patients with diabetes mellitus (DM).
UPDATED
CLINICAL CHARACTERISTICS
3/10/21
Hashan MR, Smoll N, King C, et al. | EClinicalMedicine
Aim: To define the epidemiology of COVID-19 outbreaks in RACFs to estimate the epidemiological index of the disease for these vulnerable populations.
UPDATED
CLINICAL CHARACTERISTICS
3/10/21
Gawronska K, Lorkowski J | Geriatr Orthop Surg Rehabil
Aim: To present the possible correlation between COVID-19 and diseases of the musculoskeletal system, in particular the occurrence of fall-related injuries.
CLINICAL CHARACTERISTICS
3/10/21
SeyedAlinaghi S, Afsahi AM, MohsseniPour M, et al. | Arch Acad Emerg Med
Aim: To investigate the available evidence for long-term complications of COVID-19.
CLINICAL CHARACTERISTICS
3/10/21
Gallastegui N, Zhou JY, von Drygalski A, et al. | Clin Appl Thromb Hermost
Aim: To estimate the incidence of PE during hospitalization for COVID19 within and outside ICUs.
CLINICAL CHARACTERISTICS
3/8/21
Macedo A, Gonçalves N, Febra C, et al. | Ann Epidemiol
Aim: To evaluate the mortality of COVID-19.
CLINICAL CHARACTERISTICS
3/8/21
Peddapalli A, Gehani M, Kalle AM, et al. | Viruses
Aim: To review various mechanisms of excess immune response in adult COVID-19 patients
CLINICAL CHARACTERISTICS
3/8/21
Sarma P, Bhattacharyya A, Kaur H, et al. | Indian J Pharmacol
Aim: To evaluate the efficacy and safety of steroid therapy among all severity categories of patients with COVID-19 (mild to moderate and severe to critical category) in terms of "mortality," "requirement of mechanical ventilation," "requirement of ICU" and clinical cure parameters.
UPDATED
CLINICAL CHARACTERISTICS
3/8/21
Shehab M, Alrashed F, Shuaibi S, et al. | BMJ Open Gastroenterol
Aim: To evaluate the prevalence of GI, liver function test (LFT) abnormalities, and mortality of COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
3/8/21
Booth A, Reed AB, Ponzo S, et al. | PLoS One
Aim: To systematically map all the available evidence on the association of various clinical, demographic, and lifestyle variables with the risk of specific adverse outcomes in patients with COVID?19.
UPDATED
CLINICAL CHARACTERISTICS
3/8/21
Sansone P, Giaccari LG, Aurilio C, et al. | Life
Aim: To give a comprehensive overview of the demographic characteristics, clinical features, diagnostic investigations, and outcome of SARS-CoV-2-related GBS patients. 
CLINICAL CHARACTERISTICS
3/8/21
Jamshidi P, Hajikhani B, Mirsaeidi M, et al. | Front Med
Aim: To investigate the prevalence and characteristics of cutaneous manifestations in COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
3/8/21
Wibowo A, Pranata R, Akbar MR, et al. | Int J Infect Dis
Aim: To assess the prognostic value of elevated troponin above the 99th percentile upper reference limit (URL) on mortality and factors affecting their relationship.
CLINICAL CHARACTERISTICS
3/8/21
Akbar MR, Pranata R, Wibowo A, et al. | Diabetes Metab Syndr
Aim: To evaluate the association between the elevated CK and severity and mortality in COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
3/7/21
Tondas AE, Mulawarman R, Trifitriana M, et al. | J Infect Dev Ctries
Aim: To investigate the electrocardiographic (ECG) ventricular repolarization indices in patients with COVID-19.
CLINICAL CHARACTERISTICS
3/6/21
Li Z, Li X, Shen J, et al. | Environ Sci Pollut Res Int
Aim: To systematically review case reports on COVID-19-associated MFS, including the electrophysiological and clinical phenotypes.
CLINICAL CHARACTERISTICS
3/5/21
Sinclair JE, Zhu Y, Xu G, et al. | iScience
Aim: To analyze the association of host co-morbidities (chronic respiratory illnesses, cardiovascular disease [CVD], hypertension or diabetes mellitus [DM]) with the acute cardiovascular complications associated with SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
3/5/21
Vahedian-Azimi A, Karimi L, Makvandi S, et al. | Adv Exp Med Biol
Aim: To investigate whether the causative agent of COVID-19 is found in semen. 
CLINICAL CHARACTERISTICS
3/5/21
Sheth A, Modi M, Dawson D, et al. | Sci Rep
Aim: To summarize the evidence regarding the prognostic relevance of cardiac biomarkers from data available in published reports.
CLINICAL CHARACTERISTICS
3/5/21
Makvandi S, Mahdavian M, Kazemi-Nia G, et al. | Adv Exp Med Biol
Aim: To report clinical symptoms, laboratory findings, and obstetrical complications, maternal, fetal, and neonatal complications of COVID-19 infection in pregnant women.
CLINICAL CHARACTERISTICS
3/5/21
Heidari-Beni F, Vahedian-Azimi A, Shojaei S, et al. | Adv Exp Med Biol
Aim: To investigate PCT levels in severe COVID-19 patients.
CLINICAL CHARACTERISTICS
3/4/21
Yang Y, Luo K, Jiang Y, et al. | J Nutr Health Aging
Aim: To synthesize the current studies to investigate impact of frailty on COVID-19 outcomes and provide evidence-based decisions in clinical practice.
CLINICAL CHARACTERISTICS
3/2/21
Simons D, Shahab L, Brown J, et al. | Addiction
Aim: To estimate the association of smoking status with rates of i) infection, ii) hospitalisation, iii) disease severity, and iv) mortality from SARS?CoV?2/COVID?19 disease.
UPDATED
CLINICAL CHARACTERISTICS
3/1/21
Sahranavard M, Rezayat AA, Bidary MZ, et al. | Arch Iran Med
Aim: To review the evidence on cardiac complications in patients with COVID-19.
CLINICAL CHARACTERISTICS
3/1/21
Liang C, Zhang W, Li S, et al. | Med Clin
Aim: To search the association between coronary heart disease and the prognosis of COVID-19 patients.
CLINICAL CHARACTERISTICS
3/1/21
Willi S, Luthold R, Hunt A, et al. | Travel Med Infect Dis
Aim: To evaluate the available evidence of all intermediate and long-term COVID-19 sequelae affecting formerly healthy adults.
CLINICAL CHARACTERISTICS
3/1/21
Toba N, Gupta S, Ali AY, et al. | Pediatr Pulmonol
Aim: To understand the clinical characteristics of COVID-19 in children.
CLINICAL CHARACTERISTICS
3/1/21
Yang L, Chai P, Yu J, et al. | Cancer Biol Med
Aim: To investigate cancer incidence in patients with COVID-19 and to determine whether cancer was associated with mortality among patients with COVID-19.
CLINICAL CHARACTERISTICS
3/1/21
Samadder S | Front Public Health
Aim: To identify the possible cause of secondary pneumonia infection observed in COVID-19 patients.
CLINICAL CHARACTERISTICS
3/1/21
Tassone D, Thompson A, Connell W, et al. | Intern Med J
Aim: To determine whether immunosuppressed patients are at higher risk of COVID-19 to help inform the management of patients receiving immunosuppressant therapies during the pandemic.
CLINICAL CHARACTERISTICS
3/1/21
Zhou X, Cheng Z, Luo L, et al. | Thromb Res
Aim: To evaluate the prevalence of disseminated intravascular coagulation (DIC) in COVID-19 patients and to determine the association of DIC with the severity and prognosis of COVID-19.
CLINICAL CHARACTERISTICS
3/1/21
Tang Y, Li W, Baskota M, et al. | Transl Pediatr
Aim: To describe the clinical features, treatment and outcomes of MIS-C, as well as to assess the risk of bias of published case studies, analyzing their reporting quality.
CLINICAL CHARACTERISTICS
3/1/21
Poly TN, Islam M, Yang HC, et al. | Front Med
Aim: To evaluate the effect of obesity, associated comorbidities, and other factors on the risk of death due to COVID-19. 
CLINICAL CHARACTERISTICS
3/1/21
Aghili SMM, Ebrahimpur M, Arjmand B, et al. | Int J Obes
Aim: To clarify the obesity relationship with COVID-19 severity, comorbidities, and discussing possible mechanisms.
CLINICAL CHARACTERISTICS
3/1/21
Singh AK, Jena A, Kumar-M P, et al. | United European Gastroenterol J
Aim: To investigate the risk of the acquisition of SARS-CoV-2 in patients with IBD, and to estimate whether the drugs affect the risk of acquisition and outcomes of SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
3/1/21
Barlow-Pay F, Htut TW, Khezrian M, et al. | Ther Adv Drug Saf
Aim: To summarize the current international clinical guidelines to highlight areas where research is needed through critical appraisal of the evidence base of these guidelines.
CLINICAL CHARACTERISTICS
3/1/21
Naveed H, Elshafeey A, Al-Ali D, et al. | J Clin Pharmcol
Aim: To compare specific blood markers in both groups of COVID-19 patients in order to gain a better insight into the interaction of ACEi/ARBs with the different body functions during the infection.
CLINICAL CHARACTERISTICS
2/28/21
Karruli A, Spiezia S, Boccia F, et al. | Transpl Infect Dis
Aim: To assess the effect of continuing immune suppressive therapy in solid organ transplant recipients (SOTR) with coronavirus disease 2019 (COVID-19).
CLINICAL CHARACTERISTICS
2/26/21
Tan BK, Mainbourg S, Friggeri A, et al. | Thorax
Aim: To review the evidence on the prevalence of venous thromboembolic event (VTE) and arterial thromboembolic event (ATE) thromboembolic events in patients with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
2/26/21
Mishra P, Parveen R, Bajpai R, et al. | Ann Acad Med Singap
Aim: To find the probable association between cardiovascular disease with disease severity and mortality in COVID-19 patients.
CLINICAL CHARACTERISTICS
2/26/21
Bentivegna M, Hulme C, Ebell MH | J Am Board Fam Med
Aim: To summarize the best available evidence regarding individual risk factors, simple risk scores, and multivariate models that use patient characteristics, vital signs, comorbidities, and laboratory tests in inpatients.
UPDATED
CLINICAL CHARACTERISTICS
2/26/21
Hurtado-Diaz M, de la Cruz JC, Blanco-Munoz J, et al. | Salud Publica de Mexico
Aim: To summarize and analyze the evidence of the association between Covid-19 and climatic factors. 
CLINICAL CHARACTERISTICS
2/25/21
Zhang H, Ma S, Han T, et al. | Eur J Integr Med
Aim: To review the evidence on the influence of smoking history on the severe and critical outcomes on people with COVID-19 pneumonia.
CLINICAL CHARACTERISTICS
2/25/21
McAlpine LS, Fesharaki-Zadeh A, Spusich S | Curr Opin Psychiatry
Aim: To review the outcomes in patients with COVID-19 and NDD.
CLINICAL CHARACTERISTICS
2/25/21
Yin TX, Li Y, Ying Y, et al. | BMC Infect Dis
Aim: To provide systematic evaluation and detailed estimation of prevalence rates of different kinds of common comorbidities in severe and non-severe COVID-19 patients and tries to illustrate the outcomes by combination with underlying pathogenesis to better understand how basic diseases contribute to the aggravation of SARS-CoV-2 infection.
UPDATED
CLINICAL CHARACTERISTICS
2/25/21
Ng JJ, Liang ZC, Choong A | J Intensive Care
Aim: To quantitatively synthesize available literature by using meta-analysis of proportions to estimate the weighted average incidence of PTE in critically ill COVID-19 patients admitted to the intensive care unit (ICU).
UPDATED
CLINICAL CHARACTERISTICS
2/24/21
Corona G, Pizzocaro A, Vena W, et al. | Rev Endocr Metab Disord
Aim: To provide an overview and a meta-analysis of main predictors and of country differences of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection-associated mortality rate (MR) in hospitalized patients. 
UPDATED
CLINICAL CHARACTERISTICS
2/24/21
Ma S, Xu C, Liu S, et al. | Signal Transduct Target Ther
Aim: To address the efficacy and safety of corticosteroids among severe COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
2/24/21
Widyadharma IPE, Hendellyn A, Dewi A | Egypt J Neurol Psychiatr Neurosurg
Aim: To briefly review neurologic manifestation in COVID-19 infection in the Asia region (South East Asia and the Western Pacific Region).
CLINICAL CHARACTERISTICS
2/24/21
Martins MM, Prata-Barbosa A, da Cunha AJLA | Paediatr Int Child Health
Aim: To review the evidence on clinical presentations, ways of transmission, severity and prognosis of SARS-CoV-2 infection in children and adolescents.
CLINICAL CHARACTERISTICS
2/22/21
Soheili M, Moradi G, Baradaran HR, et al. | J Matern Fetal Neonatal Med
Aim: To find out whether COVID-19 may cause different manifestations and outcomes in the antepartum and postpartum period or not.
CLINICAL CHARACTERISTICS
2/22/21
Koeppen M, Rosenberger P, Magunia H | Clin Med Insights Circ Respir Pulm Med
Aim: To assess the prevalence of cardiovascular comorbidities and complications in ICU-admitted coronavirus disease 2019 (COVID-19) patients.
CLINICAL CHARACTERISTICS
2/22/21
Patel RH, Acharya A, Chand HS, et al. | AIDS Res Hum Retroviruses
Aim: To examine trends of clinical outcomes among patients co-infected with HIV and SARS-CoV-2.
CLINICAL CHARACTERISTICS
2/22/21
Hoste L, Van Paemel R, Haerynck F | Eur J Pediatr
Aim: To perform a systematic review of published cases of this novel multisystem inflammatory syndrome in children associated with COVID-19. 
UPDATED
CLINICAL CHARACTERISTICS
2/22/21
Aloqbi HA, Shannaq GY, Douf TA, et al. | Ann Med Health Sci Res
Aim: To determine the prevalence of clinical and radiological manifestations among children and adolescents COVID-19 patients.
CLINICAL CHARACTERISTICS
2/22/21
Ahmed S, Jafri L, Hoodbhoy Z, et al. | Indian J Crit Care Med
Aim: To review the published literature on the prognostic role of serum procalcitonin (PCT) in COVID-19 cases.
CLINICAL CHARACTERISTICS
2/22/21
Gesesew HA, Koye DN, Fetene DM, et al. | BMJ Open
Aim: To provide a comprehensive evidence on risk factors for transmission, disease severity and COVID-19 related deaths in Africa.
CLINICAL CHARACTERISTICS
2/20/21
Permana H, Huang I, Purwiga A, et al. | Pharmacol Rep
Aim: To address the association between the use of statins and risk of mortality in patients with COVID-19.
CLINICAL CHARACTERISTICS
2/19/21
Zhong Z, Li H, Zhu J, et al. | Medicine
Aim: To summarize the clinical characteristics of patients with severe or critically ill coronavirus disease 2019 (COVID-19).
CLINICAL CHARACTERISTICS
2/19/21
Irfan O, Muttalib F, Tang K, et al. | Arch Dis Child
Aim: To compare paediatric COVID-19 disease characteristics, management and outcomes according to World Bank country income level and disease severity.
UPDATED
CLINICAL CHARACTERISTICS
2/19/21
Taherifard E, Taherifard E, Movahed H, et al. | Hematology
Aim: To systematically review the hematologic autoimmune complications in these patients.
CLINICAL CHARACTERISTICS
2/19/21
Javed A | CNS Neurol Disord Drug Targets
Aim: To assess the associated neurological manifestations with SARS CoV-2 infection.
CLINICAL CHARACTERISTICS
2/19/21
Creta M, Sagnelli C, Celentano G, et al. | J Med Virol
Aim: To highlight currently available literature data on the involvement of the urinary and male genital systems in SARS-SoV-2 infection.
CLINICAL CHARACTERISTICS
2/18/21
Shi L, Xu J, Xiao W, et al. | Ann Allergy Asthma Immunol
Aim: To explore the prevalence of asthma in COVID-19 patients and the relationship between asthma and COVID-19 patients with poor outcomes would be of paramount importance.
CLINICAL CHARACTERISTICS
2/18/21
Xu C, Yi Z, Cai R, et al. | Autoimmun Rev
Aim: To summarize the published and preprint literature that described the clinical characteristics and outcomes of COVID-19 patients with rheumatic diseases, and to provide a higher level of evidence for better clinical decision making.
UPDATED
CLINICAL CHARACTERISTICS
2/17/21
Henrina J, Putra ICS, Lawrensia S, et al. | Proj Pediatr Cardiol
Aim: To investigate cardiac manifestations, treatment characteristics, and outcomes of paediatric inflammatory multisystem syndrome (PIMS) temporally associated with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) (PIMS-TS).
CLINICAL CHARACTERISTICS
2/17/21
Roshdy A, Zaher S, Fayed H, et al. | Front Cardiovasc Med
Aim: To report the cardiac tissue autopsy findings in coronavirus disease 2019 (COVID-19) decedents.
UPDATED
CLINICAL CHARACTERISTICS
2/17/21
Maslennikov R, Poluektova E, Ivashkin V, et al. | Infect Dis
Aim: To provide a detailed systematic review of diarrhoea in adults with COVID-19.
CLINICAL CHARACTERISTICS
2/17/21
Atmosudigdo I, Pranata R, Anthonius M, et al.  | J Clin Exp Hepatol
Aim: To evaluate whether dyslipidemia affects the mortality and severity of COVID-19, we also aimed to evaluate whether other comorbidities influence the association.
UPDATED
CLINICAL CHARACTERISTICS
2/17/21
Gao Y, Chen Y, Liu M, et al. | Epidemiol Infect
Aim: To clarify the association between nervous system diseases and severity or mortality in patients with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
2/17/21
Mohamed MFH, A-Shokri S, Yousaf Z, et al. | Front Cardiovasc Med
Aim: To systematically review the literature and explore the pooled prevalence of VTE, PE, and DVT in critically ill COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
2/17/21
Chaudhary R, Garg J, Houghton DE, et al. | Mayo Clin Proc Innov Qual Outcomes
Aim: To evaluate differences in thrombo-inflammatory biomarkers between patients with severe COVID-19 infection/death and mild infection.
CLINICAL CHARACTERISTICS
2/17/21
Jenner WJ, Kanji R, Mirsadraee S, et al. | J Thromb Thrombolysis
Aim: To identify the rate of thrombotic complications in ICU-treated patients with COVID-19, to inform recommendations for diagnosis and management.
CLINICAL CHARACTERISTICS
2/16/21
Chang R, Elhusseiny KM, Yeh Y, et al. | PLoS One
Aim: To review the evidence on COVID-19 intensive care unit (ICU) patient characteristics, rates and risks of invasive mechanical ventilation (IMV) and associated outcomes.
UPDATED
CLINICAL CHARACTERISTICS
2/16/21
Wang J, Zhong Z, Mo Y, et al. | Eur Rev Med Pharmacol Sci
Aim: To determine the incidence of the clinical manifestations of COVID-19 in children.
UPDATED
CLINICAL CHARACTERISTICS
2/16/21
Zinellu A, Mangoini AA | Front Med
Aim: To review the available evidence on the clinical implications of this protein specifically in patients with COVID-19.
CLINICAL CHARACTERISTICS
2/12/21
Ng WH, Tipih T, Makoah NA, et al. | mBio
Aim: To evaluate the correlation between comorbidities and their role in the exacerbation of disease in COVID-19 patients leading to fatal outcomes. 
CLINICAL CHARACTERISTICS
2/11/21
Tur-Kaspa I, Tur-Kaspa T, Hildebrand G, et al. | F S Rev
Aim: To determine if COVID-19 is an STD or not, and to clarify its possible effect on fertility.
CLINICAL CHARACTERISTICS
2/11/21
Yan W, Chen D, Bigambo FM, et al. | BMC Infect Dis
Aim: To determine differences in blood cells, lymphocyte subsets, and cytokines in COVID-19 patients with different clinical stages.
CLINICAL CHARACTERISTICS
2/11/21
Vergara-Merino L, Meza N, Couve-Perez C, et al. | Acta Obstet Gynecol Scand
Aim: To conduct a comprehensive analysis of the current evidence on prognosis of COVID-19 in pregnant women.
CLINICAL CHARACTERISTICS
2/11/21
Jin Y, Trope GE, El-Defrawy S, et al. | Eur J Ophthalmol
Aim: To summarize COVID-19 research endeavors by ophthalmologists/researchers in terms of publication numbers, journals and author countries, and to detail key findings.
CLINICAL CHARACTERISTICS
2/11/21
Bavishi C, Whelton PK, Mancia G, et al. | J Hypertens
Aim: To evaluate the association of angiotensin-converting-enzyme inhibitors (ACEI) or AT1 blockers (ARB) therapy with clinical outcomes in patients with coronavirus disease 2019 (COVID-19).
CLINICAL CHARACTERISTICS
2/10/21
Syangtan G, Bista S, Dawadi P, et al. | Front Public Health
Aim: To review the evidence on the frequency of asymptomatic individuals and estimated occurrence by age group and gender.
UPDATED
CLINICAL CHARACTERISTICS
2/10/21
Jayant K, Reccia I, Virdis F, et al. | Clin Transplant
Aim: To determine the pooled prevalence of outcomes among hospitalized LTx recipients with COVID-19. 
UPDATED
CLINICAL CHARACTERISTICS
2/10/21
Dhar SK, Vishnupriayn K, Damodar S, et al. | Heliyon
Aim: To establish association between induced cytokines and COVID-19 disease severity to help in prognosis and clinical care.
CLINICAL CHARACTERISTICS
2/10/21
Marafini I, Troncone E, Rocchetti I, et al. | Front Pharmacol
Aim: To determine the risk of RTIs with vedolizumab in patients with IBD.
UPDATED
CLINICAL CHARACTERISTICS
2/10/21
Kumar J, Meena J, Yadav A, et al.  | J Matern Fetal Neonatal Med
Aim: To synthesize the current evidence for the presence of SARS-CoV-2 RNA in the human milk of mothers with confirmed COVID-19 and its potential role in neonatal SARS-CoV-2 infection.
UPDATED
CLINICAL CHARACTERISTICS
2/10/21
Umnuaypornlert A, Kanchanasurakit S, Lucero-Prisno DE, et al. | Tob Induc Dis
Aim: To determine the association between smoking and disease severity in COVID-19 infected patients.
UPDATED
CLINICAL CHARACTERISTICS
2/10/21
Dorantes-Acosta E, Ávila-Montiel D, Klünder-Klünder M, et al. | Front Oncol
Aim: To understand the survival and associated complications in pediatric cancer patients as well as their hospitalization, intensive care, and ventilation care (supplemental oxygen/endotracheal intubation) needs.
CLINICAL CHARACTERISTICS
2/10/21
Nassar M, Nso N, Baraka B, et al. | Diabetes Metab Syndr
Aim: To summarize the prevalence, clinical findings, and outcomes of COVID-19 in patients with T1DM, based on the findings of available evidence.
CLINICAL CHARACTERISTICS
2/8/21
Sunjaya AP, Allida SM, Di Tanna GL, et al. | J Asthma
Aim: To summarise evidence on the risk of infection, severe illness and death from COVID-19 in people with asthma.
CLINICAL CHARACTERISTICS
2/8/21
Laurentius A, Mendel B, Prakoso R | Egypt Heart J
Aim: To show clinical outcome of renin-angiotensin-aldosterone system blockers in hospital treatment of hypertensive patients with coronavirus disease 2019
CLINICAL CHARACTERISTICS
2/8/21
Li P, Li L, Wang S, et al. | Cancer Med
Aim: To systematically review the present evidence on the relationship between antitumor therapy and the clinical outcomes of COVID?19 and to analyze and summarize the available studies in this meta?analysis.
CLINICAL CHARACTERISTICS
2/8/21
Servante J, Swallow G, Thornton JG, et al. | BMC Pregnancy Childbirth
Aim: To determine the rate of arterial or venous thrombosis in pregnant women with confirmed or suspected COVID-19 and to estimate the rate of acquired coagulopathy in pregnant women with confirmed or suspected COVID-19.
CLINICAL CHARACTERISTICS
2/8/21
Mir T, Sattar Y, Ahmad J, et al. | Catheter Cardiovasc Interv
Aim: To meta?analyze studies that examined in?hospital cardiac arrest in COVID patients.
CLINICAL CHARACTERISTICS
2/5/21
Beyrouti R, Best JG, Chandratheva A, et al. | J Neurol
Aim: To describe the characteristics of spontaneous symptomatic intracerebral haemorrhage (ICH) associated with COVID-19.
CLINICAL CHARACTERISTICS
2/5/21
Xu Z, Tang Y, Huang Q, et al. | BMC Nephrol
Aim: To evaluate the incidence of AKI in hospitalized COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
2/4/21
Belsky JA, Tullius BP, Lamb MG, et al. | J Infect
Aim: To define clinical features, laboratory testing, therapeutic interventions and outcomes in immunocompromised patients and then compared these results to the general population with COVID-19.
CLINICAL CHARACTERISTICS
2/4/21
Elshazli RM, Kline A, Elgaml A, et al. | J Med Virol
Aim: To identify COVID-19 patients presenting with gastrointestinal (GI) symptoms during the first and second pandemic waves and investigate their association with the disease outcomes.
CLINICAL CHARACTERISTICS
2/4/21
Li G, Yang Y, Gao D, et al. | Int J Med Sci
Aim: To comprehensively explore the prevalence of transaminase elevation and liver injury in COVID-19 patients.
CLINICAL CHARACTERISTICS
2/4/21
Alamer AA, Almulhim AS, Alrashed AA, et al. | Healthcare
Aim: To estimate the pooled risks of mortality and disease severity associated with ACEI/ARB use during the first wave of the pandemic.
CLINICAL CHARACTERISTICS
2/3/21
Naeini MB, Sahebi M, Nikbakht F, et al. | Obes Med
Aim: To quantify meta-analytic findings on the association of cardiovascular disease (CVD) comorbidities and COVID-19 severity.
CLINICAL CHARACTERISTICS
2/3/21
Hatmi ZN | SN Compr Clin Med
Aim: To conduct a systematic review of published systematic reviews to provide comprehensive updated information on COVID-19.
CLINICAL CHARACTERISTICS
2/3/21
He X, Cheng X, Feng X, et al. | Front Public Health
Aim: To review the clinical symptoms of the COVID-19 epidemic systematically.
CLINICAL CHARACTERISTICS
2/3/21
Castaneda CA, Castillo M, Rojas JL, et al. | Rev Peru Med Exp Salud Publica
Aim: To describe the risk of infection and developing severe COVID-19 in cancer patients.
UPDATED
CLINICAL CHARACTERISTICS
2/3/21
Scooppettuolo P, Borrelli S, Naeije G | Brain Behav Immun Health
Aim: To provide a clinical approach of SARS-CoV-2 neurological complications based on the direct or indirect (systemic/immune-mediated) role of the SARS-CoV-2 in their genesis.
CLINICAL CHARACTERISTICS
2/3/21
Nasiri N, Sharifi H, Bazrafshan A, et al. | J Ophthalmic Vis Res
Aim: To investigate the prevalence of ocular manifestations in COVID-19 patients.
CLINICAL CHARACTERISTICS
2/3/21
Cevik M, Tate M, Lloyd O, et al. | Lancet Microbe
Aim: To characterise the viral load dynamics of SARS-CoV-2, duration of viral RNA shedding by RT-PCR, and viable virus shedding in various body fluids, and to compare SARS-CoV-2 viral dynamics with those of SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV).
UPDATED
CLINICAL CHARACTERISTICS
2/1/21
Xiang G, Li X, Chen Z, et al. | Ann Palliat Med
Aim: To systematically review the clinical risk factors for fatal outcome of COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
2/1/21
Li H, Zhao Y, Zhou L, et al. | Dermatol Ther
Aim: To present heterogeneous cutaneous, histopathological manifestations in COVID?19 patients, to investigate the possible relationship between cutaneous manifestations and histopathological features in COVID?19 infection.
CLINICAL CHARACTERISTICS
2/1/21
Pijls BG, Jolani S, Atherley A, et al. | BMJ Open
Aim: To describe the associations of age and sex with the risk of COVID-19 in different severity stages ranging from infection to death.
UPDATED
CLINICAL CHARACTERISTICS
2/1/21
Ghimire S, Sharma S, Patel A, et al. | SN Compr Clin Med
Aim: To provide a more comprehensive and generalizable understanding of the GI manifestations, and its association with severity in COVID-19 patients.
CLINICAL CHARACTERISTICS
2/1/21
Yisak H, Ewunetei A, Kefale B, et al. | Risk Manag Healthc Policy
Aim: To summarize and decide if there were a link between vitamin D status and COVID-19 infection and prognosis.
UPDATED
CLINICAL CHARACTERISTICS
2/1/21
Sood M, Sharma S, Sood I, et al. | SN Compr Clin Med
Aim: To analyse the clinical features, proposed pathogenesis and current treatment options for effective management of children with this novel entity.
CLINICAL CHARACTERISTICS
2/1/21
Diaz LA, Idalsoaga F, Cannistra M, et al. | World J Gastroenterol
Aim: To characterize hepatic pathological findings in patients with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
2/1/21
Wibowo A, Pranata R, Astuti A, et al. | J Intensive Care
Aim: To assess whether ventricular longitudinal strain can be used as a prognostication tool in patients with coronavirus disease 2019 (COVID-19).
UPDATED
CLINICAL CHARACTERISTICS
2/1/21
Yang J, Zheng Y, Gou X, et al. | Int J Infect Dis
Aim: To assess the prevalence of comorbidities in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected patients and the risk of underlying diseases in severe patients compared to non-severe patients.
CLINICAL CHARACTERISTICS
2/1/21
Merola E, Armelao F, de Pretis G | Acta Gastroenterol Belg
Aim: To assess the frequency of gastrointestinal (GI) involvement in COVID-19.
CLINICAL CHARACTERISTICS
2/1/21
Martha JW, Wibowo A, Pranata R | Postgrad Med J
Aim: To evaluate the prognostic performance of elevated lactate dehydrogenase (LDH) in patients with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
2/1/21
Lee HW, Yoon C, Jang EJ, et al. | Thorax
Aim: To investigate if ACEI/ARB use is associated with the risk of mortality and severe disease in patients with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
2/1/21
Zhang T, Huang W, Guan W, et al. | J Thorac Dis
Aim: To review the evidence on the clinical characteristics between severe and non-severe pateints in the outbreak of COVID-19.
CLINICAL CHARACTERISTICS
2/1/21
Uaprasert N, Moonla C, Sosothikul D, et al. | Clin Appl Thromb Hermost
Aim: To estimate the burden of systemic coagulation activation in patients with COVID-19.
CLINICAL CHARACTERISTICS
2/1/21
Chen C, Zhu C, Yan D, et al. | Int J Infect Dis
Aim: To summarize the epidemiological and radiographical characteristics of asymptomatic infections with COVID-19.
CLINICAL CHARACTERISTICS
1/29/21
Peravali M, Joshi I, Ahn J, et al. | JTO Clin Res Rep
Aim: To outline patient characteristics, challenges in diagnosis and treatment, and outcomes of lung cancer patients with COVID-19.
CLINICAL CHARACTERISTICS
1/29/21
Goel H, Gupta I, Mourya M, et al. | Obstet Gynecol Sci
Aim: To review the evidence on the clinical and laboratory parameters of COVID-19.
CLINICAL CHARACTERISTICS
1/29/21
Tleyjeh IM, Bin Abdulhak AA, Tlayjeh H, et al. | Am J Ther
Aim: To perform a meta-analysis of the association between prior use of ACEIs and ARBs and the risk of SARS-CoV-2 infection or hospitalization due to COVID-19 disease.
CLINICAL CHARACTERISTICS
1/29/21
Langford BJ, So M, Raybardhan S, et al. | Clin Microbiol Infect
Aim: To estimate the prevalence and associated factors of antibiotic prescribing in patients with COVID-19.
CLINICAL CHARACTERISTICS
1/29/21
Lee JJ, Montazerin SM, Jamil A, et al. | J Med Virol
Aim: To review and synthesize the current evidence on the association of RDW levels with COVID?19 mortality and severity.
UPDATED
CLINICAL CHARACTERISTICS
1/29/21
Mendes NF, Jara CP, Mansour E, et al. | Allergy Asthma Clin Immunol
Aim: To conduct a systematic review of the diagnosis of asthma as a premorbid condition in patients with COVID-19.
CLINICAL CHARACTERISTICS
1/29/21
Silverio A, Di Maio M, Citro R, et al. | BMC Cardiovasc Disord
Aim: To investigate the relationship between cardiovascular risk factors and in-hospital mortality in patients with COVID-19.
CLINICAL CHARACTERISTICS
1/29/21
Baldini T, Asioli GM, Romoli M, et al. | Eur J Neurol
Aim: To systematically review the available evidence in the literature for cerebral venous thrombosis (CVT) in association with coronavirus disease-2019 (COVID-19).
UPDATED
CLINICAL CHARACTERISTICS
1/29/21
Jafari M, Pormohammad A, Sheikh Neshin SA, et al. | Rev Med Virol
Aim: To provide comprehensive data regarding pregnant patients with SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
1/29/21
Huang C, Soleimani J, Herasevich S, et al. | Mayo Clin Proc
Aim: To synthesize the current and emerging literature describing the clinical features, treatment, outcomes, and risk factors associated with poor prognosis among critically ill patients with COVID-19 during the early months of the pandemic. To provide frontline clinicians with insights for the effective management of severely ill patients with COVID-19. To identify knowledge gaps to guide future research endeavors.
CLINICAL CHARACTERISTICS
1/29/21
Singh AK, Jena A, Kumar-M P, et al. | Intest Res
Aim: To review the evidence on the various clinical manifestations of SARS-CoV-2 in patients with IBD, and to estimate the pooled prevalence of different clinical manifestations.
CLINICAL CHARACTERISTICS
1/29/21
Gholami M, Fawad I, Shadan S, et al. | Int J Infect Dis
Aim: To describe the clinical outcomes and risk factors for SARS- CoV-2 infection in HCW.
CLINICAL CHARACTERISTICS
1/29/21
Yasuhara J, Watanabe K, Takagi H, et al. | Pediatr Pulmonol
Aim: To investigate the epidemiology and clinical course of MIS-C.
CLINICAL CHARACTERISTICS
1/29/21
Parkinson N, Rodgers N, Head Fourman M, et al. | Sci Rep
Aim: To systematically identify and combine existing data from human betacoronavirus research to generate a comprehensive ranked list of host genes involved in COVID-19.
CLINICAL CHARACTERISTICS
1/29/21
Xue Y, Sun S, Cai J, et al. | J Renin Angiotensin Aldosterone Syst
Aim: To conduct a meta-analysis on the effects of ACEI/ARB on disease symptoms and laboratory tests in hypertensive patients infected with COVID-19 virus and those who did not use ACEI/ARB.
CLINICAL CHARACTERISTICS
1/29/21
Yao MQ, Zheng QX, Xu J, et al. | Journal of Zhejiang University-SCIENCE B
Aim: To summarize data on demographic characteristics, clinical features, and laboratory findings in non-recurrence and recurrence groups as well as to explore critical factors associated with COVID-19 recurrence.
CLINICAL CHARACTERISTICS
1/29/21
Barek MA, Aziz MA, Islam MS | Heliyon
Aim: To evaluate the impact of age, sex, comorbidities, and clinical characteristics on the severity of COVID-19 to help diagnose and evaluate the current outbreak in clinical decision-making.
CLINICAL CHARACTERISTICS
1/29/21
Kitano T, Kitano M, Krueger C, et al. | PLoS One
Aim: To better understand the global epidemiology of COVID-19 in children and differences in outcome across countries.
UPDATED
CLINICAL CHARACTERISTICS
1/28/21
Yang J, Ma Z, Lei Y | Epidemiol Infect
Aim: To re-evaluate the relationship between obesity and coronavirus-2019 (COVID-19).
CLINICAL CHARACTERISTICS
1/28/21
Piri SM, Edalatfar M, Shool S, et al. | Infect Dis
Aim: To evaluate rate of SARS-CoV-2 recurrence, changes in disease severity, the interval between negative RT-PCR test for SARS-CoV-2 and disease recurrence, disease and patients’ characteristics, risk factors for predicting recurrence and outcomes, as well as the prognosis of recurrent patients.
CLINICAL CHARACTERISTICS
1/28/21
Bhattacharjee S, Banerjee M, Pal R | Postgraduate Medical J
Aim: To summarise the available literature and provide a pooled analysis of the effect of A/AB (without anti-A antibodies) on clinical outcomes in COVID-19 patients compared with B/O (with anti-A antibodies) blood groups.
CLINICAL CHARACTERISTICS
1/28/21
Paliogiannis P, Mangoni AA, Cangemi M, et al. | Clin Exp Med
Aim: To investigate the associations between serum albumin concentrations and COVID-19 disease severity and adverse outcomes.
CLINICAL CHARACTERISTICS
1/27/21
Hussein MH, Elshazli RM, Attia AS, et al. | J Asthma
Aim: To compare asthmatic and non-asthmatic patients to determine the clinical significance of pre-existing asthma in COVID-19 patients. 
CLINICAL CHARACTERISTICS
1/27/21
Xie J, Wang Q, Xu Y, et al. | Ann Palliat Med
Aim: To summarize the characteristics of COVID-19 patients in the early stage of the pandemic and explore the risk factors of disease progression.
CLINICAL CHARACTERISTICS
1/27/21
Hoogenes B, Queree M, Townson A, et al.  | J Neurotrauma
Aim: To provide an overview of the clinical presentation, course, and outcomes of COVID-19 in persons with SCI and identify risk factors for severe disease- and COVID-19-related mortality.
UPDATED
CLINICAL CHARACTERISTICS
1/27/21
Hariyanto TI, Putri C, Frinka P, et al. | AIDS Res Hum Retroviruses
Aim: To analyze the relationship between HIV and poor outcomes of COVID-19 infection.
CLINICAL CHARACTERISTICS
1/26/21
Hartmann J, Ergang A, Mason D, et al. | Diagnostics
Aim: To review the evidence on thromboelastography for management of patients with COVID-19.
CLINICAL CHARACTERISTICS
1/22/21
Shams S, Rathore SS, Anvekar P, et al. | Dermatol Ther
Aim: To summarize clinical features, histopathological hallmarks, and possible pathology behind the maculopapular skin eruptions occurring in Covid-19 patients.
CLINICAL CHARACTERISTICS
1/22/21
Pajo AT, Espiritu AI, Apor ADAO, et al. | Neurol Sci
Aim: To review the currently available neuropathological data on COVID-19 including post-mortem findings of patients following a death from COVID-19 infection.
UPDATED
CLINICAL CHARACTERISTICS
1/22/21
Lim AYH, GOH JL, Chua MCW, et al. | BMC Pulm Med
Aim: To assess the temporal progression of blood and radiology findings of patients with COVID-19.
CLINICAL CHARACTERISTICS
1/22/21
Oran DP, Topol EJ | Ann Intern Med
Aim: To estimate the proportion of persons infected with SARS-CoV-2 who never develop symptoms.
CLINICAL CHARACTERISTICS
1/20/21
Mameli S, Marcialis MA, Bassareo PP, et al. | Panmiverva Medica
Aim: To review the evidence on the features of liver involvement and damage in the course of COVID-19.
CLINICAL CHARACTERISTICS
1/19/21
Meng J, Ma Y, Jia J, et al. | Front Immunol
Aim: To compare the similarities and differences focusing on ferritin and cytokine levels between severe COVID-19 and active AOSD. 
CLINICAL CHARACTERISTICS
1/19/21
Kim J, Han SC, Jo HD, et al. | J Korean Med Sci
Aim: To investigate the factors that contribute to the inter-study variability in the prevalence of olfactory and gustatory dysfunction.
CLINICAL CHARACTERISTICS
1/19/21
Cunarro-Lopez Y, Pintado-Recarte P, Cueto-Hernandez I, et al. | J Clin Med
Aim: To describe and analyze the profile of the obstetric patients according to the country of origin of the publication.
UPDATED
CLINICAL CHARACTERISTICS
1/18/21
McClatchey K, Jackson T, Delaney B, et al. | J Allergy Clin Immunol Pract
Aim: To explore whether the information addresses relevant health actions to minimize the risk of contracting and spreading COVID-19, and encourages asthma self-management.
CLINICAL CHARACTERISTICS
1/18/21
Zeng W, Qi K, Ye M, et al. | Eur J Gastroenterol Hepatol
Aim: To explore the relationship between gastrointestinal symptoms and the severity of COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
1/18/21
Zhu JH, Peltekian KM | Can Liver J
Aim: To understand the impact of HBV coinfection on hospitalized patients with COVID-19.
CLINICAL CHARACTERISTICS
1/18/21
Martha JW, Wibowo A, Pranata R | Diabetes Metab Syndr
Aim: To evaluate the prognostic performance of hypocalcemia in patients with coronavirus disease 2019 (COVID-19).
UPDATED
CLINICAL CHARACTERISTICS
1/15/21
Shareef MA, Bashaiwth HM, AlAkbari AO, et al. | Avicenna J Med
Aim: To review the evidence on SARS-CoV-2 and HIV coinfection.
CLINICAL CHARACTERISTICS
1/15/21
Mohamadi M, Goodarzi A, Aryannejad A, et al. | Med J Islam Repub Iran
Aim: To review the evidence on SARS-CoV-2 infection complications in elderly individuals.
CLINICAL CHARACTERISTICS
1/15/21
Cirillo N, Bizzoca ME, Lo Muzio E, et al. | Acta Odontol Scand
Aim: To collect comprehensive data on the taste alterations prevalence worldwide and, precisely, in 16 countries.
CLINICAL CHARACTERISTICS
1/14/21
Zinellu A, Mangoini AA | J Clin Med
Aim: To review the evidence on the predictive role of the red blood cell distribution width (RDW), a routine hematological test, in patients with SARS-CoV-2 infection.
CLINICAL CHARACTERISTICS
1/13/21
Hassanipour S, Faradonbeh SB, Momeni K, et al. | Int J Reprod Biomed
Aim: To investigate the clinical manifestation include signs and symptoms, laboratory results, and perinatal outcomes in pregnant women with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
1/13/21
Oshay RR, Chen MYC, Fields BKK, et al. | Clin Imaging
Aim: To conduct a comprehensive systematic review of all existing literature regarding imaging findings on chest CT and associated clinical features in pregnant patients diagnosed with COVID-19.
CLINICAL CHARACTERISTICS
1/12/21
Soltani S, Tabibzadeh A, Zakeri A, et al. | Rev Neurosci
Aim: To systematically review the COVID-19 associated central nervous system manifestations, mental and neurological symptoms.
CLINICAL CHARACTERISTICS
1/11/21
Israfil SMH, Sarker MMR, Rashid PT, et al. | Front Public Health
Aim: To summarize the global clinical characteristics of the COVID-19 patients systematically and identify their diagnostic challenges to help the medical practitioners properly diagnose and for better management of COVID-19 patients. 
CLINICAL CHARACTERISTICS
1/11/21
Hariyanto TI, Japar KV, Kwenandar F, et al. | Am J Emerg Med
Aim: To evaluate the difference between these parameters in severe and nonsevere disease and to provide the optimal cutoff value for predicting severe disease.
CLINICAL CHARACTERISTICS
1/11/21
Zhao X, Gang X, He G, et al. | Front Endocrinol
Aim: To compare the impacts of obesity on the severity and mortality of influenza and COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
1/10/21
Lewis A, Frontera J, Placantonakis DG, et al. | J Neurol Sci
Aim: To review the literature on cerebrospinal fluid (CSF) testing in patients with COVID-19 for evidence of viral neuroinvasion by SARS-CoV-2.
CLINICAL CHARACTERISTICS
1/9/21
Mansourian M, Ghandi Y, Habibi D, et al. | Arch Pediatrie
Aim: To provide a meta-analysis of previously published papers on the COVID-19-related clinical features and laboratory findings in children.
CLINICAL CHARACTERISTICS
1/8/21
Aminian A, Tu C, et al. | Obes Surg
Aim: To measure the association between history of bariatric surgery and the severity of COVID-19.
CLINICAL CHARACTERISTICS
1/6/21
Islam MM, Poly TN, Walther BA, et al. | Front Med
Aim: To assess clinical manifestations and neonatal outcomes of pregnant women with COVID-19.
CLINICAL CHARACTERISTICS
1/6/21
Badawi A, Vasileva D | World J Clin Cases
Aim: To analyze and compare the profile of COVID-19 cases between China and North America as two regions that differ in many environmental, host and healthcare factors related to disease risk.
CLINICAL CHARACTERISTICS
1/6/21
Santos REA, da Silva MG, do Monte Silva MCB, et al. | Am J Otolaryngol
Aim: To conduct a systematic review of the literature to investigate the time of onset and duration of symptoms of loss of smell and taste in patients diagnosed with COVID-19.
CLINICAL CHARACTERISTICS
1/5/21
Ikeagwulonu RC, Obeta MU, Ugwu IN | New Zealand J Med Laboratory Sci
Aim: To review the evidence on reported changes in laboratory parameters in COVID-19 hospitalized patients that predict disease severity.
CLINICAL CHARACTERISTICS
1/5/21
Benito DA, Bestourous DE, Tong JY, et al. | Otolaryngol Head Neck Surg
Aim: To determine the cumulative incidences of decannulation and mechanical ventilation weaning in patients with coronavirus disease 2019 (COVID-19) who have undergone a tracheotomy. 
CLINICAL CHARACTERISTICS
1/5/21
Hashemi-madani N, Emami Z, Janani L, et al. | Clin Imaging
Aim: To assess the relationship between different chest CT features and severity of clinical presentation in COVID-19.
CLINICAL CHARACTERISTICS
1/4/21
Post N, Eddy D, Huntley C, et al. | PLoS One
Aim: To comprehensively evaluate the evidence describing the antibody response to SARS-CoV-2.
UPDATED
CLINICAL CHARACTERISTICS
1/4/21
Khamis AH, Jaber M, Azar A, et al. | J Formos Med Assoc
Aim: To systematically review all COVID-19 publications to summarize the clinical features, assess comorbidities, prevalence, and disease outcomes.
UPDATED
CLINICAL CHARACTERISTICS
1/4/21
Desai A, Gupta R, Advani S, et al. | Cancer
Aim: To assess the overall mortality in this population through a meta?analysis of published data on COVID?19 and cancer.
UPDATED
CLINICAL CHARACTERISTICS
1/4/21
Fu L, Liu X, Su Y, et al. | Clin Cardiol
Aim: To investigate prevalence of cardiac injury and its impact on the outcomes in patients with COVID?19.
CLINICAL CHARACTERISTICS
1/4/21
Del Zompo F, De Siena M, Ianiro G, et al. | Eur Rev Med Pharmacol Sci
Aim: To systematically review the prevalence of liver involvement in patients with SARS-CoV-2 infection at their hospital admission, and its correlation with disease severity and clinical outcomes in patients with or without pre-existing chronic liver disease.
CLINICAL CHARACTERISTICS
1/4/21
Liu H, Yang D, Chen X, et al.  | Cancer Med
Aim: To qualify the potential effects of anticancer therapies on the clinical outcomes, such as mortality, admission to the intensive care unit (ICU), and the severity of COVID?19, in patients with cancer infected with COVID?19.
UPDATED
CLINICAL CHARACTERISTICS
1/3/21
Cai R, Zhang J, Zhu Y, et al. | Int Urol Nephrol
Aim: To conduct a literature review and meta-analysis to understand the frequency of mortality among CKD patients infected with COVID-19.
CLINICAL CHARACTERISTICS
1/2/21
Liu N, Sun J, Wang X, et al. | Int J Infect Dis
Aim: To assess the association between low vitamin D status and COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
12/31/20
Chowdhary A, Subedi R, Tandon M | Brain Sci
Aim: To collect, analyze, and summarize the neurological findings in the MRI among patients with COVID-19
CLINICAL CHARACTERISTICS
12/31/20
Tian T, Huo X | J Infect Dev Ctries
Aim: To review the evidence on the secondary attack rate of SARS-CoV-2.
CLINICAL CHARACTERISTICS
12/30/20
Mehraeen E, Alinaghi SAS, Nowroozi A, et al. | Indian Heart J
Aim: To pinpoint different observed ECG findings and discuss their clinical significance.
CLINICAL CHARACTERISTICS
12/30/20
Lai X, Liu J, Zhang T, et al. | BMJ Open
Aim: To systematically assess the clinical, laboratory and imaging predictors as well as prediction models for severe or critical illness and mortality in patients with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
12/30/20
Dorrell R, Dourgherty MK, Barash EL, et al. | JGH Open
Aim: To characterize the prevalence of gastrointestinal (GI) and hepatic involvement in COVID?19 and specifically assess the prevalence of GI symptoms in isolation.
UPDATED
CLINICAL CHARACTERISTICS
12/30/20
Mondal R, Ganguly U, Deb S, et al. | J Neurovirol
Aim: To summarise the clinical profile, investigations and radiological findings among patients with SARS-CoV-2 associated meningoencephalitis.
UPDATED
CLINICAL CHARACTERISTICS
12/30/20
Brown WA, Moore EM, Watters DA | ANZ J Surg
Aim: To estimate the effect size of coronavirus disease 2019 (COVID-19) on post-operative mortality.
CLINICAL CHARACTERISTICS
12/30/20
Maharaj S, Alvarez MB, Mungul S, et al. | Laryngoscope Investig Otolaryngol
Aim: To describe otologic dysfunction in patients with the novel SARS?CoV?2.
CLINICAL CHARACTERISTICS
12/30/20
SeyedAlinaghi S, Oliaei S, Kianzad S, et al. | World J Virol
Aim: To summarize the recent findings and reports of COVID-19 reinfection in patients previously reCoVered from the disease.
CLINICAL CHARACTERISTICS
12/30/20
Parsay S, Vosoughi A, Khabbaz A, et al. | J Stroke Cerebrovasc Dis
Aim: To investigate the incidence of ischemic CVA and the mortality due to it in the setting of COVID-19.
CLINICAL CHARACTERISTICS
12/28/20
Pranata R, Henrina J, Lim MA, et al. | Arch Gerontol Geriatr
Aim: To quantify the dose-response relationship between CFS and mortality in COVID-19 patients.
CLINICAL CHARACTERISTICS
12/28/20
Hassani NS, Shojaee A, Khodaprast Z, et al. | J Intensive Care Med
Aim: To investigate the echocardiographic features of cardiac injury related to COVID-19 and their prognostic value.
CLINICAL CHARACTERISTICS
12/28/20
Aziz M, Goyal H, Haghbin H, et al. | Am J Med Sci
Aim: To evaluate the prevalence of “loss of smell” in COVID-19 as well as its utility for prognosticating the disease severity.
CLINICAL CHARACTERISTICS
12/28/20
Clement ND, Ng N, Simpson CJ, et al. | Bone Joint Res
Aim: To assess: 1) the prevalence of COVID-19 in hip fracture patients during the first wave of the pandemic; 2) the associated rate and risk of mortality compared to those without COVID-19; 3) the demographics associated with COVID-19-positive patients; 4) the time from the day of admission to diagnosis of COVID-19; and 5) length of follow-up after a diagnosis of COVID-19.
CLINICAL CHARACTERISTICS
12/23/20
Bhuiyan MU, Stiboy E, Hassan MZ, et al. | Vaccine
Aim: To review the evidence on the epidemiological and clinical characteristics of COVID-19 infection in children under five years.
UPDATED
CLINICAL CHARACTERISTICS
12/23/20
Scheen AJ | Diabetes Metab
Aim: To investigate the impact of previous statin therapy in patients hospitalized for COVID-19.
CLINICAL CHARACTERISTICS
12/22/20
Neef V, Buxmann H, Rabenau HF, et al. | Pediatr Neonatal
Aim: To characterize a large number of neonates delivered by rRT-PCR confirmed SARS-CoV-2 positive mothers.
CLINICAL CHARACTERISTICS
12/22/20
Fabrizi F, Alfieri CM, Cerutti R, et al. | Pathogens
Aim: To evaluate the frequency of AKI and dialysis requirement in patients who underwent hospitalization due to COVID-19.
CLINICAL CHARACTERISTICS
12/22/20
Rocha APD, Atallah ÁN, Pinto ACPN, et al. | Sao Paulo Med J
Aim: To assess whether patients undergoing pharmacological treatment for IMID present higher risk of worse outcomes when diagnosed with COVID-19.
CLINICAL CHARACTERISTICS
12/22/20
Rattka M, Dreyhaupt J, Winsauer C, et al. | Heart
Aim: To assess the mortality of patients with STEMI admitted during the COVID-19 pandemic.
UPDATED
CLINICAL CHARACTERISTICS
12/22/20
Bae S, Kim SR, Kim M, et al.  | Heart
Aim: To estimate the prevalence and risk factors for CVD among patients with COVID-19 in different age groups.
UPDATED
CLINICAL CHARACTERISTICS
12/22/20
Sarkar S, Khanna P, Singh A | J Med Virol
Aim: To evaluate the consequence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in patients with concurrent co-infections based on the publications reported to date.
UPDATED
CLINICAL CHARACTERISTICS
12/22/20
Tyrrell CSB, Mytton OT, Gentry SV, et al. | Thorax
Aim: To provide acute insights into the guidance on which patients are treated in ICU and receive ventilation during periods of high demand for ICU capacity during the COVID-19 pandemic.
UPDATED
CLINICAL CHARACTERISTICS
12/22/20
Mathioudakis AG, Fally M, Hashad R, et al. | Life
Aim: To describe the outcomes evaluated in 415 RCTs on the management of COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
12/22/20
Rabbani G, Islam SMS, Rahman MA, et al. | Expert Rev Respir Med
Aim: To investigate COVID-19 mortality and severity among patients with pre-existing COPD.
UPDATED
CLINICAL CHARACTERISTICS
12/22/20
Rodrigues C, Baía I, Domingues R, et al. | Front Public Health
Aim: To review knowledge on the impact of COVID-19 on pregnancy and describe the outcome of published cases of pregnant women diagnosed with COVID-19, as well as the characteristics of COVID-19 positive women who delivered in Portugal by 31 of March 2020. 
UPDATED
CLINICAL CHARACTERISTICS
12/22/20
July J, Pranata R | Geriatr Gerontol Int
Aim: To discover whether age, sex and other comorbidities might affect the association between dementia and mortality.
UPDATED
CLINICAL CHARACTERISTICS
12/22/20
Islam MA, Alam SS, Kundu S, et al. | Front Neurol
Aim: To conduct a comprehensive systematic review and meta-analysis to estimate the overall pooled prevalence of headache in COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
12/22/20
Viner RM, Ward J, Hudson L, et al. | Arch Dis Child
Aim: To undertake a systematic review of reviews of the prevalence of symptoms and signs of COVID-19 in those aged under 20 years.
UPDATED
CLINICAL CHARACTERISTICS
12/22/20
Wang B, Luo Q, Zhang W, et al. | Kidney Blood Press Res
Aim: To evaluate the association of chronic kidney disease (CKD) and acute kidney injury (AKI) with the clinical prognosis of patients with coronavirus disease 2019 (COVID-19).
CLINICAL CHARACTERISTICS
12/17/20
Zafari M, Rad MTS, Mohseni F, et al. | Hemoglobin
Aim: To determine mortality and morbidity of infected ?-thal patients with coronavirus disease 2019 (COVID-19).
CLINICAL CHARACTERISTICS
12/17/20
Wan J, Wang X, Su S, et al. | JGH Open
Aim: To investigate the exact prevalence of digestive symptoms and liver injury in COVID?19 patients and compare the difference between patients with and without digestive symptoms. 
CLINICAL CHARACTERISTICS
12/17/20
Suh YJ, Hong H, Ohana M, et al. | Radiology
Aim: To conduct meta-analysis of the study-level incidence of PE and DVT and to evaluate the diagnostic accuracy of D-dimer tests for PE from multicenter individual patient data. 
CLINICAL CHARACTERISTICS
12/17/20
Silver SA, Beaubien-Souligny W, Shah PS, et al. | Kidney Med
Aim: To determine the pooled prevalence of AKI and KRT among hospitalized patients with COVID-19.
CLINICAL CHARACTERISTICS
12/16/20
Thakkar S, Arora S, Kumar A, et al. | Clin Med Insights Cardiol
Aim: To provide a foundation for understanding the CV manifestations and outcomes of COVID-19.
CLINICAL CHARACTERISTICS
12/16/20
Lazarus G, Audrey J, Kharisma Wangsaputra V, et al. | Diabetes Res Clin Pract
Aim: To investigate the prognostic value of admission blood glucose (BG) in predicting COVID-19 outcomes, including poor composite outcomes (mortality/severity), mortality, and severity.
CLINICAL CHARACTERISTICS
12/16/20
Liu S, Cao Y, Du T, et al. | J Allergy Clin Immunol Pract
Aim: To investigate the asthma prevalence among COVID-19 patients and compare outcomes between asthma and non-asthma patients.
UPDATED
CLINICAL CHARACTERISTICS
12/16/20
Zhang R, Ni L, Di X, et al. | J Vasc Surg Venous Lymphat Disord
Aim: To identify the prevalence of VTE, PE, and DVT in consecutive hospitalized patients, ICU patients, and non-ICU patients with COVID-19 by a meta-analysis based on currently available clinical studies.
CLINICAL CHARACTERISTICS
12/16/20
Liu N, Zhang T, Ma L, et al. | Blood Rev
Aim: To elucidate the association between ABO blood group and increased COVID-19 morbidity and mortality.
CLINICAL CHARACTERISTICS
12/15/20
Moazzami B, Chaichian S, Kasaeian A, et al. | PLoS One
Aim: To assess the association of metabolic risk factors and risk of Covid-19.
CLINICAL CHARACTERISTICS
12/15/20
Siow I, Lee KS, Zhang JJY, et al. | J Stroke Cerebrovasc Dis
Aim: To evaluate the epidemiology, clinical course, and outcomes of patients who suffer from stroke as a complication of COVID-19.
CLINICAL CHARACTERISTICS
12/14/20
Ojha V, Verma M, Pandey NN, et al.  | J Thorac Imaging
Aim: To assess the important imaging features on CMR in patients diagnosed with COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
12/14/20
Liao S, Shao S, Cheng C, et al. | Crit Care
Aim: To review the evidence on the incidence and mortality rates after incident arrhythmia in COVID-19 patients.
CLINICAL CHARACTERISTICS
12/14/20
Novelli L, Motta F, De Santis M, et al. | J Autoimmun
Aim: To evaluate the COVID-19-related autoimmune/rheumatic disorders.
CLINICAL CHARACTERISTICS
12/12/20
Badawi AE, Elsheikh SS, Addeen SZ, et al. | J Curr Ophthalmol
Aim: To discuss the ocular manifestations provoked by novel coronavirus 2019 (COVID-19) disease in humans, the natural history of the disease in the eye, and its treatment.
CLINICAL CHARACTERISTICS
12/9/20
Sriwastava S, Kataria S, Tandon M, et al. | J Neurol Sci
Aim: To compare and summarize the demographics, clinical features, Brighton criteria, immunological and laboratory findings with a focus on modified Erasmus GBS Outcome Score (mEGOS) in SARS-CoV-2 patients with GBS and its variants.
CLINICAL CHARACTERISTICS
12/8/20
Keshavarz P, Rafiee F, Kavandi H, et al. | Clin Imaging
Aim: To review the clinical and radiologic features of GI ischemia and its related complications in thirty-one COVID-19 patients reported in literature.
CLINICAL CHARACTERISTICS
12/8/20
Badal S, Bajgain KT, Badal S, et al. | J Clin Virol
Aim: To conduct a comprehensive meta-analysis and systematic review to collect and analyze current evidence about COVID-19 in the pediatric population.
CLINICAL CHARACTERISTICS
12/2/20
Loomba RS, Aggarwal G, Villarreal EG, et al. | Blood Coagul Fibrinolysis
Aim: To compare laboratory results in COVID-19 patients with and without DVT with the aim of identifying risk factors for DVT in this population.
CLINICAL CHARACTERISTICS
12/1/20
Yang J, Tian C, Chen Y, et al. | J Med Virol
Aim: To evaluate the impact of obesity on the onset, exacerbation, and mortality of coronavirus disease 2019 (COVID?19); and compare the effects of different degrees of obesity. 
UPDATED
CLINICAL CHARACTERISTICS
11/27/20
Zhang X, Yang X, Jiao H, et al. | Aging
Aim: To investigate the role of coagulation dysfunction in the severity of COVID-19 progression.
CLINICAL CHARACTERISTICS
11/27/20
Asadi-Pooya AA, Simani L, Shahisavandi M, et al. | Neurol Sci
Aim: To discuss the evidence on the occurrence of de novo seizures in patients with COVID-19, the consequences of this catastrophic disease in people with epilepsy (PWE), and the electroencephalographic (EEG) findings in patients with COVID-19.
CLINICAL CHARACTERISTICS
11/27/20
Rostami A, Sepidarkish M, Leeflang MMG, et al. | Clin Microbiol Infect
Aim: To estimate the global and regional seroprevalence rates in humans of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and to assess whether seroprevalence is associated with geographical, climatic and/or sociodemographic factors.
CLINICAL CHARACTERISTICS
11/26/20
Lombardi A, Asahi AM, Gupta A, et al.  | Radiol Med
Aim: To review the most common extra-pulmonary manifestations of SARS, Influenza, MERS, and COVID-19.
CLINICAL CHARACTERISTICS
11/25/20
Vakhshoori M, Heidarpour M, Shafie D, et al. | Arch Iran Med
Aim: To analyze the available COVID-19 data on acute cardiac injury, using troponin and brain natriuretic peptide (BNP) levels.
CLINICAL CHARACTERISTICS
11/25/20
Yang X, Tian S, Guo H | Int Immunopharmacol
Aim: To gain clarity regarding AKI incidence and renal replacement therapy (RRT) use in COVID-19 patients.
CLINICAL CHARACTERISTICS
11/25/20
Chu C, Zeng S, Hasan AA, et al. | Br J Clin Pharmacol
Aim: To review the evidence on the effect of RAAS blockers on the expression of ACE2 and the risk of SARS-Cov-2 infection.
CLINICAL CHARACTERISTICS
11/25/20
Sameni F, Hajikhani B, Yaslianifard S, et al. | Front Med
Aim: To provide a systematic review and meta-analysis of various skin manifestations among patients with COVID-19 through case reports/case series and prevalence studies.
CLINICAL CHARACTERISTICS
11/25/20
Jindal R, Chauhan P | J Family Med Prim Care
Aim: To describe the cutaneous manifestations of COVID-19 patients from diverse regions with the aim of highlighting any important associations.
CLINICAL CHARACTERISTICS
11/25/20
Kiss S, Gede N, Hegyi P, et al. | Med Microbiol Immunol
Aim: To review the evidence on the correlation between early changes in the laboratory parameters and the clinical outcomes of COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
11/25/20
Wang KC, Xiao R, Cheung ZB, et al. | J Orthop
Aim: To assess the risk of early mortality in hip fracture patients with COVID-19 infection who undergo surgical intervention.
CLINICAL CHARACTERISTICS
11/25/20
Li B, Zhang S, Zhang R, et al. | Front Pediatr
Aim: To evaluate the epidemiological spectrum and clinical characteristics of children infected with SARS-CoV-2.
UPDATED
CLINICAL CHARACTERISTICS
11/25/20
Jiménez D, García-Sanchez A, Rali P, et al. | Chest
Aim: To review the evidence on the incidence of VTE and bleeding among hospitalized patients with COVID-19?
UPDATED
CLINICAL CHARACTERISTICS
11/25/20
Saniasiaya J, Islam MA, Abdullah B | Laryngoscope
Aim: To estimate the overall pooled prevalence of olfactory dysfunction in COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
11/25/20
Singh AK, Jena A, Kumar-M P, et al. | United European Gastroenterol J
Aim: To review the evidence on the risk of severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) infection and clinical outcomes of coronavirus disease (COVID-19) in inflammatory bowel disease.
CLINICAL CHARACTERISTICS
11/25/20
Galanis P, Vraka I, Fragkou D, et al. | J Hosp Infect
Aim: To determine the seroprevalence of SARS-CoV-2 antibodies among HCWs, and to find out the factors that are associated with this seroprevalence.
UPDATED
CLINICAL CHARACTERISTICS
11/25/20
Katsanos AH, Palaiodimou L, Zand R, et al. | Ann Neurol
Aim: To evaluate the potential impact of coronavirus disease (COVID-19) on the management and outcomes of acute stroke.
CLINICAL CHARACTERISTICS
11/24/20
Chang PC, Yang CC, Kao KC, et al  | Aging
Aim: To compare clinical outcomes in patients hospitalized for COVID-19 with those of patients hospitalized for SARS.
CLINICAL CHARACTERISTICS
11/24/20
Novoa RH, Quintana W, Llancarí P, et al. | Travel Med Infect Dis
Aim: To review all cases from the current literature and provide up-to-date scientific evidence on the clinical characteristics, maternal outcomes, perinatal outcomes and the possibility of vertical transmission in the infected pregnant women.
UPDATED
CLINICAL CHARACTERISTICS
11/23/20
Zhang J, Wang H, Wei M, et al.  | Aging
Aim: To assess the incidence of cerebrovascular disease as a comorbidity in COVID-19 patients.
CLINICAL CHARACTERISTICS
11/20/20
Ji P, Zhu J, Zhong Z, et al. | Medicine
Aim: To review the evidence on the potential association between inflammatory markers and severe COVID-19.
CLINICAL CHARACTERISTICS
11/20/20
Bin Arif T, Khalid S, Siddiqui MS, et al. | Hong Kong Med J
Aim: To provide insight into the incidence, patterns, risk factors, histopathological findings, and relationship with disease severity of COVID-19-associated liver injury.
CLINICAL CHARACTERISTICS
11/20/20
Vijenthira A, Gong IY, Fox TA, et al. | Blood
Aim: To perform a systematic review and meta-analysis to estimate the risk of death and other important outcomes for patients with hematologic malignancy infected with COVID-19 .
CLINICAL CHARACTERISTICS
11/20/20
Wang C, Zhang H, Zhou M, et al. | Eur Rev Med Pharmacol Sci
Aim: To explore the relationship between the prognosis of COVID-19 patients and thromboembolic events.
CLINICAL CHARACTERISTICS
11/20/20
Tsankov BK, Allaire JM, Irvine MA, et al  | Int J Infect Dis
Aim: To investigate the effects of pediatric comorbidities on COVID-19 severity. 
CLINICAL CHARACTERISTICS
11/20/20
Dorantes-Acosta E, Ávila-Montiel D, Klünder-Klünder M, et al. | Bol Med Hosp Infant Mex
Aim: To analyze the available data associated with COVID-19 infection and mortality in pediatric cancer patients and to provide useful information to plan and design strategies in this group.
CLINICAL CHARACTERISTICS
11/19/20
Haque A, Minhaj A, Ahmed A, et al. | AIMS Medical Science
Aim: To analyze the prevalence of thromboembolic events in the hospitalized COVID-19 patients.
CLINICAL CHARACTERISTICS
11/19/20
Kashour T, Abdulhak AAB, Tlayjeh H, et al. | Am J Ther
Aim: To review the evidence on the association between prior use of ACEIs and ARBs and mortality due to COVID-19 disease.
CLINICAL CHARACTERISTICS
11/19/20
Ouyang L, Gong Y, Zhu Y, et al. | Am J Emerg Med
Aim: To explore the relationship of acute kidney injury (AKI) with the severity and mortality of coronavirus disease 2019 (COVID-19).
CLINICAL CHARACTERISTICS
11/19/20
Kubjane M, McCreedy N, Cariou B, et al. | Endocrinol Metab
Aim: To investigate the association between diabetes and COVID-19 disease severity in patients hospitalized due to COVID-19.
CLINICAL CHARACTERISTICS
11/19/20
Cheruiyot I, Kipkorir V, Ngure B, et al. | Am J Emerg Med
Aim: To evaluate whether malignancies are associated with a significantly enhanced odds of COVID-19 severity and mortality.
CLINICAL CHARACTERISTICS
11/19/20
Udomsinprasert W, Jittikoon J, Sangroongruangsri S, et al. | J Clin Immunol
Aim: To determine associations of circulating levels of inflammatory cytokines with severity and mortality of COVID-19 by systematic review and meta-analysis.
CLINICAL CHARACTERISTICS
11/19/20
Sze S, Pan D, Nevill CR, et al. | EClinicalMedicine
Aim: To determine whether the risk of SARS-CoV-2 infection, COVID-19 intensive care unit (ICU) admission and mortality are associated with ethnicity. 
UPDATED
CLINICAL CHARACTERISTICS
11/19/20
Meng M, Zhao Q, Kumar R, et al. | Aging
Aim: To review the evidence on the effects of coronary heart disease (CHD), hypertension and diabetes on the development of severe COVID-19. 
CLINICAL CHARACTERISTICS
11/19/20
Yang J, Tian C, Chen Y, et al. | J Med Virol
Aim: To explore the relationship between obesity and COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
11/19/20
Li X, Liu C, Mao Z, et al. | Crit Care
Aim: To evaluate the predictive values of NLR on disease severity and mortality in COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
11/19/20
Wu T, Zou Z, Yang D, et al. | Age Aging
Aim: To explore the factors associated with prevalence of venous thromboembolism (VTE) in COVID-19 patients.
UPDATED
CLINICAL CHARACTERISTICS
11/18/20
Abdulla S, Hussain A, Azim D, et al. | Cureus
Aim: To draw generalized conclusions regarding impaired liver biochemistry and its potential relationship with COVID-19 disease severity.
CLINICAL CHARACTERISTICS
11/18/20
Bansal A, Kumar A, Patel D, et al. | Am J Cardiol
Aim: To evaluate the association between cardiac injury and all-cause mortality, intensive care unit (ICU) admission, mechanical ventilation, acute respiratory distress syndrome, acute kidney injury and coagulopathy.
CLINICAL CHARACTERISTICS
11/18/20
Koshy AN, Murphy AC, Farouque O, et al. | Intern Med J
Aim: To investigate whether RAS inhibitors increased the likelihood of a positive test or death/severe illness in patients with COVID-19.
CLINICAL CHARACTERISTICS
11/17/20
Yonas E, Alwi I, Pranata R, et al. | Diabetes Metab Syndr
Aim: To comprehensively study the various levels of immunological parameters in patients with COVID 19.
CLINICAL CHARACTERISTICS
11/16/20
Raharja A, Tamara A, Kok LT | J Racial Ethn Health Disparities
Aim: To review the association between ethnicity and poor Covid-19 outcomes including all-cause mortality, hospitalisation, critical care admission, respiratory and kidney failure.
UPDATED
CLINICAL CHARACTERISTICS
11/16/20
Wong CKH, Wong JYH, Tang EHM, et al. | Sci Rep
Aim: To investigate the comorbidities, symptoms, clinical characteristics and treatment of COVID-19 patients. 
UPDATED
CLINICAL CHARACTERISTICS
11/16/20
Kouhsari F, Azizian K, Sholeh M, et al. | Indian J Med Microbiol
Aim: To review data of the novel Coronavirus (2019-nCoV) by analyzing all the published retrospective studies on the clinical, epidemiological, laboratory, and radiological characteristics of patients with 2019-nCoV.
CLINICAL CHARACTERISTICS
11/16/20
Yang Q, Yang X | PLoS One
Aim: To evaluate the association of kidney impairment with the development of COVID-19.
CLINICAL CHARACTERISTICS
11/16/20
Juhasz MF, Ocskay K, Kiss S, et al. | World J Gastroenterol
Aim: To assess all the available evidence in the literature relating to coronavirus disease 2019 (COVID-19) and AP.
UPDATED
CLINICAL CHARACTERISTICS
11/16/20
Akin H, Kurt R, Tufan F, et al. | Diseases
Aim: Too present the currently available data regarding the GI symptoms of COVID-19 patients, and to compare the frequency of GI symptoms in early stage (Eastern) mostly Chinese data to the current stage (Western) non-Chinese data. 
CLINICAL CHARACTERISTICS
11/16/20
Bustos R, Jaramillo-Bustamante JC, Vasquez-Hoyos P, et al. | Pediatr Emerg Care
Aim: To review the evidence on pediatric inflammatory multisystem syndrome associated with SARS-CoV-2.
CLINICAL CHARACTERISTICS
11/16/20
Pinedo-Torres I, Flores-Fernandez M, Yovera-Aldana M, et al. | Clin Med Insights Endocrinol Diabetes
Aim: To determine the prevalence of diabetes comorbidity and its associated unfavorable health outcomes in patients with acute respiratory syndromes for coronavirus disease according to virus types.
UPDATED
CLINICAL CHARACTERISTICS
11/14/20
Zou H, Lu J, Liu J, et al. | Int J Infect Dis
Aim: To collect current evidence on pediatric PMIS and provide insights into pathogenesis, hopefully, providing possible clues for further research and treatment at this moment.
CLINICAL CHARACTERISTICS
11/13/20
Haiduc AA, Ogunjimi M, Shammus R, et al. | Cardiol Young
Aim: To examine the literature to determine if both paediatric and adult patients diagnosed with congenital heart disease (CHD) are at a higher risk of poor outcomes if they have the coronavirus disease 2019 (COVID-19), compared to those without CHD.
CLINICAL CHARACTERISTICS
11/13/20
Kubota T, Kuroda N | Clin Neurol Neurosurg
Aim: To evaluate the severity of COVID-19 and its effect on neurological symptoms in patients with preexisting neurological disorder and COVID-19.
CLINICAL CHARACTERISTICS
11/13/20
Bellos I, Pandita A, Panza R | Eur J Obstet Gynecol Reprod Biol
Aim: To evaluate maternal and neonatal outcomes in covid-19 pregnancies and identify factors associated with perinatal viral transmission.
CLINICAL CHARACTERISTICS
11/13/20
Lin L, Wang X, Ren J, et al. | BMJ Open
Aim: To analyse the incidence, risk factors and impact of acute kidney injury (AKI) on the prognosis of patients with COVID-19.
CLINICAL CHARACTERISTICS
11/12/20
Vardhelli V, Pandita A, Pillai A, et al. | Eur J Pediatr
Aim: To summarize available literature on the clinical spectrum of COVID-19 in neonates and mothers and suggest a practical approach towards management of clinical scenarios.
CLINICAL CHARACTERISTICS
11/12/20
Li P, Wang Y, Peppelenbosch MP, et al. | Int J Infect Dis
Aim: To comprehensively compare the clinical features of hospitalized COVID-19 patients with hospitalized 2009 influenza pandemic patients.
CLINICAL CHARACTERISTICS
11/11/20
Kuswardhani RAT, Henrina J, Pranata R, et al. | Diabetes Metab Syndr
Aim: To assess the association between CCI and a composite of poor outcomes in COVID-19 patients.
CLINICAL CHARACTERISTICS
11/11/20
Zuin M, Guasti P, Roncon L, et al. | Int J Geriatr Psychiatry
Aim: To evaluate the mortality risk in elderly patients with dementia and COVID?19 infection.
CLINICAL CHARACTERISTICS
11/11/20
Aziz M, Haghbin H, Lee-Smith W, et al. | Ann Gastroenterol
Aim: To review the evidence on the gastrointestinal predictors of severe COVID-19.
CLINICAL CHARACTERISTICS
11/11/20
Choi Y, Lee MK | Eur J Radiol
Aim: To comprehensively evaluate the incidences of abnormal neuroimaging findings in patients with COVID-19 via a systematic review and meta-analysis.
CLINICAL CHARACTERISTICS
11/11/20
Mudatsir M, Fajar JK, Wulandari L, et al. | F1000
Aim: To identify the predictors associated with poor clinical outcomes in patients with COVID-19.
CLINICAL CHARACTERISTICS
11/9/20
Alimohamadi Y, Sepandi M, Taghdir M, et al.  | J Prev Med Hyg
Aim: To estimate the prevalence of clinical symptoms of COVID-19 in a systematic review and meta-analysis.
CLINICAL CHARACTERISTICS
11/9/20
Ye L, Yang Z, Liu J, et al. | J Gastroenterol Hepatol
Aim: To highlight the gaps in our knowledge about the prevalence and clinical significance of GI symptoms in patients with COVID-19.
CLINICAL CHARACTERISTICS
11/9/20
Aggarwal K, Agarwall A, Jaiswal N, et al.  | PLoS ONE
Aim: To evaluate the epidemiology and clinical features of ocular surface manifestations and complications related to COVID-19 infection, to assess the risk of transmission to patients and healthcare workers through ocular secretions and to determine whether ocular involvement has any correlation with the severity of respiratory symptoms and overall prognosis.
UPDATED
CLINICAL CHARACTERISTICS
11/9/20
Hasan I, Rashid T, Suliman S, et al. | Rom J Intern Med
Aim: To review the evidence on COVID-19 in kidney transplant recipients.
CLINICAL CHARACTERISTICS
11/9/20
Ssentongo A, Ssentongo P, Heilbrunn E, et al | Open Heart
Aim: To explore the association of RAAS inhibitors, including angiotensin-converting inhibitors (ACEi) and angiotensin II receptor blockers (ARBs) with COVID-19 mortality in patients with hypertension. 
UPDATED
CLINICAL CHARACTERISTICS
11/9/20
Matsushita K, Ding N, Kou M, et al. | Glob Heart
Aim: To explore pre-existing CVD and its traditional risk factors as risk factors of severe COVID-19 (defined as death, acute respiratory distress syndrome, mechanical ventilation, or intensive care unit admission). 
UPDATED
CLINICAL CHARACTERISTICS
11/9/20
Sridharan GK,  Vegunta R, Rokkam VRP, et al. | Am J Ther
Aim: To examine and appraise the incidence of VTE, major VTE, PE, and DVT in hospitalized COVID-19 patients by meta-analysis methods and, in particular, analyze whether the use of therapeutic anticoagulation decreased the odds of thromboembolic events compared with prophylactic anticoagulation.
CLINICAL CHARACTERISTICS
11/5/20
Crestani NG, Zhou JY, von Drygalski A, et al. | Blood
Aim: To estimate the actual incidences of VTE (including pulmonary embolism (PE), deep vein thrombosis (DVT)) during hospitalization for COVID-19.
CLINICAL CHARACTERISTICS
11/4/20
Wu Z, Yang D | Eur J Med Res
Aim: To explore the probable clinical severity and mortality of COVID-19 patients and their liver dysfunction.
CLINICAL CHARACTERISTICS
11/3/20
Zhou Y, Ren Q, Chen G, et al.  | Front Med
Aim: To review the evidence on the clinical characteristics of COVID-19 patients, with a focus on the prevalence of CKD and AKI, as well as their association with poor prognosis.
CLINICAL CHARACTERISTICS
11/3/20
Lakbar I, Luque-Paz D, Mege J, et al. | PLoS One
Aim: To systematically review the literature relating to men versus women on SARS-CoV-2 in order to seek differences in disease characteristics (e.g. infectivity, severity) and outcomes (e.g. mortality).
CLINICAL CHARACTERISTICS
11/3/20
Mesas AE, Cavero-Redondo I, Alvarez-Bueno C, et al. | PLoS One
Aim: To synthesize the results of primary studies and provide pooled effect size estimators for a comprehensive set of potential predictors of in-hospital mortality in patients with confirmed COVID-19.
UPDATED
CLINICAL CHARACTERISTICS
11/3/20
Lane MY, Winters N, Fregonese F, et al. | PLoS One
Aim: To conduct a systematic review and meta-analysis on the proportion of asymptomatic infection among coronavirus disease 2019 (COVID-19) positive persons and their transmission potential.